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Abstract 
Due to the escalating challenge of antibiotic resistance in bacteria over the past several 
decades, interest in the identification and development of antibiotic alternatives has intensified. 
Antimicrobial peptides (AMPs), which serve as part of the innate immune systems of most 
eukaryotic organisms, are being researched extensively as potential alternatives. However, the 
mechanism behind their bactericidal capabilities is not well understood.  Previous studies have 
suggested that AMPs may first attach to the cell membranes, leading to pore formation caused by 
peptide insertion, lipid removal in the form of peptide-lipid aggregates, or a combination of both 
mechanisms. In addition to the lack of mechanistic knowledge, a significant hurdle in AMP-
based drug development is their potential cytotoxicity to mammalian cells. Understanding AMP 
interactions with eukaryotic model membranes would allow therapeutics to be tailored for 
preferential action toward specific classes of bacterial membranes. In this study, we developed 
novel methods of quartz crystal microbalance with dissipation monitoring (QCM-D) data 
analysis to determine the fundamental mechanism of action between eukaryotic and bacterial 
membrane mimics and select membrane-active AMPs. A new technique for creating supported 
membranes composed entirely of anionic lipids was developed to model Gram-positive bacterial 
membranes. Atomic force microscopy (AFM) imaging was also used to capture the progression 
of AMP-induced changes in supported lipid membranes over time and to validate our method of 
QCM-D analysis.  
QCM-D and AFM were used to investigate the molecular-scale interactions of four 
peptides, alamethicin, chrysophsin-3, sheep myeloid antimicrobial peptide (SMAP-29) and 
indolicidin, with a supported zwitterionic membrane, which served as a model for eukaryotic cell 
membranes. Since established methods of QCM-D analysis were not sufficient to provide 
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information about these interaction mechanisms, we developed a novel method of using QCM-D 
overtones to probe molecular events occurring within supported lipid membranes. Also, most 
previous studies that have used AFM imaging to investigate AMP-membrane interactions have 
been inconclusive due to AFM limitations and poor image quality. We were able to capture high-
resolution AFM images that clearly show the progression of AMP-induced defects in the 
membrane. 
Each AMP produced a unique QCM-D signature that clearly distinguished their 
mechanism of action and provided information on peptide addition to and lipid removal from the 
membrane. Alamethicin, an -helical peptide, predominantly demonstrated a pore formation 
mechanism. Chrysophsin-3 and SMAP-29, which are also -helical peptides of varied lengths, 
inserted into the membrane and adsorbed to the membrane surface. Indolicidin, a shorter peptide 
that forms a folded, boat-shaped structure, was shown to adsorb and partially insert into the 
membrane. An investigation of rates at which the peptide actions were initiated revealed that the 
highest initial interaction rate was demonstrated by SMAP-29, the most cationic peptide in this 
study. The mechanistic variations in peptide action were related to their fundamental structural 
properties including length, net charge, hydrophobicity, hydrophobic moment, accessible surface 
area and the probability of α-helical secondary structures.  
Due to the charges associated with anionic lipids, previous studies have not been 
successful in forming consistent anionic supported lipid membranes, which were required to 
mimic Gram-positive bacterial membranes. We developed a new protocol for forming anionic 
supported lipid membranes and supported vesicle films using a vesicle fusion process. 
Chrysophsin-3 was shown to favor insertion into the anionic lipid bilayer and did not adsorb to 
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the surface as it did with zwitterionic membranes. When introduced to supported anionic vesicle 
films, chrysophsin-3 caused some vesicles to rupture, likely through lipid membrane disruption. 
This study demonstrated that molecular-level interactions between antimicrobial peptides 
and model cell membranes are largely determined by peptide structure, peptide concentration, 
and membrane lipid composition. Novel techniques for analyzing QCM-D overtone data were 
also developed, which could enable the extraction of more molecular orientation and interaction 
dynamics information from other QCM-D studies. A new method of forming supported anionic 
membranes was also designed, which may be used to further investigate the behavior of bacterial 
membranes in future studies. Insight into AMP-membrane interactions and development of AMP 
structure-activity relationships will facilitate the selection and design of more efficient AMPs for 
use in therapeutics that could impact the lives of millions of people per year who are threatened 
by antibiotic-resistant organisms.  
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1.1 Research motivation 
Antibiotics have served as a valuable tool in the fight against infections for the last 70 
years, but their wide usage has allowed pathogens to adapt against them, making the drugs less 
effective. The CDC estimates that every year, more than 2 million people are sickened by 
antibiotic resistant infections and at least 23,000 die as a result.1 Patients can become infected 
with antibiotic resistant pathogens through contact with multiple sources, including hospital 
environments and meat products derived from animals that are given antibiotics to treat disease 
and improve growth. These illnesses typically require prolonged or more expensive treatments 
and have a greater risk of disability and death than infections that respond to antibiotic therapy. 
The resulting healthcare costs have been estimated to be as high as $20 billion/year with an 
additional cost to society of $35 billion/year due to lost productivity.1 Clearly, antibiotics must 
be replaced with alternatives that are equally as effective at killing pathogens but do not cause 
the same level of resistance. 
Antimicrobial peptides (AMPs) are being actively researched for their potential as an 
alternative to antibiotics. AMPs are naturally derived molecules that form part of the innate 
immune system in most eukaryotic organisms. Approximately 2,000 AMPs have been isolated 
from natural sources such as frogs, moths, or fungi.2 Many of these peptides are membrane-
active, meaning that they kill bacteria by destabilizing their membranes and causing the cells to 
lyse. Due to their unique bactericidal mechanism, they do not cause the same level of resistance 
as antibiotics. To resist the action of AMPs, bacteria must significantly alter the compositions of 
their membranes, develop a mechanism to degrade the peptides through proteolysis, or extrude 
the peptides from the cell.3 Using similar mechanisms, AMPs are also able to kill cancer cells 
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and microbes that are resistant to antibiotics.4-6 Oncolytic AMPs, for instance, are thought to 
disrupt plasma membranes of target tumor cells or destabilize mitochondrial membranes.2 
Although AMPs are thought to kill pathogens by disrupting their membranes, the exact 
mechanism behind the membrane destabilization is not fully understood. Theoretical models of 
AMP-membrane interactions suggest that some AMPs may insert into cell membranes and form 
pores, allowing large molecules to enter and exit the cell.7 The formation of large pores may also 
disturb ion gradients, thereby killing the cell. Other theories postulate that AMPs may adsorb to 
the membrane surface and rearrange the lipid molecules to form micelles or peptide-lipid 
aggregates that can leave the membrane, causing it to disintegrate.8 Variations of these two 
primary models postulate that the mechanism of action depends on the peptide concentration and 
structure.9 
Understanding AMP-membrane interactions and the role of AMP structural 
characteristics in determining their action is crucial for the selection and design of AMPs for use 
in therapeutics. Before these peptides can be approved as drugs, their effects on both pathogens 
and patients must be fully understood. Therefore, investigations of AMP interactions must be 
conducted on at least two types of membranes: eukaryotic and bacterial.  
Studying AMP-membrane interactions could also provide valuable information about 
how bacteria are unable to develop resistance to AMPs and give clues about other peptide-lipid 
interactions in biological systems. The membrane destabilization mechanism used by AMPs is 
believed to hinder the development of bacterial resistance, but understanding the factors behind 
this phenomenon will enable us to design novel peptides that have the same robust properties. 
Peptides in general (not necessarily antimicrobial) also play a large role in biological systems as 
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signaling molecules (e.g. neuropeptides) and fundamental knowledge about how they interact 
with lipid membranes can be valuable in designing other types of therapeutics or understanding 
biological systems in general. 
 Our research is driven by increasing interest in selecting and designing AMPs to target 
and kill specific pathogens. To accomplish this, we must first develop a fundamental 
understanding of AMP interactions with eukaryotic and bacterial membranes on a molecular 
level. Our aims in this study were to: 
1. Develop a method for analysis of quartz crystal microbalance with dissipation 
monitoring (QCM-D) data that will enable the characterization of interactions 
between 4 AMPs (chrysophsin-3, indolicidin, alamethicin, SMAP-29) and a zwitterionic 
membrane that models an eukaryotic membrane. At the start of this study, a method of 
QCM-D interpretation that could give detailed information about molecular-scale 
membrane interactions did not exist. We therefore developed an analysis method that 
helped us derive mechanistic models and infer details about the dynamics of AMP-
membrane interactions. 
2. Use atomic force microscopy (AFM) to image AMP-induced changes in a supported 
lipid membrane and relate the observed interactions to our mechanistic models derived 
from QCM-D results. By using AFM to capture visible AMP-induced changes to a lipid 
membrane, we could validate the QCM-D analysis method developed in Aim 1. 
3. Develop a novel procedure for forming a fully anionic supported lipid bilayer, which 
models a Gram-positive bacterial membrane, and determine the mechanism of action of 
AMPs on this membrane. Previous studies have had limited success with forming 
bilayers composed entirely of lipids with anionic headgroups, which is an invaluable 
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system for studying Gram-positive bacterial membrane behavior. We developed a simple 
method for forming these membranes and examined the action of various AMP 
concentrations on 3 different anionic lipid membrane systems. 
The following sections of this document focus on the completion and results of these aims. The 
implications of this study with respect to understanding AMP-membrane interactions for future 
applications are also discussed. 
1.2  Research summary 
Chapter 2 contains a literature review of AMPs and QCM-D. Structural characteristics 
unique to AMPs are discussed, as well as potential applications and limitations as therapeutics. 
QCM-D is one of the main techniques used in this study to examine AMP-membrane 
interactions and the theory behind QCM-D is presented in this chapter. More in-depth data 
presentation and analysis methods that were developed during this study are introduced in the 
following chapters. 
Chapter 3 represents the culmination of our investigation of AMP action on eukaryotic 
membrane mimics. The membrane interactions of four peptides: alamethicin, chrysophsin-3, 
indolicidin, and sheep myeloid antimicrobial peptide (SMAP-29) were examined and related to 
their unique structural properties. Since previous methods of QCM-D overtone interpretation did 
not give sufficient information about the structural organization of surface supported membranes 
that was necessary for our work, we developed a novel method of QCM-D overtone 
interpretation. This QCM-D analysis technique enabled us to infer detailed information about 
molecular processes occurring within lipid bilayers during interactions with AMPs.  
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Chapter 4 describes an in-depth study on chrysophsin-3 action on zwitterionic 
membranes that laid the groundwork for the work presented in Chapter 3 and is provided for the 
reader’s reference. This chapter discusses the theory behind QCM-D overtone analysis and 
documents our early work with examining AMP-membrane interactions. The QCM-D results for 
chrysophsin-3 in this study are included as one of the AMPs presented in Chapter 3. 
Chapter 5 documents an in-depth examination of alamethicin action on zwitterionic 
membranes that built upon the QCM-D analysis process explored in Chapter 4 and is also 
provided for the reader’s reference. In this study, we calculated bilayer and peptide-induced pore 
properties from QCM-D results, allowing us to further develop our QCM-D interpretation 
methods. The QCM-D results shown in this study for alamethicin action on zwiitterionic 
membranes are also presented in Chapter 3 as one of the 4 experimental AMPs. 
Chapter 6 presents an AFM study on AMP action on zwitterionic membranes and 
expands on the work presented in Chapters 3, 4 and 5. AFM imaging of morphological changes 
in lipid bilayers resulting from exposure to alamethicin and indolicidin was used to validate the 
suggested models derived from the QCM-D experiments. Visual evidence of pore formation and 
mass loss from the membrane at concentrations were compared to processes identified in our 
mechanistic models. 
Chapter 7 documents our attempts at developing a technique to create supported lipid 
membranes composed purely of anionic lipids. We performed a preliminary screening study to 
examine the bilayer-forming capabilities of various lipid compositions, buffers, vesicle sizes, and 
surface treatments. Membrane formation was monitored using QCM-D and three successful 
anionic lipid membrane systems were chosen (based on similarity of the QCM-D responses to 
those of the zwitterionic lipid membrane formation that was detailed in Chapters 3 and 4) for 
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further examination and verification of bilayer formation. Chrysophsin-3 action on these anionic 
lipid films was monitored using QCM-D to demonstrate the capability of these films as bacterial 
membrane mimics. Interactions between chrysophsin-3 on anionic and zwitterionic membranes 
were also compared. 
Chapter 8 presents the overall conclusions from this project and identifies how the 
techniques developed in this study can benefit future research. Recommendations are made for 
future studies on AMP-membrane interactions and the potential for AMP use in therapeutics is 
discussed.  
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Chapter 2 
Antimicrobial Peptides and QCM-D 
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2.1  Antimicrobial peptides  
AMPs are naturally occurring molecules that can be chemically synthesized or derived 
from various organisms, including frogs and moths.1, 2 Australian tree frogs, for instance, secrete 
a wealth of AMPs, such as maculatin 1.1, from their skin when exposed to surface electrical 
shocks or pharmacological stimulation (e.g. adrenaline).3, 4 Over 2,000 naturally occurring AMPs 
have been identified and shown to kill a broad spectrum of pathogenic bacteria, fungi, and 
viruses.5 Many of these peptides protect their hosts against bacterial infection primarily by 
disturbing the membrane and causing the cells to lyse. AMPs are thought to be able to target 
bacteria over mammalian cells due to different membrane characteristics. Detailed knowledge of 
the mechanism behind AMP action on both bacterial and mammalian cells is essential for 
developing effective AMPs for use in therapeutics. 
AMPs can exhibit a wide range of different structural characteristics that are thought to 
influence their interactions with cell membranes. Each AMP’s unique amino acid sequence may 
lend charges to the molecule, enabling cationic AMPs to target anionic cell membranes, for 
example. Techniques such as circular dichroism (CD) and nuclear magnetic resonance (NMR) 
spectroscopy have been used to determine the secondary structures of antimicrobial peptides.6-8 
Many membrane-active AMPs exhibit random structural conformations in solution and form -
helical structures when in contact with biological membranes.9 Some cationic AMPs that are rich 
in cysteine residues, such as protegrins, can adopt -sheet structures by stabilizing the structure 
with disulfide bond formation.5 Other peptides do not exhibit a specific motif due to 
intramolecular interactions and high concentrations of specific residues that may limit their 
structure. Indolicidin, for instance, contains a large number of tryptophan residues and assumes a 
folded, boat-shaped structure due to intramolecular cation- electron interactions.8, 10, 11 
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Calculating the solvent accessible surface area (ASA) of component amino acid residues using 
the web-based tool NetsurfP also gives clues about the conformation of AMPs.12 ASA gives 
information about the level of exposure or accessibility each amino acid will have with 
surrounding molecules and is related to the hydrophobicity of the amino acids.  
AMPs can also exhibit variations in hydrophobicity, which is derived from the relative 
hydrophobicities of its component amino acid residues. Various hydrophobicity scales have been 
developed to describe the relative hydrophobicity of each amino acid. Urry et al., for instance, 
based their scale on the hydrophobic association between peptides and determined the 
contribution of each amino acid to the hydrophobic association free energy of a model protein.13, 
14 White et al. developed hydrophobicity scales based on experimentally determined transfer free 
energies for each amino acid.15-17 A comparison of prominent hydrophobicity scales showed that 
the varied methods used to derive these scales resulted in variations in the assignment of relative 
hydrophobicity values to each amino acid.18 Some of the values can be correlated across 
different scales, however, and provide a sense of the relative hydrophobicities of each peptide.  
Peptides can differ in hydrophobic moment, which is a measure of amphiphilicity. For an 
amino acid sequence consisting of N residues, with residue n having the hydrophobicity Φn, the 
hydrophobic moment can be calculated using 
ߤு ൌ   ہሼΦ௡ cosሺߜ௔݊ሻሽଶ ൅ ሼΦ௡ sin ሺߜ௔݊ሻሽଶۂଵ/ଶ    (2.1) 
where δa is the angle (in radians) of the amino acid side chains. The amphiphilic nature of many 
peptides is believed to enable their interactions with both hydrophilic lipid headgroups and 
hydrophobic lipid bilayer interiors.19 
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2.2  AMP­membrane interactions 
Plasma membranes of bacterial cells differ from those in eukaryotic membranes. The 
lipid composition of Gram-positive bacterial membranes (e.g. Staphylococcus aureus) is 
predominantly composed of anionic lipids, while that of eukaryotic membranes primarily 
consists of zwitterionic lipids.20 Gram-negative bacterial membranes, like those of Escherichia 
coli, contain a mixture of anionic and zwitterionic lipids (Table 2.1). Bacterial membranes are 
encased by a peptidoglycan layer, which allow particles that are approximately 2 nm in size to 
pass.21 Many -helical peptides such as alamethicin can be modeled as cylinders that are 1.1 nm 
in diameter and are therefore able to pass through this layer.22, 23  
Table 2.1. Examples of membrane lipid compositionsa 
 Zwitterionic Negatively Charged 
PE PC SM PS PG DPG LPG 
Erythrocyte membrane  50% 50%     
E. coli (Gram-negative) 82%    6% 12%  
S. aureus (Gram-positive)     57% 5% 38% 
PE - phosphatidylethanolamine, PC - phosphatidylcholine, SM - sphingomyelin,  
PS - phosphatidylserine, PG - phosphatidylglycerol, DPG - diphosphatidylglycerol,  LPG 
– lysophosphatidylglycerol  
a Adapted from Blondelle et al.20 
Gram-negative bacteria also contain an outer membrane that includes lipopolysaccharides 
(LPS) and proteins. Cationic peptides are able pass through the LPS and outer membrane by 
interacting with negatively charged divalent-cation-binding sites on the LPS. Once attached, the 
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bulky AMPs disrupt the barrier properties of the outer membrane, resulting in “cracks” that 
enable peptides and other molecules to enter.24 
Two main theories have been proposed to explain how AMPs destabilize bacterial cell 
membranes. In each case, the peptides first attach to bacterial membranes through electrostatic 
interactions.25 In the barrel-stave model, the AMPs insert themselves into the bacterial cell 
membrane perpendicularly and form a pore (Figure 2.1B).9, 26 The pores enable large molecules 
to enter or exit the cell and disrupt ion gradients, causing the cell to die. The carpet model 
postulates that AMPs align themselves parallel to the membrane surface (Figure 2.1A), which is 
facilitated by their amphipathicity. AMPs surround the lipids, forming micelles that detach from 
the lipid membrane (Figure 2.1C).  The mechanism is thought to differ among AMPs and is 
related to the structure and charge of the peptide, as well as the lipid composition of the cell 
membrane.27, 28 In some cases, both micelle formation and pore insertion may occur, depending 
on the peptide-to-lipid concentration ratio.29 Further studies are required to understand the 
factors that enable AMP targeting and interactions with bacterial membranes. 
 
Figure 2.1 Possible mechanisms of AMP action on cell membranes. (A) Surface adsorption, (B) membrane 
insertion, (C) mass loss from the membrane. 
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Some AMPs may target intracellular components, such as DNA or ribosomes, once they 
have passed across the plasma membrane. Indolicidin, for instance, has been found to inhibit 
protein and nucleic acid synthesis, leading to cell death.25, 30 Anionic peptides have also been 
shown to induce flocculation or aggregation of intracellular components.31 Other peptides may 
also impede cytoplasmic membrane septum formation during cell division,30, 32, 33  inhibit cell 
wall synthesis,34 or inhibit enzymatic activity.35, 36  
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2.3  Potential applications of AMPs 
 Infections involving antibiotic-resistant microbes have increased dramatically in recent 
decades, posing a significant health threat to patients. The short doubling time exhibited in 
bacteria enables them to evolve quickly, thereby increasing their likelihood of developing drug 
resistance. In the United States, hospitalizations related to methicillin-resistant Staphylococcus 
aureus (MRSA) more than doubled from 127,036 in 1999 to 278,203 in 2005.37 AMPs are being 
studied as an alternative to antibiotics, therapeutically and in self-decontaminating surfaces.38 
Due to the nature of the mechanism of interaction, membrane-active AMPs are less prone to the 
development of pathogen resistance than antibiotics. Bacterial resistance to antibiotics typically 
occurs when bacteria (a) are able to alter cellular components to that certain antibiotics cannot 
reach or interact with its intracellular target or (b) induce chemical modification and subsequent 
inactivation of the antibiotic.39 By targeting bacterial cell membranes (based on membrane 
charge, which is difficult for cells to change) and relying on membrane destabilization to kill 
cells, membrane-active AMPs do not easily induce bacterial resistance.  
Potential uses for AMPs also include wound healing applications. The human cathelicidin 
antimicrobial peptide LL37, for example, has been found to promote wound healing through re-
epithelialization and vascularization. Wounds in mice that were treated with LL37 formed a 
higher number of new blood vessels.40  
Interest in AMP-coated surfaces has also increased recently due to public health concerns 
related to pathogenic bacteria. Self-decontaminating materials may be incorporated into 
children’s toys, medical devices, and instruments used in the food-industry to kill hazardous 
pathogens.38 Previous studies in our lab have shown that certain orientations of the AMP, 
cecropin P1, attached to a surface may facilitate binding and killing of bacteria.41 Another study 
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from our lab has also shown that peptides that are chemically linked to a surface are more 
effective in killing bacteria than adsorbed AMPs.42 
Regardless of the application, one of the primary gaps in knowledge that limits AMP use 
is its exact mechanism of interaction. Understanding this mechanism and how it is affected by 
AMP structure will facilitate the selection and design of more effective AMPs for targeting 
specific pathogens. Detailed information about how specific amino acid combinations can affect 
AMP action may also allow them to be combined with other drugs to create therapeutics with 
multiple types of antimicrobial activity. These multi-faceted, or “dirty” drugs would further 
decrease the risk of developing resistance and are being considered for the treatment of complex 
diseases such as cancer.43, 44 
2.4  Limitations as therapeutics 
Despite showing promise as antimicrobial agents, AMPs have not been approved for use 
in therapeutics. Indolicidin- and magainin-based topical drugs have demonstrated efficacy in 
treating infections, but failed during Phase III clinical trials due to safety concerns or failing 
clinical endpoints due to low numbers of enrolled patients.45, 46 Problems with commercialization 
primarily stem from issues such as peptide stability in vivo, high cost, and toxicity to eukaryotic 
cells at bactericidal concentrations.47, 48 Peptides can be susceptible to proteolysis by enzymes 
present in bodily fluids and if taken orally, may be broken down in the digestive tract if not 
protected. Synthetic peptides are also expensive to produce and are 100-500 times more 
expensive than conventional antibiotics.45 Therefore, identifying structural characteristics of 
AMPs that allow them to be effective at lower concentrations will be crucial for making AMP 
therapeutics more affordable. 
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Although AMP activity is largely targeted towards bacteria, the effects of these same 
AMPs on mammalian cells are not well known. Studies have shown promising results that 
indicate that some AMPs are more destructive to bacteria than eukaryotic cells at low 
concentrations. The AMP chrysophsin-1 which is lethal to E. coli at a peptide concentration of 
0.25 M, for example, is only toxic to cultured human lung fibroblasts at the higher 
concentration of EC50 = 4.6 M (half maximal effective concentration).6, 49 NMR experiments 
revealed that chrysophsin-1 attached to the cell membranes, aligning parallel to the membrane 
surface and disrupting the lipid bilayer structure.49 Melittin, however, is toxic to mouse fibroblast 
and human erythrocyte cells at a minimum inhibitory concentration (MIC) of 1 M, but requires 
higher concentrations (3-6 M) to kill Gram-positive and Gram-negative bacteria (also 
hypothesized to occur through membrane destabilization).50 Jacob et al. have synthesized sheep 
myeloid antimicrobial peptide (SMAP) analogs that retained the original peptide’s antimicrobial 
effectiveness and reduced hemolytic activity.51 More research is needed to examine the effects of 
more AMPs on eukaryotic cells to determine if they can be altered to be less toxic to mammalian 
cells while retaining their antimicrobial activity. 
2.5  Quartz crystal microbalance with dissipation monitoring (QCM­D) 
Using quartz crystal microbalance with dissipation monitoring (QCM-D), we can monitor 
real-time mass and viscoelasticity changes during AMP exposure to a supported lipid membrane 
with a sensitivity of ~1.8 ng/cm2 in liquid. Inside the QCM-D chamber, mass (e.g. lipids) is 
added to the surface of an oscillating quartz sensor crystal (Figure 2.2) while measuring changes 
in frequency (∆f) and energy dissipation (∆D) of the crystal due to alterations in the film.  
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Figure 2.2. Diagram showing both faces of a QCM-D sensor crystal. Mass is deposited on the silica 
surface and the electrodes enable voltage to be applied to the crystal to induce oscillation. 
 
The Sauerbrey equation describes the relationship between ∆f and change in mass (∆m) 
in a rigid film: 
     ∆݂ ൌ ିଶ௙బమ஺ඥఘ೜ఓ೜ ∆݉     (2.2) 
where f0 is the resonant frequency of the quartz crystal (5 MHz), A is the piezoelectrically active 
crystal area, q is the density of quartz (2.648 g/cm3), and μq is the shear modulus of the crystal 
(2.947 x 1011 g/cm·s2). Therefore, the change in frequency is inversely related to the change in 
mass attached to the sensor.  In the case of a less rigid film, such as the films used in this study, 
the frequency is still inversely related to mass, but the Sauerbrey equation must be adjusted to 
reflect the effects of a viscoelastic film and the bulk solution.52, 53 Also, since QCM-D 
measurements are taken at consistent time intervals (0.7 s), the rate of frequency change (related 
to mass change) can be derived from these measurements. 
Changes in dissipation are related to the rigidity of the film and can be described by 
     ܦ ൌ ீ"ଶగீᇱ      (2.3) 
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where G” is the loss modulus and G’ is the storage modulus. A softer film will result in a larger 
D. 
Several different frequency overtones, or harmonics, are measured and can be related to 
processes throughout the film. Overtone analysis has been used by Mechler et al. to infer details 
about the fundamental mechanisms behind AMP action on supported bilayers.54 The penetration 
depth, , of an acoustic wave can be found: 
     ߜ ൌ ൬ ೑௡గ௙బ೑൰
ଵ ଶൗ
     (2.4) 
where f is the viscosity of the film, n is the overtone number, and f is the density of the film.55 
As a result, higher overtones can be related to processes closer to the sensor surface. Larger 
frequency decreases at the 3rd overtone, for instance, indicate that mass has been added to the 
surface of the mass, farthest from the sensor surface. Similar ∆f and ∆D values at all overtones 
indicate a homogeneous change in mass and viscoelasticity of the membrane on the crystal’s 
surface.   
In this study, QCM-D measurements were taken in liquid after the instrument was 
allowed to equilibrate in buffer to establish stable f and D baselines. Lipid vesicle solutions were 
then flowed over the QCM-D sensors until stable lipid bilayers were formed, as detailed in 
Chapters 3-5 (representative QCM-D traces shown in Figure 2.3). Buffer was injected to remove 
weakly attached particles from the bilayers, which was followed by the addition of an AMP 
solution of the desired concentration. The AMP solution was allowed to flow for 10 minutes to 
insure that the QCM-D chamber was filled with the correct concentration and the flow was 
paused for 1 h for the AMP action occur and equilibrate. Finally, the chamber was rinsed with 
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buffer and the changes in frequency (f) and dissipation (D) resulting from AMP exposure 
were determined (f = (final f) – (f at time point 4)). 
 
Figure 2.3. Typical frequency and dissipation measurements taken during an experiment examining AMP 
interactions with membranes. (1) Injection of lipid vesicle solution, (2) vesicle ruptures into a supported 
lipid bilayer on the QCM-D sensor surface, (3) buffer rinse, (4) injection of AMP solution, and (5) final 
buffer rinse. 
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Monitoring overtone similarity can provide information about the mechanism of action of 
AMPs on a lipid bilayer surface. Initial adsorption of AMPs onto the membrane surface will 
result in non-homogeneous negative f values at lower overtones (e.g. 3rd) if no other action 
occurs (Figure 2.4A). The barrel-stave model for peptide-membrane interactions should therefore 
result in uniformly negative ∆f values at all overtones, which would represent cylindrical pore 
formation (Figure 2.4B). In the case of toroidal pore formation, however, more lipids would be 
lost at the top and bottom of the bilayer and replaced by pore-forming peptides, resulting in 
heterogeneous frequency changes at different overtones. Combinations of membrane surface 
adsorption and pore formation will result in non-uniform ∆f results across overtones. Given that 
a full phosphatidylcholine (PC) lipid bilayer (~5 nm thick) assembled on a clean QCM-D crystal 
corresponds with a ∆f of ~-26 Hz, we can calculate the approximate ∆f due to adsorption of a 
monolayer of -helical peptides (~1.2 nm thick) to be ~2-4 Hz.56, 57 Therefore, if the carpet 
model is operative, membrane lysis will be demonstrated through uniform positive ∆f values up 
to 26 Hz at all overtones (Figure 2.4C).   
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Figure 2.4. Expected frequency responses corresponding with various models of AMP-membrane 
interactions. (A) Peptide (shown in red) adsorption on the lipid bilayer (blue) surface, (B) cylindrical and toroidal 
pore formation through peptide insertion into the membrane, (C) mass loss from the membrane through removal of 
lipid-peptide aggregates. 
 
The equations presented in this chapter represent the fundamental theory behind QCM-D 
measurements and overtone analysis. A more detailed discussion of QCM-D data interpretation 
that was developed in the following studies is presented in Chapters 3, 4, and 5.  
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chrysophsin-3, indolicidin and SMAP-29: Differentiation through  
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3.1  Abstract 
 Many antimicrobial peptides (AMPs) are thought to kill bacteria by attaching to cell 
membranes and disrupting the lipid bilayer structure. They act either by creating stable pores 
through which ions and molecules may travel or by destroying the membrane through lipid 
removal. Although many studies have confirmed the pore formation and membrane lysis caused 
by the AMPs, the direct relationship between AMP structural characteristics and its mechanism 
of membrane interaction are not yet well understood. In this study, we have used quartz crystal 
microbalance with dissipation monitoring (QCM-D) to probe the interactions between a 
phosphatidylcholine (PC) supported bilayer membrane and the four peptides: alamethicin, 
chrysophsin-3, indolicidin, and sheep myeloid antimicrobial peptide (SMAP-29), with the goal 
of identifying QCM-D signatures that clearly differentiate the mechanism of action of these 
peptides. Multiple signatures from the QCM-D measurements were extracted that provided 
information on peptide addition to and lipid removal from the membrane, the dynamics of their 
interactions and the rates at which the peptide actions are initiated. The QCM-D signatures were 
interpreted in terms of molecular processes including pore formation, surface adsorption of 
peptide, and the insertion of the peptide or peptide aggregate into the bilayer.  We found that the 
membrane interactions of each peptide involved a different sequence of molecular processes. 
These mechanistic variations in peptide action were related to the fundamental structural 
properties of the peptides including the number of amino acids, net charge, hydrophobicity, 
hydrophobic moment, accessible surface area and the probability of α-helical secondary 
structures. The study demonstrates that QCM-D provides a rich collection of unique signatures 
capable of differentiating the detailed mechanism of action of antimicrobial peptides. 
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3.2  Introduction 
Antimicrobial peptides (AMPs) are pathogen-killing molecules that were originally 
derived from various organisms, including frogs and moths.1, 2 They are known to kill a broad 
spectrum of pathogenic bacteria, fungi, and viruses. AMPs are believed to kill bacteria by 
destabilizing bacterial membranes or translocating through the membranes to interact with 
intracellular targets. Because of the nature of these interactions, pathogenic bacteria are less able 
to develop resistance against the membrane-active AMPs, in contrast to the ease of developing 
antibiotic resistance. A bacterium must substantially change the characteristics of its membrane 
if it has to succeed in developing resistance to AMPs, but because the lipids are highly conserved 
in microorganisms, this possibility appears remote.3-5 This unusual property of low or no 
susceptibility to development of AMP resistance by the microorganisms has stimulated major 
research efforts to chemically synthesize AMPs replicating some of the structural features of the 
naturally occurring AMPs, with the expectation of reproducing their mechanism of action in 
killing bacteria for practical applications.   
The membrane-destabilizing mechanisms exhibited by AMPs are thought to fall into one 
of several categories. Many membrane-active peptides have been shown to insert into lipid 
bilayers and create pores using a mechanism described by the barrel-stave model.6 These pores 
have been detected by studying voltage-dependent conductance that occurs via transmembrane 
channels that are created as a result of peptide insertion.7, 8 The AMPs may also disrupt cell 
membranes by first attaching to the surface and forming lipid-peptide aggregates, which then 
leave the membrane causing lysis, in a mechanism described by the carpet model. Variations of 
these models have also been developed. For instance, the barrel-stave cylindrical pores, in which 
the edges are lined by perpendicularly-oriented peptides, may be distinguished from toroidal 
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pores, in which the pore edges consist of peptides and lipid head groups that bend continuously 
from the top bilayer leaflet to the bottom bilayer.9 The mechanism of interaction between a 
peptide and a cell membrane may follow any one or a combination of these molecular events, 
depending on the type of peptide and lipid present in the system. 
Peptide characteristics of secondary structure, charge, and hydrophobicity are usually 
thought to play substantial roles in determining AMPs’ mechanisms of action on a cell 
membrane.10 Studies have shown that increased helicity in AMPs can be correlated with 
increased antibacterial activity.11, 12 The cationic nature of AMPs is also thought to play a large 
role in their ability to target negatively charged bacterial cell membranes. Electrostatic 
interactions are largely responsible for drawing cationic AMPs to anionic bacterial cell 
membranes. If the membrane is primarily made up of zwitterionic lipids, then the strong ionic 
attractions that exist between the anionic lipid membranes and the AMP are replaced by 
relatively weaker attractive interactions between the dipoles of the neutral membrane and the 
charges on the AMP.  In this case, the hydrophobicity of the peptide may become a more 
significant factor in determining antimicrobial activity.  Hydrophobicity has been shown to affect 
the antibacterial and hemolytic activity of AMPs, but the correlation with antibacterial activity 
may not be strong.10, 13-17 Although numerous studies in the literature have examined the 
relationship between AMP structure and antibacterial or hemolytic activity (represented by 
experimentally determined minimum inhibitory concentrations), less is known about how the 
structure of the AMP and its resulting physicochemical properties determine the specific 
mechanism of interaction with cell membranes.  
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Table 3.1 Characteristics and Natural Sources of Various Antimicrobial Peptides 
Peptide 
Number 
of Amino 
Acids 
Predominant 
Secondary 
Structurea 
Nominal 
Charge at 
pH 7 
Comments 
Alamethicin 20 -helix18 0 19 
Contains unnatural amino 
acids aminoisobutyric acid 
and phenylalaninol 
Chrysophsin-3 20 -helix20 +4 21  
Indolicidin 13 
Folded, boat-
shaped 
conformation22 
+4 23 
Smallest peptide with 
dominant presence of 
tryptophan and proline 
SMAP-29  29 -helix24 +10 25 
Cysteine was attached at the 
c-terminus to support other 
research 
 
aThe secondary structures mentioned in the literature for the peptides. 
 
To discover the mechanistic variations between different AMPs, four molecules, 
alamethicin, chrysophsin-3, indolicidin, and sheep myeloid antimicrobial peptide (SMAP-29), 
with varying secondary structure, charge, and hydrophobicity were chosen for this study (Table 
3.1). The helical wheel diagrams for these four peptides are shown in Figure 3.1. This diagram 
provides a projection of amino acids perpendicular to the helix long axis assuming that the 
peptide exists in an α-helical secondary structure.  Since the α-helix contains 3.6 residues per 
turn, adjacent residues on the peptide are separated by 100o on the helical wheel.  The extent of 
separation of the hydrophobic and hydrophilic residues on the wheel either confirms or rejects 
the possible existence of the peptide in the α-helical secondary structure. The helical wheel 
representation of -helical alamethicin, for example, reveals that its non-polar (shown in blue) 
amino acid side chains are positioned on one side of the wheel, enabling the -helical 
conformation to create a non-polar section in the peptide. Indolicidin does not show clustering of 
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non-polar side chains and, in fact, exhibits a folded conformation, rather than an -helical 
structure. 
 
Figure 3.1. Helical wheel diagrams for alamethicin, chrysophsin-3, indolicidin, and SMAP-29. -
Aminoisobutyric acid and L-phenylalaninol are represented by “U” and “F,” respectively. These diagrams 
reveal differences in the placement of charged amino acid residues, as well as hydrophobic and polar side 
chains. “Special Case” amino acids exhibit unique properties, such as being able to form disulfide bonds 
(cysteine) or being more flexible than other amino acids (glycine). 
 
The first AMP, alamethicin, is a 20-amino-acid, -helical peptide that is derived from the 
fungus Trichoderma viride and is known to insert into membranes at higher concentrations, 
forming well-defined cylindrical pores.26-28 The structure of alamethicin is unique because it 
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includes two amino acids that are rarely found in nature, aminoisobutyric acid and L-
phenylalaninol. Alamethicin contains a negative charge associated with the glutamic acid residue 
near the C-terminus. However, this side chain is typically protonated when the peptide is 
oriented in a transmembrane state, making alamethicin’s net charge effectively zero in a peptide-
lipid membrane system.19 The helical wheel diagram shows a clear separation between the 
dominant hydrophobic face and a smaller polar face in the alpha-helical structure for this 
peptide. 
Chrysophsin-3, another 20-amino-acid AMP, is derived from the gills of the red sea 
bream, Chyrsophrys major.20 It also assumes an -helical structure when in contact with a 
biological membrane and is amphipathic. Chrysophsin-3 exhibits a positive net charge of +4, 
which differentiates it from alamethicin.21 Again in this case, the helical wheel diagram shows a 
clear separation between the dominant hydrophobic face and a polar charged face in the alpha-
helical structure for this peptide. 
Indolicidin, a 13-residue AMP derived from bovine neutrophils, is one of the smallest of 
the known naturally occurring linear peptides.29 Indolicidin’s amino acid content is quite 
remarkable because of its five tryptophan and three proline residues. Indolicidin carries a net 
charge of +4 at pH 7 and assumes a specific coiled and folded conformation when in contact 
with a cell membrane, unlike the -helical or -sheet conformations formed by most other 
AMPs.23, 30 Intramolecular cation-π electron interactions allow it to assume a folded, boat-shaped 
conformation with positive charges at the peptide termini and a hydrophobic core.22, 31, 32 Studies 
have shown that indolicidin does not cause hemolytic lysis at concentrations below 30 μM.33 The 
helical wheel diagram shows a separation of hydrophobic and hydrophilic residues but the large 
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presence of prolines in this small peptide prevent it from assuming a -helical secondary 
structure. 
Sheep myeloid antimicrobial peptide (SMAP-29) is a cationic AMP composed of 29 
amino acids that carries a +10 net charge at pH 7.25 Its structure is predominantly -helical, with 
the hydrophobic residues aligned along one side and the polar residues along the other24, 34, 35 as 
can be seen from the helical wheel diagram. The SMAP-29 used in our study contains a terminal 
cysteine residue, which was introduced to support other research where the AMP was attached to 
fluorescent dyes or other surfaces through the sulfhydryl functionality of cysteine.36, 37 The 
presence of the terminal cysteine could possibly give rise to the formation of SMAP dimers in 
solution through disulfide bonding. Bulky dimers could interact with lipid membranes differently 
than SMAP-29 monomers and would contribute more mass when attaching to the membranes. 
The presence of large peptide aggregates could be detected with dynamic light scattering 
experiments to determine the particle sizes in solution. -mercaptoethanol could also be added to 
the AMP solution to reverse dimerization and QCM-D experiments could be conducted to 
determine if the interaction mechanisms changed as a result. 
We used quartz-crystal microbalance with dissipation monitoring (QCM-D) to follow 
AMP interactions with lipid membranes in real-time and to search for QCM-D signatures 
specific to each peptide. Nanoscale changes in mass and viscoelasticity of a solid surface-
supported lipid bilayer can be monitored by the changes in frequency (∆f) and energy dissipation 
(∆D), respectively, of a sensor on which the bilayer is assembled.37-43 Multiple frequency 
overtones, or harmonics, can also be measured and related to homogeneity of processes through 
the depth of the bilayer. Due to varying penetration depths of the different overtones, higher 
overtones are correlated with processes occurring closer to the sensor surface.38 Similar ∆f and 
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∆D values at all overtones indicate a homogeneous change in mass and viscoelasticity of the 
membrane on the crystal’s surface.  Overtone analysis was pioneered by Mechler et al. to infer 
details about the fundamental mechanisms behind AMP action on supported bilayers.39  
Since the formation of highly reproducible bilayers has been demonstrated for 
zwitterionic phospholipids,41-43 we have used PC as the lipid in all the experiments reported and 
discussed here.  Egg PC was chosen for the model membrane because we were able to form 
supported lipid bilayers (SLBs) consistently from PC vesicles using the method described 
previously.40 
Further, monitoring the dynamic behavior of AMPs on lipid membranes has typically 
been difficult, due to the small scale of these interactions.  However, QCM-D offers some 
information on the dynamics of the process because of the real time monitoring of very small 
mass and dissipation changes. Information about specific structural characteristics of each AMP, 
such as charge and hydrophobicity, were also gathered and compared with the QCM-D results to 
correlate peptide structural characteristics with their membrane interactions. Since we have 
already reported on the QCM-D studies on chrysophsin-340 and alamethicin,41 only the 
information pertinent to making comparison between all four peptides is discussed in this paper. 
3.3  Materials and methods 
3.3.1  Materials 
Indolicidin and cysteine-terminated SMAP-29 were purchased from New England 
Peptide (Gardner, MA). Alamethicin was purchased from Sigma-Aldrich (St. Louis, MO) and 
chrysophsin-3 was acquired from Bachem (Torrance, CA). Peptide and lipid vesicle solutions 
were prepared in Tris-NaCl buffer [100 mM sodium chloride and 10 mM 
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tris(hydroxymethyl)aminomethane at pH 7.8]. Lyophilized egg phosphatidylcholine (PC) was 
purchased from Avanti Polar Lipids (Alabaster, AL) and stored in ethanol at -20˚C. 
3.3.2  Supported lipid bilayer preparation 
The stored egg PC was dried with nitrogen gas to remove the ethanol and stored under 
vacuum in a desiccator overnight. The dried lipids were then resuspended in Tris-NaCl buffer 
and brought to a final concentration of 2.5 mg/mL. The mixture was subjected to 5 freeze-thaw 
cycles and small unilamellar vesicles (SUVs) were formed using an ultrasonic dismembrator 
(Model 150T, Fisher Scientific, Waltham, MA) in pulse mode for 30 min at 0˚C. The pulse was 
set to stay on for 3 sec at an amplitude of 60, followed by a 7 sec pause, resulting in a 30% duty 
cycle. The SUV solution was then centrifuged at 17,500 rpm (37,000 g) for 10 min at 4˚C (J2-MI 
Centrifuge, Beckman Coulter, Brea, CA). The supernatant containing homogeneous SUVs was 
collected and stored under nitrogen at 4˚C for up to 5 weeks. This stock solution was aliquoted 
and diluted to 0.1 mg/mL before each experiment.  Experiments were performed with peptide 
concentrations between 0.5 M and 10 M. Lower concentrations between 0.01 M (data 
presented in Appendix A1.1) and 0.5 M were also tested with alamethicin, chrysophsin-3, and 
SMAP-29 to determine the critical concentration at which AMP action occurs. 
3.3.3  Quartz crystal microbalance with dissipation monitoring (QCM­D) 
 The Q-SENSE E4 system (Biolin Scientific, Stockholm, Sweden) was used to monitor 
the formation of an SLB on a silica surface and changes to the membrane upon exposure to 
AMPs in real-time. This technique uses the piezoelectric qualities of a quartz sensor crystal to 
measure the relative change in mass on its surface. The instrument measures the change in 
frequency (∆f) and change in energy dissipation (∆D) of the crystal and any associated mass.  
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All the experiments involved the following steps (see a typical trace of frequency and 
dissipation measurements over time in Appendix 2).  First, at time t0, a PC vesicle solution (0.1 
mg/mL) was allowed to flow over the QCM-D silica sensor surface at 0.15 mL/min at 23˚C until 
the frequency and dissipation stabilized, indicating the formation of a stable bilayer.42, 43  The 
vesicles initially attach to the silica surface and when a critical concentration of vesicles on the 
surface is reached, they rupture spontaneously forming a stable and uniform membrane.  Then at 
time t1, the buffer was injected into the QCM-D chamber to rinse away any unattached particles.  
When the system showed a stable response at time t2, a solution of the AMP in the buffer at the 
desired peptide concentration was allowed to flow.  After 10 minutes of AMP injection (enough 
time for the QCM-D chamber to completely fill with the AMP solution), at time t3, the flow was 
stopped and the system was left to equilibrate for 1 hr. This incubation was performed to allow 
the AMPs time to act on the membrane. Following this equilibration step, at time t4, a final 
buffer rinse was applied until the frequency and dissipation stabilized at time t5.  The change in 
frequency Δf and change in dissipation ΔD data reported everywhere in this paper are the 
difference in values between that at time point t2 associated with a stable supported bilayer just 
before AMP injection and the time point t5 at the end of the final buffer rinse. The differences 
thus reflect solely the consequences of AMP interaction with the bilayer and are unaffected by 
all other system variables. 
 The ∆f and ∆D values were measured with the 3rd, 5th, 7th, 9th, and 11th harmonics, or 
overtones, of the QCM-D crystal’s resonant frequency. Due to different penetration depths of the 
acoustic waves associated with different overtones, higher overtones (e.g. the 9th and 11th 
harmonics) are associated with activity near the crystal surface and lower overtones are more 
related to processes occurring near the external surface of the attached mass.39, 40 Homogeneous 
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∆f and ∆D values at all overtones suggest that the processes occurring throughout the thickness 
of the bilayer are uniform.  
3.3.4  QCM­D data analysis  
Methods to relate the measured frequency and dissipation changes to changes in mass 
and in the viscoelastic properties of the membrane on the surface are briefly outlined here. For a 
rigid film on the crystal surface exposed to air, the areal mass mf (mass per unit area) is related to 
the normalized (with respect to the overtone number) frequency change ∆f by the Sauerbrey 
equation, while the dissipation change ∆D is zero. 
∆݂ ൌ െ ௢݂ ݉௙݉௤ ൌ െܥ ݉௙ , Δܦ ൌ 0 (3.1)
Here, fo is the natural frequency of the oscillator, mq is the areal mass of the quartz crystal and C 
is the Sauerbrey constant. Net mass addition is reflected by a negative ∆f while net mass loss is 
indicated by a positive ∆f. If the film is not rigid but viscoelastic and is submerged in a 
Newtonian liquid (water or buffer), then the frequency and dissipation changes are given by 
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where ρf is the density of the film on the crystal, ηL is the viscosity of the liquid, δL is the decay 
length of the acoustic wave in the liquid, and G” and G’ are the loss modulus and the storage 
modulus connected to the dissipation, D = G′′/(2π G′).  The first term in the expressions for Δf 
and ΔD are due to the solvent effect and they vanish when we consider peptide-induced changes 
in the bilayer for our purposes. Since the bilayer is immersed in the liquid both before and after 
contact with the peptide, which is the time period that is considered when calculating ∆f and ∆D, 
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the solvent is negligible in our calculations. The mass change is now given by the Sauerbrey 
term with a correction factor accounting for the viscoelastic properties of the film. The change in 
dissipation ∆D is related to the changes in the rigidity or viscoelasticity of the bilayer. Small ∆D 
implies bilayer rigidity similar to that of the unperturbed bilayer and in this case the mass change 
is given by the simple Sauerbrey term without the viscoelastic correction.  
3.4  Results 
3.4.1  Dependence of frequency changes on peptide interaction modes 
In order to link the frequency changes measured in the QCM-D experiments to molecular 
events, we first established a connection between the frequency changes and the different modes 
of peptide interaction with the bilayer. Four different states of peptide interacting with the 
membrane are shown in Figure 3.2: (i) peptide is inserted into the bilayer as a single molecule, 
occupying an area ap per peptide; (ii) peptide is adsorbed on the bilayer surface in the lipid head 
group region, occupying an area Ap; (iii) peptide is inserted into the bilayer as an aggregate 
without any water channel, occupying an area ap per peptide and (iv) peptide is inserted into the 
bilayer as a n-size cluster forming the pore wall around a water channel, occupying an area AH/n 
per peptide, AH being the pore area. On the addition of peptide to the bilayer, lipid molecules are 
removed from the bilayer and replaced either by pores or inserted peptides or peptide aggregates. 
In contrast, if the peptide adsorbs on the bilayer surface, it will not require any lipid removal 
from the membrane to do so. If a fraction λ of the bilayer area is affected by these peptide 
interactions, then the resulting frequency changes can be calculated (see details in Appendix 3) 
as the areal mass change divided by the Sauerbrey constant C: 
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(3.3) 
In this equation, MP and ML are molecular masses of the peptide and lipid molecule, respectively, 
calculated from their molecular weights.   
 
Figure 3.2. Four states of peptide-membrane interactions: (A) peptide insertion into the bilayer as a single 
molecule, (B) peptide adsorption to the membrane surface, (C) peptide insertion as an aggregate without a 
water channel and (D) peptide insertion as a cluster forming a pore around a water channel. For 
simplicity, lipid removal as a result of peptide insertion is not shown in this figure. 
 
Setting the fractional area λ to be unity, we have calculated the theoretical maximum in 
the frequency change and the results are given in Table 3.2. From the calculated results, we 
observe that for alamethicin, pore formation will give rise to a positive Δf and will be 
measurable.  In contrast, if alamethicin simply inserts into the bilayer either as a single molecule 
or as an aggregate, Δf is negative but will be too small to be observed. QCM-D can measure 
small changes in frequency (smaller than 0.01 Hz changes), but variations within experimental 
repetitions typically result in standard deviations larger than 0.01 Hz. If alamethicin adsorbs on 
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the bilayer surface with the helix being flat, Δf will be negative and large enough to be 
observable. For chrysophsin-3, pore formation will give rise to a positive Δf and will be 
measurable. If the peptide simply inserts into the bilayer or if it adsorbs on the bilayer, the 
frequency change will be negative and measurable. For indolicidin, pore formation will give rise 
to a positive Δf and will be measurable.  If the peptide simply inserts into the bilayer, Δf will be 
positive but too small to be measurable. If indolicidin adsorbs flat on the bilayer surface, Δf will 
be negative and large enough to be observable.  For SMAP-29, formation of a large pore will 
give rise to a positive Δf, while for a small pore Δf will be negative.  If the peptide simply inserts 
into the bilayer, Δf is negative and large enough to be observed. Also, if the peptide is adsorbed 
flat on the bilayer surface, Δf will be negative and large enough to be observable.  Also included 
are the results for the dimeric state of SMAP-29 since there is the possibility of dimerization due 
to the presence of a terminal cysteine added to SMAP-29 tested in our work.  For the SMAP-
dimer, all states of interaction give rise to negative Δf and the magnitude is significantly large 
compared to all other cases considered in Table 3.2.  These calculated maximum Δf estimates 
allow us to look at specific peptide induced changes on the bilayer in molecular terms. 
Table 3.2. Calculated estimates of maximum frequency changes resulting from various modes of 
peptide-bilayer interactions 
Peptide 
Molecular 
weight of 
peptide 
(Da) 
Expected maximum change in Δf (Hz) 
Insertion as 
monomer or 
as cluster 
Pore formation 
with 8 
peptides/pore 
Pore formation 
with 20 
peptides/pore 
Surface 
adsorption 
Flat 
Alamethicin 1965 - 0.10 6.92 12.08 - 4.85 
Chrysophsin-3 2287 - 3.26 4.91 10.91 - 4.85 
Indolicidin 1906 0.48 7.29 12.29 - 4.85 
SMAP-29 3256 - 12.78 - 1.14 7.41 - 4.85 
SMAP-29 Dimer 6512 - 44.74 - 21.47 - 4.37 - 4.85 
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3.4.2  Alamethicin prefers pore formation 
The net changes in the frequency and the dissipation for the bilayer exposed to 
alamethicin are shown on Figure 3.3A for various concentrations of alamethicin in the aqueous 
phase.  For all alamethicin concentrations, the experimental data show (i) that the frequency 
changes are positive suggesting a net mass loss occurs, (ii) all overtones show uniform 
responses, suggesting a process that is homogeneous along the depth of the bilayer and (iii) the 
dissipation changes are very small, indicating that the membrane retained the relatively rigid 
order similar to the unperturbed lipid bilayer. The mass loss and the uniform response at all 
overtones are consistent with alamethicin causing some amount of lipid molecules to be removed 
from the bilayer and creating cylindrical pores (Figure 3.3B).  The very small dissipation change 
is consistent with alamethicin occupying the pore walls to make the bilayer as rigid as its original 
state.  
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Figure 3.3. (A) Changes in frequency and dissipation corresponding to various concentrations of 
alamethicin interacting with a PC membrane (data previously published).41 Error bars represent the 
standard deviation based on at least 3 replicate experiments. The uniform increases in frequency and 
dissipation at all overtones for each peptide concentration point to mass changes throughout the 
membrane thickness, which are indicative of peptide insertion (B). Peptides are represented in red and 
lipids are colored blue. 
 
The dynamics of the interaction process are revealed by the D vs. f plots in Figure 3.4. 
As discussed by McCubbin et al. and a previous paper from our lab,41, 44 these plots reveal the 
time dependent changes that occurred in the membrane which are not captured by the plots of net 
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changes in D and f shown on Figure 3.3. Net D and f values capture changes that occurred 
over the entire time duration of AMP action, but do not reveal processes that may have occurred 
during this time. The direction of each line in the graphs in Figure 3.4 can be related to different 
molecular scale mechanisms occurring in the membrane. The x-axis is scaled such that the 
frequency changes to the “east” would correspond with mass increases. At bulk solution 
concentrations of 0.5 M and 1 M alamethicin, the membrane did not show significant 
changes. At 5 M, simultaneous increases in mass and dissipation occurred initially, which 
corresponded with a line moving in the north-east direction (labeled i). The data then shifted to 
the north-west direction (labeled ii), indicating that the viscoelasticity of the membrane was still 
increasing, but mass had been lost. The bilayer then became more rigid with a small increase in 
mass and appreciable decrease in dissipation (labeled iii), followed again by mass loss (labeled 
iv). A similar phenomenon occurred at 10 M alamethicin, but with larger changes in mass 
throughout the process and a faster initial rate of peptide adsorption to the membrane surface.  
These graphs showed that alamethicin first attached to the bilayer (mass addition) and caused the 
membrane to become more viscoelastic. The increasing “softness” of the bilayer could be due to 
decreasing organization of the membrane structure. The alamethicin then promotes pore 
formation in the bilayer, causing lipid removal and a more rigid bilayer structure as the peptides 
stabilized the edges of pores.  
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Figure 3.4. Representative D vs. f plots showing the action of alamethicin at 0.5, 1, 5, and 10 M 
concentrations on a supported PC membrane. The arrows indicate the progression of data points over 
time. The changing directions of the arrows (i-iv) can be related to several different processes occurring 
in the membrane. The frequency axis has been reversed so that increases in mass are represented by 
frequency shifts to the right. Representative data from each peptide concentration were chosen from sets 
of at least 3 replicate experiments. 
 
3.4.3  Chrysophsin­3 displays insertion, surface adsorption and pore formation 
Chrysophsin-3 exhibited a concentration-dependent interaction mechanism on the PC 
bilayer (Figure 3.5). At a concentration of 0.25 M, f was negative and uniform at different 
overtones suggesting that a small amount of chrysophsin-3 was inserted into the membrane. 
Between 1 M and 2 M chrysophsin-3 (not shown), f was negative and the 3rd overtone 
showed a larger magnitude compared to the higher overtones suggesting that the peptide 
continued to insert into the membrane, but also was adsorbed on the bilayer surface. At 4 M 
chrysophsin-3, the net f values and overtone responses were similar to that at 1 M, indicating 
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peptide insertion and surface adsorption. The dissipation changes were larger, however, 
suggesting that the peptide induced actions were perturbing the organization of the bilayer. At 
the largest experimental chrysophsin-3 concentration of 10 M, f became positive, overtone 
responses were more uniform, and the dissipation significantly decreased to small values, all 
suggesting that the net mass loss could be due to the formation of pores with the peptide 
stabilizing the pore walls and making the membrane reasonably rigid as in its unperturbed state.   
  
Figure 3.5. (A) Frequency and dissipation shifts for chrysophsin-3 (data previously published).40 
Frequency changes at all overtones suggest insertion of the peptide into the membrane and greater 
decreases in frequency at the 3rd overtone are indicative of peptide adsorption to the bilayer surface (B). 
Peptides are represented in green and lipids are colored blue. 
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The dynamics of the interactions between chrysophsin-3 and the PC bilayer displayed in 
the D vs f plots in Figure 3.6 show that at the low concentration no significant change 
occurred on the bilayer.  However, for 1 M and 4 M concentrations, an initial shift in the 
north-east direction (i) indicated simultaneous increases in mass and membrane viscoelasticity as 
peptide attached to the membrane. The 3rd overtone showed greater change than the 11th 
overtone, suggesting that most of the peptide-membrane dynamics was taking place near the 
surface of the membrane. The graph then shifted to a south-west direction (ii), indicating that 
mass had been lost from the membrane, leaving a more structurally organized and rigid film that 
still contained more mass than the original lipid membrane before peptide exposure. The results 
at 10 M showed the same trends, but revealed a larger initial mass addition to the membrane, 
followed also by a larger mass loss (ii), resulting in a more rigid film.  
 
Figure 3.6. Representative D vs. f plots for chrysophsin-3 at 0.25, 1, 4, and 10 M concentrations. The 
arrows reveal two distinct processes occurring in the membrane as a result of exposure to chrysophsin-3: 
(i) increasing mass and dissipation, due to peptide incorporation into the bilayer and (ii) simultaneous 
decreasing mass and dissipation. 
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3.4.4  Indolicidin prefers surface adsorption 
The QCM-D responses for indolicidin at different peptide concentrations are shown on 
Figure 3.7A. The QCM-D responses for 0.5 M and 1 M indolicidin were not strong, indicating 
some interactions but no significant changes to the membrane. At 5 M indolicidin, frequency 
change was negative at the 3rd harmonic, but positive at higher overtones, suggesting that mass 
had been added to the bilayer surface, but removed from within the bilayer. These results 
showing both mass gain and loss may be explained by simultaneous peptide adsorption at the 
surface (corresponding to the negative frequency shift in the 3rd harmonic) and promoting some 
lipid loss from the bilayer (corresponding to the positive frequency shift at higher overtones). 
The dissipation changes also show significant positive values indicating that the membrane 
organization is somewhat disrupted because of the removal of lipids without accompanying 
space filling by the peptide. At the highest concentration of 10 μM indolicidin, the membrane 
experienced mass gain that was non-uniform at different overtones, the largest gain being in the 
3rd overtone. This indicated significant surface adsorption of indolicidin with increasing 
concentration and partial peptide insertion into the membrane space where lipid molecules had 
been removed (Figure 3.7B). The 10 M indolicidin concentration also resulted in larger ∆D 
values and, therefore, the “softest” film compared to other indolicidin concentrations. The 
creation of a “softer” film suggests that the lipid bilayer has been disrupted, allowing more water 
to enter the membrane space since the inserted amount of peptide was probably small compared 
to the adsorbed amount of peptide. 
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Figure 3.7. (A) Frequency and dissipation shifts resulting from indolicidin action on a supported PC 
bilayer at various peptide concentrations. The differences shown in each overtone indicate that the 
processes occurring throughout the membrane thickness are not uniform. The error bars represent the 
standard deviation based on at least 3 replicate experiments. (B) The hypothesized mechanism of 
interaction between indolicidin (violet) and PC membranes (blue): surface adsorption and partial 
insertion. 
 
The dynamics of indolicidin action on PC membranes as seen from the D vs. f plot 
(Figure 3.8) showed that the rate of peptide attachment to the bilayer at the beginning of the 
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process was higher than with alamethicin and chrysophsin-3 discussed earlier. This is revealed 
by the substantial separation of data points in the D vs. f trace (since two adjacent frequency 
data points correspond to some fixed time interval, points separated by long distance indicate a 
rapid change of frequency compared to a situation where the points are very close to one 
another). The plot at 10 M indolicidin indicated a higher rate of initial adsorption in the 3rd 
harmonic (i), followed by a slower loss of mass from the membrane (ii). Before the membrane 
stabilized during the 1-hr incubation period with the peptide, the bilayer regained a small amount 
of mass and continued to decrease in dissipation (iii), indicating that the molecules within the 
membrane were becoming more ordered. The subsequent increases in dissipation and mass (iv) 
resulted from the start of buffer flow after incubation with the peptide. The mechanism then 
shifted to a loss in mass and dissipation (v) as the membrane lost weakly attached particles and 
began to stabilize.  
 
Figure 3.8. Representative D vs. f plots for indolicidin at 0.5, 1, 5, and 10 M concentrations. The 
arrows show that the addition of peptide into the membrane (i) is followed by a series of more complex 
interactions (ii-v) as time progresses. 
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3.4.5  SMAP­29 adsorption, insertion and presence of dimers 
For SMAP-29, significant changes in frequency or dissipation were not observed at or 
below the 1.0 M concentration (Figure 3.9A). Between 2 M and 10 M peptide 
concentrations, large frequency decrease and dissipation increase occurred, that were not 
homogeneous over the various overtones. The negative shifts in frequency were larger at lower 
overtones and the largest ∆f values were observed for 10 M SMAP-29. These results indicate 
that more mass was added to the membrane surface than throughout the membrane thickness, 
suggesting that peptides were adsorbing as well as inserting into the bilayer (Figure 3.9B). Pore 
formation is also possible but as the estimates in Table 3.2 show, the positive frequency change 
due to pore formation can be more than compensated by the negative frequency change 
associated with peptide insertion and surface adsorption.   
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Figure 3.9. (A) Frequency and dissipation shifts resulting from SMAP-29’s action on a supported PC 
bilayer at various peptide concentrations. Error bars represent the standard deviation based on at least 3 
replicate experiments. The non-uniform changes at each overtone indicate that the interaction mechanism 
consists of a combination of peptide adsorption and insertion (B). Peptides are shown as orange coils and 
lipids are shown in blue (B). 
 
The frequency change for concentrations of 5M to 10 M SMAP-29 was notably large, 
about -21 Hz at the 3rd overtone. The calculated maximum free energy changes in Table 3.2 for 
SMAP are well below this value for all states of the peptide considered. Therefore, the large 
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frequency shifts resulting from exposing the lipid bilayer to these concentrations of SMAP-29 
require alternate molecular reasoning. The most likely explanation comes from the possible 
dimerization of SMAP because of the formation of disulfide bonds between the terminal cysteine 
residues attached to the peptide. This phenomenon was reported previously in a study by Uzarski 
et al., in which cysteine-terminated cecropin-P1 peptide formed disulfide bonds, resulting in 
peptide dimers.36 The peptide dimer could still insert into the membrane or form a pore in the 
membrane but a significant portion of the dimer (almost 30 amino acid residues) would remain 
exposed to water on the bilayer surface. 
Positive shifts in dissipation indicating a softer membrane were observed for all peptide 
concentrations with the largest ∆D values recorded for the third overtone. We noted that the 
SMAP dimers inserted into the bilayer or the dimers forming pores would have a significant part 
of them outside the bilayer membrane creating a water filled region crowded with the exposed 
parts of the dimers.  Such a molecular system would make the effective membrane soft or 
viscoelastic and would give rise to the high dissipation changes observed. 
The presence of dimerized SMAP-29 molecules could also explain the fast rate of initial 
mass attachment (i) to the lipid bilayer at 5-10 M concentrations (Figure 3.10). The membrane 
became substantially more viscoelastic upon this mass addition, suggesting that it was becoming 
more structurally disorganized. The rate of change slowed as peptide attachment reached a 
saturation point around ∆f = 18 Hz for both concentrations and the membrane began to lose 
mass, while increasing in viscoelasticity (ii). During the final buffer rinse, the dissipation then 
continued to increase along with the membrane mass (iii).  This suggests that the mass gain may 
stem from trapping of some buffer by the exposed parts of peptide dimer on the bilayer surface 
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while the increase in dissipation or viscoelasticity may reflect a structural disorganization of a 
more hydrated, peptide containing region on the bilayer surface.  
 
Figure 3.10. Representative D vs. f plots for SMAP-29 at 0.5, 1, 5, and 10 M concentrations. The 
spacing between the data points indicates that mass was added to the membrane at a faster rate than the 
other peptides, possibly due to the large mass of the dimerized SMAP-29 molecules. 
 
3.4.6  Comparison of kinetics of peptide­membrane interactions  
We have used the QCM-D data to estimate some kinetic information about how the 
peptides interact with bilayer. The frequency response of the QCM-D traces show that when the 
peptide comes into contact with the bilayer, a significant change in the frequency occurs in the 
initial period of contact following time point denoted as t2 in the experiment (see QCM-D time 
trace in Appendix 2).  The duration of this initial period as well as the rate of change of 
frequency during this initial period are found to be different for the four peptides (Figure 3.11).  
The duration of change for this initial period of contact is the smallest for alamethicin and largest 
for chrysophsin-3 and the other two peptides have comparable behaviors. The rate of mass or 
frequency change in this initial period is the largest for SMAP-29 and smallest for alamethicin 
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and chrysophsin-3. Indolicidin exhibits an intermediate rate of change.  We observe that the 
initial interaction times (duration of initial change) of the four peptides are better differentiated at 
lower peptide concentrations whereas the initial interaction rates (frequency change over time) of 
the four peptides are better differentiated at the higher peptide concentrations. 
 
Figure 3.11. Initial interaction times and rates for various AMP concentrations. These values represent 
the rate of change during the initial stage of contact between the bilayer and the peptide.  
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3.4.7  Calculated peptide structural properties 
Key peptide structural properties were calculated to establish a connection between the 
QCM-D results and the molecular processes they signify, with the molecular structural features 
of the peptides. The most common properties used to differentiate peptides in the literature are 
hydrophobicity, charge, and secondary structure.  Many numerical scales of hydrophobicity Φn 
for each peptide residue n have been developed in the literature (see Appendix 4). Although they 
show some correlation with one another, the numerical measures can be very different. Therefore 
they are used more for the purposes of comparison. We have calculated the hydrophobicity of the 
four peptides using the normalized consensus scale of Eisenberg and the Urry scale based on 
phase inversion and the results are provided in Table 3.3.45, 46 The hydrophobicity of the entire 
peptide Φ (= ∑Φn for all n=1 to N amino acids considered) and the hydrophobicity per residue 
(Φ/N) are both shown. For alamethicin containing two unnatural amino acids, the hydrophobicity 
of aminoisobutyric acid (U) was taken to be the average of the chemically similar amino acids, 
alanine and valine, and the hydrophobicity for phenylalaninol was taken to be the same as for 
phenylalanine. 
Table 3.3. Hydrophobicity and hydrophobic moment of peptides 
Peptide 
Urry Hydrophobicity  Eisenberg
 
Hydrophobicity Eisenberg hydrophobic 
moment per residue For whole 
peptide 
Per 
residue 
For whole 
peptide 
Per 
residue 
Alamethicin -30.7 -1.54 6.22 0.3110 0.3084 
Chrysophsin-3 -41.5 -2.08 1.52 0.0762 0.1537 
Indolicidin -44.45 -3.42 0.29 0.0223 0.0795 
SMAP-29  -40.95 -1.41 -5.25 -0.1810 0.1957 
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In the Urry scale that is based on hydrophobic association, indolicidin was the most 
hydrophobic (both based on the entire peptide and also on a per residue basis) and alamethicin 
was the least hydrophobic, because of the large hydrophobicity estimates for tryptophan 
compared to the small estimates for alanine and valine.    In the Eisenberg consensus scale based 
on various transfer free energies, alamethicin was the most hydrophobic while SMAP-29 was 
hydrophilic, reflecting the total absence of charge on alamethicin and the presence of 10 charged 
groups on SMAP-29.  
A second characteristic used for analyzing amino acid sequences of membrane-related 
proteins is the hydrophobic moment, a measure of the amphiphilicity of the peptide. It is 
calculated for an amino acid sequence of N residues, with residue n having the hydrophobicity 
Φn from the definition, 
ߤு ൌ   ہሼΦ௡ cosሺߜ௔݊ሻሽଶ ൅ ሼΦ௡ sin ሺߜ௔݊ሻሽଶۂଵ/ଶ    (3.4) 
where δa is the angle (in radians) at which successive side chains emerge from the backbone 
when the peptide is viewed down its axis. For an α-helix, this angle is 100o.  The hydrophobic 
moment will be small for a helix where all residues are evenly distributed about the helix, and 
large for the case where most of the hydrophobic residues are on one side and most of the 
hydrophilic residues are on the other. Thus, the hydrophobic moment measures the extent of 
amphiphilicity of a helix. Any of the hydrophobicity scales could be used to provide the residue 
contributions Φn and we have used the Eisenberg consensus scale for this purpose. The 
calculated hydrophobicity moment per residue for all four peptides are also given in Table 3.3.  
The hydrophobic moment is the largest for alamethicin, indicating its preference for helical 
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secondary structure, and is the smallest for indolicidin, indicating the low probability of a α-
helix.  Both chrysophsin-3 and SMAP-29 have intermediate values of hydrophobic moment 
indicating a larger likelihood of α-helices. 
In contrast to the hydrophobicity scales established for amino acids based on 
experimental measurements of free energy change of some relevant processes (discussed in 
Appendix 4), methods based on data mining have also been developed to predict the 
hydrophobicity and amphiphilicity of polypeptides.46 Artificial neural networks were trained on a 
set of experimentally solved protein structures to predict properties including the relative surface 
accessibility of the amino acids and the probability of having a given secondary structure.  In this 
approach, a given amino acid does not have a fixed value for a property but it depends on where 
the amino acid occurs in the peptide chain. The solvent accessible surface area (ASA) of amino 
acid residues within a native folded protein is calculated by rolling a sphere the size of a water 
molecule over the protein surface. For comparative purposes, the ASA is transformed into a 
relative surface area, which is calculated as the ASA of a given amino acid residue in the 
polypeptide chain, relative to the one where the amino acid is in maximal possible exposure, 
with the residue in the center of a tri-peptide between either glycine or alanine residues. The 
neural networks were also trained on the same protein data set to learn the probability of a 
secondary structure for each amino acid depending on where it may occur in a polypeptide.  
Using the web-based tool NetSurfP where these neural network calculations can be 
implemented, we have calculated and plotted the relative solvent accessible surface area for the 
four peptides in Figure 3.12 and the probability of the residue being part of a α-helix in Figure 
3.13.  Since this neural network learning is based on a protein data set with experimentally 
solved protein structures, no information on the non-natural amino acids are available.  For the 
75 
 
purposes of our calculations, we have used alanine and valine as replacements for 
aminoisobutyric acid and phenylalanine for phenylalaninol while calculating for alamethicin and 
have provided two sets of results corresponding to either alanine (A) or valine (V).  The 
calculated results show a set of amino acids with larger surface accessibility and a set of amino 
acids with low surface accessibility for all peptides, suggesting the possibility of amphiphilic 
nature for their secondary structures.  The fact that such facial segregation may not occur for 
indolicidin is likely due to the small number of amino acids present in it.  The predicted 
probability of a residue having α-helical structure shown on Figure 3.13 clearly indicates that 
alamethicin, chrysophsin-3 and SMAP-29 can all have α-helical secondary structures while 
indolicidin has a random coil secondary structure (calculated data for random coils and beta 
structure are not plotted on the figure).  
 
Figure 3.12. Relative solvent accessible surface area of the amino acid residues in each peptide. Alanine 
(A) and valine (V) were used as replacements for aminoisobutyric acid and phenylalanine was substituted 
for phenylalaninol. These values were calculated using NetSurfP.46  
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Figure 3.13. Probability of amino acid residues having an -helical structure. These values were 
calculated using NetSurfP.46  
 
3.5  Discussion 
3.5.1  Linking peptide molecular structure to membrane interactions 
The calculated structural properties of hydrophobicity, accessible surface area and 
probability of α-helical secondary structures as well as the net charge on the peptide can be 
related to the molecular scale descriptions of peptide-membrane interactions derived from QCM-
D measurements.  In Figure 3.14, we summarize the molecular scale models for peptide-bilayer 
interactions by combining the results obtained from the QCM-D experiments with the insights 
provided by the calculated peptide properties.  
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Figure 3.14. Representative mechanistic models for alamethicin, chrysophsin-3, indolicidin, and SMAP-
29 action on a supported PC membrane. AMPs and lipids are shown in red and blue, respectively. 
 
For alamethicin, the dominant molecular event suggested by QCM-D data is pore 
formation over the range of concentrations studied. Alamethicin is amphiphilic with α-helical 
structure as determined by the calculated hydrophobic moment, relative accessible surface area 
and the probability for α-helical secondary structure. It has zero charges on the surface. It has the 
largest hydrophobicity among the four peptides in the Eisenberg scale, which is based on the free 
energy of transfer water to a second bulk phase or to an interface.  These molecular properties of 
alamethicin all promote its insertion into the bilayer creating pores, as part of the pore wall 
separating the lipid tails from water channels. Further, in the Urry scale which is based on 
hydrophobic association, the hydrophobicity of alamethicin is the smallest.  That would suggest 
that it is less likely that alamethicin is inserted into the bilayer either as a single molecule or as 
an aggregate devoid of water channel, even though it cannot be ruled out.  
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For chrysophsin-3, the dominant molecular events suggested by the QCM-D data include 
membrane insertion and pore formation, as well as surface adsorption. Chrysophsin-3 is 
amphiphilic with α-helical structure as shown by the calculated hydrophobic moment, relative 
surface accessibility and the probability for α-helical secondary structure.  Therefore it is 
reasonable to expect its presence in the bilayer as a part of pores, similar to alamethicin.  The 
four charges on chrysophsin-3 can contribute to attractive charge-dipole interactions with the 
zwitterionic head groups on the PC bilayer, thereby allowing the peptide to also be in the 
adsorbed state on the bilayer. At the same time, the four charges are all concentrated near the C-
terminus and the rest of the peptide is significantly hydrophobic as measured by both the Urry 
and Eisenberg scales.  Consequently, chrysophsin-3 can also just insert as a single molecule or as 
an aggregate into the bilayer. 
In the case of indolicidin, the dominant molecular events suggested by the QCM-D data 
include surface adsorption and partial insertion into the bilayer. The peptide is not amphiphilic, 
does not have the α-helical secondary structure and is really a random coil. Therefore, indolicidin 
does not promote pore formation in the bilayer (at least over the peptide concentration range 
studied).  The low probability of indolicidin being part of a pore wall separating hydrophobic 
tails of the lipid from water channels is also supported by the small magnitude of hydrophobicity 
on the Eisenberg scale. Indolicidin has four charges and has the largest hydrophobicity, among 
the four peptides, in the Urry scale because of the presence of the tryptophan residues. As a 
result it can strongly adsorb at the bilayer surface both through the attractive charge-dipole 
interactions as well as through hydrophobic association with the bilayer surface uncovered by the 
lipid head groups.  Further, because of the hydrophobicity and the coil-like conformation, it can 
also partially insert itself into the bilayer. 
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For SMAP-29, the QCM-D experiments suggest significant surface adsorption and also 
pore formation. Also, there was clear indication that the sample SMAP-29 used which contained 
a C-terminus cysteine had dimerized (this would not be relevant in the case of SMAP-29 without 
the cysteine modification). The calculated hydrophobic moment, accessible surface area and 
probability of α-helical secondary structure are all consistent with the possibility of pore 
formation with the peptide being at the pore walls. The large number of ten charges on the 
peptide supports the idea of strong surface adsorption through attractive charge-dipole 
interactions as well as hydrophobic association. The significantly large mass changes observed in 
the QCM-D required consideration of the peptide dimers and could not be explained if 
dimerization had not occurred.  
3.5.2  QCM­D “fingerprinting” clearly differentiates antimicrobial peptides 
The most interesting conclusion from this study, however, is the recognition that QCM-D 
provides many unique signatures or fingerprints to differentiate the action of antimicrobial 
peptides.  The most obvious and easy to observe fingerprint was the static (actually difference 
between two steady-state conditions which we have termed static for simplicity) net frequency 
change and net dissipation change caused solely by the peptide, at different overtones and at 
different peptide concentrations as shown on Figures 3.3, 3.5, 3.7 and 3.9. Even if we had not 
been able to interpret these data in molecular mechanistic terms, there is no denying the obvious 
differences in the signatures shown by each of the four peptides. A second unique fingerprinting 
was provided by the dynamic Δf-ΔD plots, as shown on Figures 3.4, 3.6, 3.8 and 3.10. Although 
not as obvious as the static data, these dynamic data also showed significant variations in the 
multistep interactions of the peptides with the bilayer.  A third fingerprint was the data 
quantifying the initial stage of contact of the peptide with the bilayer as shown on Figure 3.11. 
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Changes in the membrane occurred quickly in the first stage followed by a slower process. Both 
the time duration of this first stage as well as the rate or intensity of change in this first stage 
were peptide-specific. We believe that it may be possible to identify yet other unique signatures 
by performing additional data mining of the rich steady state and dynamic measurements derived 
from the QCM-D experiments,   
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4.1  Abstract 
Antimicrobial peptides (AMPs) are naturally occurring polymers that can kill bacteria by 
destabilizing their membranes. Quartz crystal microbalance with dissipation monitoring (QCM-
D) was used to better understand the action of the AMP chrysophsin-3 on supported lipid 
bilayers (SLB) of phosphatidylcholine. Interaction of the SLB with chrysophsin-3 at 0.05 μM 
demonstrated changes in frequency (∆f) and energy dissipation (∆D) that were near zero, 
indicating little change in the membrane. At higher concentrations of chyrsophsin-3 (0.25 - 4 
μM), decreases in ∆f of up to 7 Hz were measured. These negative frequency changes suggest 
that mass was being added to the SLB, possibly due to peptide insertion into the membrane. At a 
chrysophsin-3 concentration of 10 μM, there was a net mass loss, which was attributed to pore 
formation in the membrane. QCM-D can be used to describe a mechanistic relationship between 
AMP concentration and interaction with a model cell membrane.  
 
4.2  Introduction 
Antimicrobial peptides (AMPs) serve as a natural defense for living organisms against 
pathogenic bacteria. They can be derived from various organisms, including frogs, moths, and 
pigs, as well as synthesized.1, 2 AMPs exhibit broad-spectrum activity against bacteria and are 
less prone to the development of pathogen resistance than antibiotics. Increasing concerns over 
antibiotic-resistant pathogens and public health issues have led to interest in using AMPs 
therapeutically and in self-decontaminating surfaces.3, 4 For example, omiganan, a synthetic 
cationic peptide, has been shown to inhibit the growth of pathogens that cause catheter-
associated infections, such as Gram-positive Staphylococcus aureus and Gram negative 
Pseudomonas aeruginosa (P. aeruginosa).5 
86 
 
The ability of AMPs to avoid pathogen resistance is largely due to the mechanism by 
which they kill bacteria. AMPs attach to bacterial cell membranes and, at a critical concentration, 
cause the cells to lyse by disrupting the membrane.6 However, the mechanism of cell lysis is not 
well understood. The attachment of AMPs to cells, such as cecropin P1 to E. coli, has been 
studied, but questions remain on the exact nature of the cecropin P1-E. coli interaction.7, 8 
Detailed knowledge of the mechanism behind AMP action is essential for developing 
applications that make use of AMPs, such as biosensors or AMP-coated materials. 
Two main theories have been proposed to explain how AMPs destabilize bacterial cell 
membranes. In each case, the AMPs first attach to components of bacterial surfaces through 
electrostatic interactions.9 The carpet model supposes that AMPs align themselves parallel to the 
membrane surface, which is facilitated by their amphipathicity. AMPs surround the lipids and 
micelles break off from the lipid membrane. In the barrel-stave model, the AMPs insert 
themselves into the bacterial cell membrane perpendicularly and form a pore.10, 11 The pores 
enable large molecules to enter or exit the cell and disrupt ion gradients, causing the cell to die. 
The disruption of the lipid membrane may also allow AMPs to enter the cell and destroy 
intracellular components.8 The mechanism is thought to differ among AMPs and is related to the 
structure and charge of the peptide, as well as the lipid composition of the cell membrane.12, 13 
For some cases, both micelle formation and pore insertion may occur, depending on the peptide-
to-lipid concentration ratio.14 
The peptide investigated in this study is chrysophsin-3, a histidine-rich AMP that is found 
in red sea bream gills. The red sea bream, Chrysophrys major, secretes AMPs from exposed 
areas, such as gills, to defend itself against bacterial infection.15 Chrysophsin-3 consists of 20 
amino acids in an α-helical structure, which is highly cationic and amphipathic (Figure 4.1). It 
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exhibits antimicrobial activity against Gram-positive and Gram-negative pathogenic bacteria and 
exhibits hemolytic activity at approximately 1 μM.16 AMPs have been shown to be effective 
against P. aeruginosa in vivo using rat models, suggesting that AMPs may still be used 
clinically, despite their hemolytic properties.17 Peptide mimics may also play a role in 
therapeutic treatments, as chrysophsin-3 can be made less harmful to eukaryotic cells by 
removing the characteristic C-terminal RRRH amino acid sequence.18 
 
Figure 4.1. Helical wheel diagram of chrysophsin-3. The diagram represents the peptide viewed along the 
axis of the helix, in which the peptide backbone is shown by the inner circle and the spokes represent 
amino acids. The amino acids are numbered according to their sequence. The helical wheel diagram 
reveals the concentration of amino acids with positively charged side chains on one side of the helix and 
the clustering of non-polar, aliphatic side chains.  
 
In this study, a supported phosphatidylcholine (PC) bilayer was used as a model 
zwitterionic membrane to observe the interaction between chrysophsin-3 and a cell. Phospholipid 
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vesicles have been studied extensively for their ability to self-assemble into planar bilayers on 
solid surfaces.19, 20 
Quartz crystal microbalance with dissipation (QCM-D) monitoring was used to 
investigate the mechanism behind the peptide-lipid system of chrysophsin-3 and PC. QCM-D 
has become a valuable tool for monitoring real-time mass changes of various biological systems, 
including fatty acid attachment to supported lipid bilayers and cell adsorption to fibronectin.21, 22 
Frequency and dissipation measurements at various overtones can be used to determine the 
nature of mass attachment to a quartz sensor crystal.  
Overtone analysis was used by Mechler et al. to infer details about the fundamental 
mechanisms behind AMP action on supported bilayers. Similar changes in frequency (∆f) and 
dissipation (∆D) at all overtones indicate a homogeneous change in mass and viscoelasticity of 
the membrane on the crystal’s surface. Studies exposing lipids 1,2-dimyristoyl-sn-glycero-3-
phosphocholine (DMPC) and 1,2-dimyristoyl-sn-glycero-3-phospho-rac-(1-glycerol) (DMPG) to 
1 to 20 μM concentrations of peptides aurein 1.2, maculatin 1.1, and caerin 1.1 resulted in 
qualitative and quantitative differences in the frequencies that were specific to each system.23  
Monitoring overtone similarity can provide significant information about the mechanism 
of action of AMPs on a lipid bilayer surface. The barrel-stave model for peptide-membrane 
interactions should ultimately result in uniformly negative ∆f and ∆D values at all overtones, 
which would represent cylindrical pore formation (Figure 4.2B, F). In the case of toroidal pore 
formation, however, more lipid would be lost at the top and bottom of the bilayer and replaced 
by pore-forming peptides, resulting in heterogeneous frequency changes at different overtones 
(Figure 4.2D). Initial adsorption of AMPs onto the membrane surface will theoretically result in 
non-homogeneous negative changes in frequency if no other action occurs (Figure 4.2A). Since 
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the changes occur primarily on the surface of the membrane, the adsorption process will not be 
homogeneous throughout the membrane, which would result in different response at various 
overtones. Combinations of membrane surface adsorption and pore formation will result in non-
uniform ∆f results across overtones (Figure 4.2C). Given that a full PC bilayer (~5 nm thick) 
assembled on a clean QCM-D crystal corresponds with a ∆f of ~-26 Hz, we can calculate the 
approximate ∆f due to adsorption of a monolayer of -helical peptides (~1.2 nm thick) to be ~2-
4 Hz.20, 24 Therefore, if the carpet model is operative, membrane lysis will be demonstrated 
through uniform positive ∆f values up to 26 Hz at all overtones (Figure 4.2E, G).  
 
Figure 4.2. Possible mechanisms of peptide action on cell membranes (A-E) and corresponding estimated 
∆f values (F-G). A) Monolayer of peptide adsorbed on the lipid bilayer surface. B) Cylindrical pore 
formation. C) Pore formation with adsorption. D) Toroidal pore: lipids bend at the pore site to create a 
toroidal shape around peptides forming a pore. E) Large pore formation. Negative ∆f values indicate 
mass addition (F), which may occur in A-D. Positive ∆f values indicate mass removal (G), which 
corresponds to the large pore formation shown in E. The baseline at ∆f = 0 would indicate the 
presence of a bilayer on the QCM-D crystal.  
 
 The action of chrysophsin-3 on a PC membrane supported on a QCM-D sensor crystal 
was monitored in real-time in this study. Changes and frequency and dissipation were monitored 
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when chrysophsin-3, at concentrations between 0.05 μM and 10 μM, interacted with the PC 
bilayer. Values of ∆f and ∆D were also monitored after rinsing the system with buffer to remove 
any unattached particles and to reveal the irreversible effect of peptide on the lipid bilayer. 
QCM-D data is used to propose a mechanism for how chyrsophsin-3 interacts with cell 
membranes.  
4.3  Experimental methods 
4.3.1  Vesicle and peptide preparation 
Lyophilized powder PC derived from chicken egg yolk was purchased from Sigma 
Aldrich (St. Louis, MO) and Avanti Polar Lipids (Alabaster, AL). PC was dissolved in ethanol to 
create 100 mg/mL stock solutions that were stored at -15˚C. A buffer of 100 mM sodium 
chloride and 10 mM tris(hydroxymethyl)aminomethane (Sigma-Aldrich, St. Louis, MO) at pH 
7.9 was prepared in ultrapure water.25 
The PC stock solution was measured and dried with nitrogen gas to remove the ethanol. 
Dried lipids were placed in a vacuum desiccator overnight and suspended in buffer at 2.5 
mg/mL.26 The lipid mixture was vortexed and homogenized through five freeze-thaw and 
subsequent vortexing cycles.20  
Small unilamellar vesicles (SUVs) were formed by sonicating the mixture in a glass test 
tube with an ultrasonic dismembrator (Model 150T, Fisher Scientific, Waltham, MA) for 30 min 
in pulsed mode with a 30% duty cycle (3-second pulse at an amplitude of 60, followed by a 7-
second pause) at 0˚C. Probe particles were removed from the solution through centrifugation 
(Sorvall Discovery 100SE, Kendro, Newtown, CT) at 15,000 rpm (38,500g) for 10 min at 4˚C. 
The supernatant containing the SUVs was collected and stored at 4°C under nitrogen for up to 5 
weeks.20 Dynamic light scattering experiments (Zetasizer Nano ZS, Malvern, Worcestershire, 
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UK) revealed the size of the vesicles to be approximately 37 nm in diameter. The stock solution 
was diluted to 0.1 mg/mL for each experiment. 
Chrysophsin-3 (FIGLLISAGKAIHDLIRRRH) was purchased from Bachem (Torrance, 
CA) and stored at -15 ˚C. Samples were prepared at chyrsophsin-3 concentrations of 0.05, 0.25, 
1, 2, 4, and 10 μM in tris buffer. Solutions were brought to 23°C before use in experiments. 
4.3.2  Quartz crystal microbalance with dissipation monitoring (QCM­D) 
QCM-D measurements were performed using the Q-SENSE E4 system (Biolin Scientific, 
Sweden). Quartz sensor crystals were placed into the QCM-D’s four chambers and exposed to 
solutions of buffer, lipids, or peptides. We measured overtones, or harmonics, of the resonant 
frequency and the energy dissipation of the sensors as mass attached to the exposed silica-coated 
surfaces. The normal mass and dissipation sensitivities of QCM-D measurements in liquid are 
~1.8 ng/cm2 and ~0.1 x 10-6, respectively.  
The Sauerbrey equation describes the relationship between ∆f and change in mass (∆m) 
in a rigid film: 
     ∆݂ ൌ ିଶ௙బమ஺ඥఘ೜ఓ೜ ∆݉     (4.1) 
where f0 is the resonant frequency of the quartz crystal (5 MHz), A is the peizoelectrically active 
crystal area, q is the density of quartz (2.648 g/cm3), and μq is the shear modulus of the crystal 
(2.947 x 1011 g/cm·s2). Therefore, the change in frequency is inversely related to the change in 
mass attached to the sensor. However, in the case of a less rigid film, the Sauerbrey equation 
must be adjusted to reflect the effects of a viscoelastic film and the bulk solution.27, 28 Changes in 
dissipation are related to the rigidity of the film and can be described by 
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     ܦ ൌ ீ"ଶగீ′      (4.2) 
where G” is the loss modulus and G’ is the storage modulus. A softer film will result in a larger 
∆D. 
Different harmonics of a sensor crystal can be correlated with changes in various depths of a film 
deposited on the crystal. The penetration depth, , of an acoustic wave can be found: 
     ߜ ൌ ൬ ೑௡గ௙బ೑൰
ଵ ଶൗ
     (4.3) 
where f is the viscosity of the film, n is the overtone number, and f is the density of the film.29 
Penetration depths of various overtones are greater in the membrane than in water (Table 4.1). 
Table 4.1. Penetration depths of different overtones in water and in a membrane.  
overtone 
number 
penetration depth in water
(f = 1 g·cm-3, ηf = 0.01 g·cm-1·s-1)a 
penetration depth in membrane 
(f = 1 g·cm-3, ηf = 1 g·cm-1·s-1)a 
3 146 nm 1460 nm 
5 113 nm 1130 nm 
7 95 nm 950 nm 
9 84 nm 840 nm 
11 76 nm 760 nm 
a f and f are the density and viscosity of the film, respectively. 
 QCM-D measurements can be sensitive to changes in viscosity and density of the bulk 
solution, which can complicate interpretation of the data. Bordes and Höök developed methods 
to quantify the bulk response and separate the bulk effect from the response of the adsorbed 
mass. The measured ∆f is effectively a sum of the ∆f of the adsorbed mass and ∆f of the bulk 
solution (where the frequencies are normalized to each overtone).30 The bulk solution effect in 
these experiments, which consists of the buffer, lipids, and/or AMPs, was determined to be 
negligible at the measured harmonics, which were the 3rd-11th harmonics of the sensor crystal’s 
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natural frequency (5 MHz). Due to the low concentrations of AMPs and lipids used, the viscosity 
and density of the solutions would not change enough to produce a significant effect on the 
measured frequencies. The measured harmonics were normalized to each overtone (f/n, where f 
is frequency and n is the harmonic number) by the Q-SENSE software. The fundamental 
frequency was not analyzed due to a higher sensitivity to changes in the bulk solution during 
flow.23  
 
4.3.3  Sensor preparation 
Silica-coated sensor crystals were placed into the QCM-D flow chambers and cleaned by 
flowing ultrapure water, 2% sodium dodecyl sulfate solution (Sigma, St. Louis, MO), and 
ultrapure water through the system. The sensors and chambers were dried with nitrogen gas. A 
Plasma Prep II oxygen plasma cleaner (SPI Supplies, West Chester, PA) was used to etch the 
sensor surface before each experiment to remove the outer atomic layers of the crystal surface 
and make it more hydrophilic. This latter step facilitates vesicle rupture into a bilayer. 
4.3.4  Bilayer formation and peptide exposure 
Buffer was flowed over QCM-D sensors at 0.15 mL/min for ~15 min. until the frequency 
and dissipation responses were stable. The lipid SUV solution was flowed over the crystals for 
~8 min. to form a stable supported lipid bilayer (SLB). The crystals were rinsed with buffer to 
remove any unattached lipids. After establishing a baseline, peptide solution was added for 10 
min., at which time the pump was stopped. QCM-D crystals were exposed to a stagnant peptide 
solution for 1 hr, after which, the peptide solution was replaced with a final buffer rinse at 0.15 
mL/min until the frequency stabilized. Each experiment was repeated at least 3 times for each 
concentration of chrysophsin-3. 
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4.4  Results   
Bilayer formation was monitored by observing patterns in QCM-D frequency and 
dissipation responses. During bilayer formation, lipid vesicles first attach to the QCM-D sensor 
surface, adding mass. The vesicles then burst, releasing the fluid within the vesicle and creating a 
supported lipid bilayer.31, 32 Typically, the frequency decreased by ~80 Hz when vesicles 
adsorbed, and showed an increase as soon as the vesicles ruptured to form the bilayer (Figure 
4.3). The dissipation showed a characteristic increase to ~6 x 10-6 in response to the attachment 
of the water-filled vesicles. After bilayer formation, dissipation decreased because the bilayer is 
more rigid than vesicles. A complete bilayer could be characterized by a final ∆f of ~26 Hz and 
change in dissipation (∆D) of ~1 x 10-6 in the 3rd harmonic. 
 
 
Figure 4.3. Typical QCM-D response for PC bilayer formation. (1) Initial buffer baseline, (2) vesicle 
deposition, (3) vesicle rupture and release of water, (4) stable bilayer. The lines represent different 
overtone responses for frequency and dissipation. 
 
When peptide was added and allowed to remain in contact with the bilayer, changes in 
frequency and dissipation were monitored continuously for ~60 min (Figure 4.4). Typical 
frequency responses at all overtones showed an initial decrease in frequency, and therefore an 
increase in mass, on the crystal as peptides attached to the bilayer (Figure 4.5). The frequency 
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response produced using the 0.05 μM solution of chrysophsin-3 showed the smallest change of 
the concentrations tested (Figure 4.5A). Between chrysophsin-3 concentrations of 0.25 μM and 2 
μM, the frequency decreased up to several Hz upon peptide exposure (Figure 4.5B-D). At higher 
chrysophsin-3 concentrations, dissipation values increased upon the sensor’s contact with the 
peptide solution, suggesting that the film upon the sensor crystal became less rigid, or more 
saturated with fluid (Figure 4.4B). The subsequent buffer rinse resulted in a decrease in mass on 
the crystal and a more rigid film. Exposure to peptide at 4 μM and 10 μM concentrations also 
caused ∆f to decrease rapidly, and this gradually stabilized to a value between -6 and -7 Hz, 
suggesting that the peptides approached a critical concentration on the supported lipid bilayer 
surface (Figures 4.5 E-F). 
 
 
Figure 4.4. Typical frequency (A) and dissipation (B) responses for PC bilayer formation and subsequent 
chrysophsin-3 deposition. This experiment represents a chrysophsin-3 concentration of 4 μM. (1) Initial 
buffer baseline, (2) lipid vesicle deposition, (3 and 5) buffer rinse, (4) peptide addition.  
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Figure 4.5. Typical concentration-dependent QCM-D responses in the 3rd harmonic for PC bilayers 
exposed to chrysophsin-3 at (A) 0.05 μM, (B) 0.25 μM, (C) 1 μM, (D) 2 μM, (E) 4 μM, (F) 10 μM 
chrysophsin-3 concentrations. The initial time of 0 min corresponds to time position (4) in Figure 4.4 and 
the final buffer rinse occurs at about 70 to 80 min, which corresponds to time position (5) in Figure 4.4. 
 
Data were analyzed in terms of ∆f and ∆D at all measured overtones before and after the 
final buffer rinse. The first measurement represents the stable state reached after 1 hr of peptide 
exposure, while the second measurement taken after the buffer rinse shows the irreversible 
change due to peptide-bilayer interactions. The ∆f was calculated by taking the difference 
between frequencies at the beginning of peptide exposure and before (Figures 4.6, 4.7) or after 
the subsequent buffer rinse (Figures 4.8, 4.9):23 
    ∆݂ ൌ ൫∆ b݂ilayer and peptide െ ∆ b݂ilayer൯ ଵ௡    (4.4) 
At a very low concentration (0.05 μM chrysophsin-3), the peptide did not destabilize the bilayer, 
and ∆f and ∆D were typically small, positive, and uniform across all overtones (Figures 4.6A, 
4.7A, 4.8A, 4.9A). The average ∆f for 0.25 μM chrysophsin-3 was between -0.7 Hz and -1.0 Hz 
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(Figures 4.6B, 4.8B) and the average ∆D was positive (Figures 4.7B, 4.9B). At intermediate 
chrysophsin-3 concentrations of 1, 2, and 4 μM, the greatest decreases in frequency and increases 
in dissipation occurred at the 3rd harmonic. The changes became less pronounced at higher 
overtones (Figures 4.6C-E, 4.7C-E, 4.8C-E, 4.9C-E). For the highest concentration tested (10 
μM chrysophsin-3), non-homogeneous ∆f and ∆D values were produced at the stable stage 
before the buffer rinse (Figures 4.6F, 4.7F). However, positive ∆f values were observed at all 
overtones after the buffer rinse (Figure 4.8F), while the ∆D values were lower than those for 1, 2, 
and 4 μM and before the buffer rinse (Figure 4.9 F).  
 
 
Figure 4.6. Average ∆f at different overtones for (A) 0.05 μM, (B) 0.25 μM, (C) 1 μM, (D) 2 μM, (E) 4 
μM, (F) 10 μM chrysophsin-3 concentrations, before the buffer rinse. The graphs show the amount of 
mass that is attached to or removed from the bilayer after the SLB was exposed to chrysophsin-3 for 1 hr. 
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Figure 4.7. Average ∆D at different overtones for (A) 0.05 μM, (B) 0.25 μM, (C) 1 μM, (D) 2 μM, (E) 4 
μM, (F) 10 μM chrysophsin-3 concentrations, before the buffer rinse. The changes reveal the 
homogeneous (at 0.05 and 0.25 μM concentrations) and heterogeneous (at larger concentrations) nature of 
the viscosity of the mass after exposure of the lipid bilayer to chrysophsin-3 for 1 hr. 
 
 
Figure 4.8. Average ∆f at different overtones for (A) 0.05 μM, (B) 0.25 μM, (C) 1 μM, (D) 2 μM, (E) 4 
μM, (F) 10 μM chrysophsin-3 concentrations, after the buffer rinse. The changes show the amount of 
mass that is not removed by the final buffer rinse and is irreversibly attached to the crystal surface. 
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Figure 4.9. Average ∆D at different overtones for (A) 0.05 μM, (B) 0.25 μM, (C) 1 μM, (D) 2 μM, (E) 4 
μM, (F) 10 μM chrysophsin-3 concentrations, after the buffer rinse.  
 
4.5  Discussion 
4.5.1  Formation of supported lipid bilayer 
The ∆f values corresponding to PC bilayer formation were compared to published 
values.20 According to prior researchers, a PC bilayer on silica corresponds to an initial ∆f of 
about -70 Hz, and a net change of -26 Hz, which are similar to what we observed. However, our 
initial ∆f was slightly higher at -80 Hz, which may be attributed to the use of Texas Red DHPE 
in this previous study, which we did not use.20 Supported PC bilayers can be made reproducibly 
and easily on silica surfaces, which has led to them being used widely as model cell 
membranes.24, 32, 33 
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4.5.2  Mechanism of chrysophsin­3 action on PC bilayer 
Once formation of the PC bilayer was validated through ∆f and ∆D data, various 
concentrations of chrysophsin-3 were introduced to the membrane. At 0.05 μM chrysophsin-3, 
small ∆f values (<1 Hz) were observed for each overtone (Figure 4.6A, 4.8A) and small, positive 
∆D values were recorded before and after the final buffer rinse (Figure 4.7A, 4.9A). These 
results indicate that little or no mass change occurred in the bilayer. A small ∆f (~0.4-0.7 Hz) 
was seen in the 3rd harmonic, which indicates a small amount of non-homogeneity in AMP 
action. The difference was not uniform at all overtones, and the positive ∆f indicates that small 
amounts of mass are being removed after the final buffer rinse. Only a small fraction of lipid 
mass was removed, however, since the ∆f values were much less than 26 Hz, which corresponds 
to removal of the full bilayer. 
The frequency data for 0.25 μM chrysophsin-3 resulted in ∆f values of ~-1 Hz (Figure 
4.6B, 4.8B) and positive ∆D for all recorded overtones before and after the buffer rinse (Figure 
4.7B, 4.9B), which indicates that the final buffer rinse did not significantly affect the mass and 
viscoelasticity of the membrane. Relatively uniform mass changes were observed at all measured 
overtones of the bilayer, which indicates that mass changes were homogeneous at all depths of 
the bilayer. The positive ∆D values observed at all overtones suggest that the membrane became 
less rigid with the addition of peptide. The ∆f and ∆D data combined indicate cylindrical pore 
formation may have occurred, as peptides are positioned perpendicularly through the lipid 
bilayer and the mass changes at all depths are similar (Figure 4.10A). Also, the creation of pores 
would allow more water to enter the membrane space, making the film less rigid. At the 3rd 
harmonic, a mass change similar to that of the other overtones was observed. Therefore, the 
peptides that attached to the SLB likely formed pores and did not remain on the bilayer surface, 
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which would have resulted in heterogeneous changes and non-uniform responses. The difference 
in results at these low concentrations indicates that chrysophsin-3 will begin to form pores in the 
PC membrane at some critical concentration between 0.05 μM and 0.25 μM. 
 
 
Figure 4.10. A proposed mechanism of chrysophsin-3 action on a supported PC bilayer as a function of 
peptide concentration. A) At low chrysophsin-3 concentrations (~0.25 μM), peptides prefer insertion into 
the membrane over adsorption onto the surface. B) As the concentration increases (~1 μM), peptides 
continue to form pores and begin to adsorb onto the bilayer surface. C) The amount of peptides adsorbed 
on the bilayer surface and inserted to form pores increases (~2 μM). D) At a certain critical concentration 
(~4 μM), peptide-lipid aggregates begin to be removed from the membrane. E) Large concentrations of 
chrysophsin-3 (~10 μM) result in the loss of large areas of the bilayer. 
 
At 1, 2, and 4 μM concentrations, the 3rd harmonic exhibited the most mass addition (∆f) 
after peptide exposure and after the final buffer rinse. The other ∆f values decreased in absolute 
magnitude with increasing overtones (Figures 4.6C-E, 4.8C-E). The 3rd harmonic also 
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demonstrated behavior of a less rigid film (∆D) compared to the other harmonics, which also 
decreased as the overtones increased (Figures 4.7C-E, 4.9C-E). This indicates that the mass 
changes and viscoelasticity changes were heterogeneous throughout the membrane. One possible 
interpretation of these results is a large amount of peptide absorbed to the bilayer surface, 
resulting in non-uniform change in the bilayer. The ∆D results suggest that the film may be 
“softer” at the liquid-membrane interface due to the presence of water between the peptide 
molecules and the less rigid structure of the peptides adsorbed to the membranes. Since 
chrysophsin-3 formed cylindrical pores at 0.25 μM, the system likely consists of both pores and 
adsorbed AMPs at 1, 2, and 4 μM concentrations. In the proposed mechanism, the peptides 
adsorbed onto the surface of the SLB and formed pores in the membrane, as in the barrel-stave 
model (Figure 4.10B, C). The frequency response curve for 4 μM chrysophsin-3 shows the 
AMPs adsorbed on the lipid membrane rapidly reaching saturation, due to the ∆f reaching steady 
state at -6.5 Hz (Figure 4.5E). 
At a concentration of 10 μM, chrysophsin-3 addition to the PC bilayer resulted in 
negative ∆f values at the 3rd harmonic and positive ∆f values at higher overtones after 1 hour of 
peptide exposure (Figure 4.6F). However, the buffer rinse produced uniform positive ∆f values at 
all overtones (Figure 4.8F). The raw frequency data showed an initial mass addition on the PC 
bilayer surface upon exposure to the AMP, followed by a decrease in mass that seemed to 
approach steady state (Figure 4.5F). These results suggest that at high concentrations, 
chrysophsin-3 initially adsorbs to the surface of the bilayer, forms pores in the membrane, and 
gradually causes mass removal, which may be in the form of peptide-lipid aggregates (Figure 
4.10D, E). The mass loss was also increased by rinsing the system with buffer. The dissipation 
results suggest that the film became less rigid after 1 hour of peptide exposure (Figure 4.7F), but 
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more rigid after the buffer rinse (Figure 4.9F). The membrane also became more rigid with 10 
μM chrysophsin-3 than it did at lower chrysophsin-3 concentrations. This could be due to the 
remaining large “islands,” or areas, of lipids on the crystal surface surrounded by large regions of 
water created by mass lipid removal. The water may not be incorporated into the membrane as it 
is when there are fewer pores in the membrane, causing the measured film to be composed of the 
more rigid PC bilayer. 
Mechler et al. followed a similar procedure to investigate the action of the peptides caerin 
1.1, maculatin 1.1, and aurein 1.2 on DMPC and DMPC/DMPG (4:1) bilayers using QCM-D. 
The negative ∆f resulting from chrysophsin-3 in this experiment correlated most closely with 
those of caerin 1.1, a 25-amino acid AMP isolated from the skin of the Australian tree frog23. 
Like chrysophsin-3, caerin 1.1 also exhibits an amphipathic -helical conformation at the cell 
membrane surface.34 On a DMPC bilayer, larger ∆f values were measured for the 10 μM and 20 
μM caerin 1.1 concentrations, which were significantly larger than those used in this study. The 
results for maculatin 1.1 revealed a critical concentration between 5 μM and 7 μM at which the 
system transitioned between overall mass removal and mass addition. Aurein 1.2 also appeared 
to exhibit different behavior at higher overtones between 7 μM and 10 μM solutions. The much 
smaller critical concentration of chrysophsin-3 may be attributed to the difference in peptide 
composition and structure, as well as the different lipids used in the membrane. Chrysophsin-3 
has a higher molecular weight than aurein 1.2 and maculatin 1.1.16, 23 Also, DMPC has a lower 
molecular weight than PC; the latter of which may be more conducive to pore formation. 
4.5.3  Relating QCM­D results to chrysophsin­3 activity against bacteria 
Pore formation can represent the start of the killing process in bacteria. Chrysophsin-3 
has been tested for its antimicrobial activity against some Gram-negative and Gram-positive 
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bacteria, although the lethal concentration is different for each case. Iijima et al. found 0.25 μM 
to be the minimal lethal concentration of chrysophsin-3 required to kill 99% of Bacillus subtilis 
or Escherichia coli. Certain strains of Gram-positive and Gram-negative pathogenic bacteria, 
such as Lactococcus garvieae and Vibrio anguillarum, required 10 μM synthetic chrysophsin-3 
to achieve the same level of killing, while other strains were resistant or required as low as 5 μM 
chrysophsin-3.16 Research from our laboratory has shown that 0.22 mM chrysophsin-3, with 
added inosine and L-alanine, was needed to kill 99% of spores of B. anthracis, the cause of 
anthrax, and this killing occurred within one hour of exposure. Inosine and L-alanine are 
germination agents that promote the breakdown of the spore coat. Without any germinants, the 
same concentration of chrysophsin-3 killed about 80% of B. anthracis spores.35  
In QCM-D experiments, we showed that at 0.25 μM chrysophsin-3, pore formation began 
to develop along the thickness of the membrane. At a much higher concentration of 10 μM, pore 
formation was greater and more mass was lost from the lipid bilayer membrane. These results 
seem consistent with the observed range of experimental lethal concentrations on bacterial cells. 
It is not yet known how specific differences in the lipid composition affect the ability to break 
down the membrane. The lipid PC, which we used in the present studies, has a zwitterionic 
headgroup. This is similar to the zwitterionic headgroup of E. coli and other Gram-negative 
bacterial membrane lipids.36 Gram-positive bacteria, including Bacillus spp., have negatively 
charged headgroups in their lipid membranes.36  
 
4.6  Conclusions 
QCM-D frequency and dissipation data were used to elucidate the mechanism of AMP 
action on SLBs. Our results demonstrate that the nature of chrysophsin-3 interactions with a PC 
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bilayer is concentration-dependent. The AMP appears to destabilize the model membrane by 
forming pores and leaving the bilayer via peptide-lipid aggregates. QCM-D was shown to be an 
effective technique for studying AMP and SLB interactions. This method can be applied to other 
systems of peptides and lipid bilayers to provide a better understanding of AMP action on cell 
membranes. 
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5.1  Abstract 
Alamethicin is a 20-amino-acid, -helical antimicrobial peptide that is believed to kill 
bacteria through pore formation in the inner membranes. We used quartz crystal microbalance 
with dissipation monitoring (QCM-D) to explore the interactions of alamethicin with a supported 
lipid bilayer. Changes in frequency (∆f) and dissipation (∆D) measured at different overtones as 
a function of peptide concentration were used to infer peptide-induced changes in the mass and 
rigidity of the membrane as well as the orientation of the peptide in the bilayer. The measured ∆f 
were positive, corresponding to a net mass loss from the bilayer, with substantial mass losses at 5 
M and 10 M alamethicin. The measured ∆f at various overtones were equal, indicating that the 
mass change in the membrane was homogeneous at all depths consistent with a vertical peptide 
insertion. Such an orientation coupled to the net mass loss was in agreement with cylindrical 
pore formation and the negligibly small ∆D suggested that the peptide walls of the pores 
stabilized the surrounding lipid organization. Dynamics of the interactions examined through ∆f 
vs. ∆D plots suggested that the peptides initially inserted into the membrane and caused 
disordering of the lipids. Subsequently, lipids were removed from the bilayer to create pores and 
alamethicin caused the remaining lipids to reorder and stabilize within the membrane. Based on 
model calculations, we concluded that the QCM-D data cannot confirm or rule out whether 
peptide clusters coexist with pores in the bilayer. We have also proposed a way to calculate the 
peptide-to-lipid ratio (P/L) in the bilayer from QCM-D data and found the calculated P/L as a 
function of the peptide concentration to be similar to the literature data for vesicle membranes. 
5.2  Introduction 
Antimicrobial peptides (AMPs) are naturally occurring molecules that target and kill a 
broad spectrum of pathogenic bacteria, fungi, and viruses. All eukaryotic organisms that have 
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been analyzed for the production of AMPs, such as fish, frogs, and moths, have been found to 
express these molecules.1, 2 AMPs, which are largely cationic and amphiphilic, are believed to 
kill bacteria by interacting with their negatively charged membranes. Once associated with the 
bacterial cell surface, AMPs can kill bacteria either by destabilizing the membrane or by 
translocating through the membrane to interact with intracellular targets. Because of this 
membrane destabilizing mechanism, the AMPs are less prone to the development of pathogen 
resistance than antibiotics.3-6 Their broad spectrum of activity, lower levels of bacterial 
resistance, and the speed of their action on pathogens, hold promise for AMPs as alternatives to 
antibacterials, therapeutically and in self-decontaminating surfaces.7, 8  
AMPs exist in solution with various secondary structures.  When in contact with the 
membrane, many AMPs assume an -helical secondary structure3, with clearly differentiated 
hydrophilic and hydrophobic surfaces.  They attach to and interact with lipid membranes through 
electrostatic interactions as well as through their hydrophobic and polar domain properties.3 A 
fundamental model for AMP-membrane interactions has been advanced by Huang based on the 
proposition that the peptide exists in two distinct states in the membrane.9-12  At very low peptide 
to lipid (P/L) ratios, the peptides are considered to be in adsorbed mode, referred to as the 
“surface” or “S” state, with the peptides embedded in the lipid head group region of the bilayer 
(Figure 5.1A). The resulting displacement of lipid head groups causes thinning of the lipid 
membrane.9, 11  This perturbation of the lipids, at sufficiently high peptide to lipid ratios, drives a 
phase transition of the peptide to the “inserted” or “I” state wherein the peptides insert into the 
membrane, giving rise to the barrel-stave or cylindrical pores (Figure 5.1B). Some AMPs are 
presumed to form a different kind of pore structure in which the lipid head groups bend 
continuously from the outer membrane leaflet to the inner leaflet, giving rise to toroidal pores in 
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which the peptides are always in contact with the lipid headgroups. (Figure 5.1B).13, 14 Once 
cylindrical or toroidal pores form, the cell is permeabilized, causing the cell to die.  
 
Figure 5.1. Mechanistic models of AMP action on lipid membranes with -helical peptides represented 
as coils and lipids represented with headgroups and attached tails. (A) Peptide adsorption on the 
membrane surface or the “S” state, (B) peptide insertion into the bilayer resulting in cylindrical pore (“I” 
state) or toroidal pore formation, and (C) membrane disruption with the formation of lipid-peptide 
aggregates (“Carpet” model). 
 
 
Another mode of interaction known as the carpet model [14] supposes that AMPs first 
align themselves parallel to the lipid membrane surface (Figure 5.1A) and at a large enough 
surface concentration of the peptide, directly cause membrane disintegration through the 
formation of  peptide-lipid aggregates (micelles or bicelles) that detach from the membrane 
(Figure 5.1C). Some AMPs are also thought to translocate across the cell membrane and destroy 
intracellular components in addition to their membrane interactions.15 The specific mechanism of 
action of the AMP is dependent on the structure and charge of the peptide, as well as the lipid 
composition of the cell membrane.14  
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Alamethicin is a 20-amino-acid, predominantly -helical peptide that is derived from the 
fungus Trichoderma viride. It has been widely studied as a model for membrane proteins 
forming ion channels. Alamethicin is most effective against Gram-positive bacteria and fungi, 
with known minimum inhibitory concentrations (MICs) between ~1.5-25 M against mollicutes, 
a class of bacteria that lack cell walls, and which are thought to have developed from Gram-
positive bacteria. Alamethicin was also found to deform the helical cell structure of mollicute 
parasite Spiroplasma melliferum at a lower concentration of 0.1 M.16-19 Although alamethicin is 
less effective against Gram-negative bacteria, possibly due to the lipopolysaccharide barrier 
present in the bacterium’s outer membrane, it can still inhibit growth at higher concentrations. 
Alamethicin at 25 M was found to inhibit the growth of Sinorhizobium meliloti, a Gram-
negative bacterium.20   
Alamethicin (Ac-Aib-Pro-Aib-Ala-Aib-Ala-Gln-Aib-Val-Aib-Gly-Leu-Aib-Pro-Val-Aib-
Aib-Glu-Gln-Phl) contains eight -aminoisobutyric acid (Aib) residues and one L-
phenylalaninol (Phl) residue, which are not commonly found in nature. The alamethicin 
sequence contains four residues having polar side chain groups: Gln7, Glu18, Gln19 and Phl20. 
Alamethicin also contains a negative charge associated with the glutamic acid residue (Glu18) 
located near the peptide’s C-terminus. The helical wheel diagram for alamethicin is shown on 
Figure 5.2.  A propensity for the α-helical secondary structure, a clear separation of hydrophobic 
and hydrophilic regions and significant hydrophobicity of this peptide are indicated by the 
helical wheel.  The X-ray crystallographic structure of alamethicin21 suggests that the 
amphipathic -helical region is about 2.9 nm long. The crystal structure shows small deviations 
from a continuous α-helical conformation in the form of short (one to two residues) 310 
helical regions in the C-terminal domain, with a bend at the Pro14 residue. This conformation 
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allows for the formation of a polar region, consisting of the Gln7 and Glu18 residues and a 
nonpolar area that includes Val, Aib, Ala, and Leu residues.  The Glu18 side chain is typically 
protonated when the peptide is in a transmembrane state, making alamethicin’s net charge 
effectively zero. The neutral nature of alamethicin is interesting in that AMPs are typically 
cationic, which plays a role in their ability to target negatively charged bacterial membranes. 
However, other factors, such as the hydrophobic side chains on many of alamethicin’s amino 
acids, may increase alamethicin’s affinity to bacterial membranes.   
 
Figure 5.2. Helical wheel diagram of alamethicin. The diagram represents the peptide viewed along the 
axis of the helix, in which the peptide backbone is shown by the inner circle and the spokes represent 
amino acids. The amino acids are represented by their single letter codes and the number indicates their 
location in the primary structure starting from the amino end.  
Since an α-helix contains 3.6 residues per turn, side-chains adjacent in the linear sequence are separated 
by 100o of arc on the wheel. Residues are color coded for their functionalities and the helical wheel shows 
a mostly hydrophobic peptide with a small region of hydrophilicity (see text for details). 
 
Multiple techniques have been used to explore how alamethicin interacts with different 
model membrane systems and a brief survey of literature22-37 is summarized in Table 5.1.  It is 
reasonable to conclude that these studies offer evidence for membrane leakage due to pore 
formation,23, 33 surface adsorbed state of the peptide,24, 29, 30, 35, 36 membrane thinning,25 and the 
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transition from the surface state of the peptide to the membrane inserted state.24, 27, 29, 36  Different 
pore sizes have been proposed with 6 to 12 peptides per pore22, 26, 28, 31, 32, 37 and the coexistence 
of peptide clusters along with water-filled pores has also been suggested.31, 32  The most 
definitive experimental conclusions have come from studies using hydrated multilayers of 
stacked bilayers as membrane models rather than simple bilayers typical of cell membranes. In 
these studies, equilibrium structures generated at pre-determined peptide-to-lipid ratios were 
characterized and there was no possibility of discerning any information about the dynamics of 
the process when the peptide encounters the membrane.   
Table 5.1. Brief survey of experimental methods and membrane models employed in the 
literature to explore alamethicin-membrane interactionsa 
Experimental Technique Membrane System/ Lipids Experimental observations Ref. 
Circular dichroism; 
phenylalaninol 
fluorescence 
Vesicles in aqueous 
phase DMPC or 
DOPC 
Alamethicin is not aggregated in the aqueous phase but aggregated in 
vesicle membrane; The P/L ratio in the vesicle was estimated as a 
function of peptide concentration in aqueous phase. 
23 
Oriented circular 
dichroism 
Multilayers of 
oriented bilayers  
DPhPC 
If P/L is below a critical value, most of the peptide molecules are on 
the membrane surface. If P/L is above the critical value, most of the 
peptide molecules are incorporated in the membrane. 
24 
X-ray lamellar diffraction 
Multilayers of 
oriented bilayers 
DPhPC 
Bilayer thickness decreases with increasing peptide concentration in 
proportion to the P/L ratio 25 
Neutron in-plane 
scattering 
Multilayers of 
oriented bilayers 
DLPC, DPhPC 
In DLPC, the pores are made of 8-9 peptides, with a water pore 1.8 nm 
in diameter and an effective outside diameter of 4 nm. In DPhPC, the 
pores are made of 11 peptides, with a water pore of 2.6 nm in diameter 
and an effective outside diameter of 5 nm. 
22, 26
Oriented circular 
dichroism 
Multilayers of 
oriented bilayers 
DPhPC, DPhPE and 
mixtures 
Observed sigmoidal insertion behavior indicating cooperative action in 
pore formation.  Concluded that cooperativity is not associated with a 
micelle-like aggregation process, but instead, is driven by lipids 
through membrane-mediated interactions. 
27 
Multiwavelength 
anomalous diffraction 
(MAD) 
Multilayers of 
oriented bilayers 
Brominated lipid (di 
18:0 (9, 10 Br) PC) 
Constructed electron density distribution profiles confirmed the 
formation of barrel-stave pores with eight alamethicin molecules per 
pore. 
 
28 
Calorimetry, sound 
velocity, atomic force 
microscopy 
Unilamellar 
vesicles and (for 
AFM) fused 
vesicles on mica.  
DMPC, DPPC 
Sound velocity data showed three distinct concentration dependent 
regions that can be associated with the “S” to “I” transition. AFM 
images in DPPC system showed peptide-induced defects (”holes”). 
29 
Oriented 15N solid-state 
NMR;  Electron 
Paramagnetic Resonance-
Electron Spin Echo 
Envelope Modulation 
Multilayers of 
oriented bilayers  
DPPC 
Alamethicin was in the surface-oriented “S” state at peptide 
concentrations of 1 mol % in gel-phase DPPC 30 
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Indeed, monitoring the dynamic behavior of AMPs on lipid membranes has typically 
been difficult, due to the small scale of these interactions.  We chose to examine the interactions 
of alamethicin with lipid membranes using quartz-crystal microbalance with dissipation 
monitoring (QCM-D), which can monitor these systems in real-time with a mass sensitivity of 
~1.8 ng/cm2 in liquid.  Lipid bilayer supported on the quartz crystal was used as the model 
membrane. Changes in frequency (∆f) and energy dissipation (∆D) of an oscillating sensor 
crystal were measured as mass attaches to and/or removed from the surface of the crystal, during 
the peptide-membrane interactions.  A decrease in frequency can be related to an increase in 
X-ray scattering 
Multilayers of 
oriented bilayers 
DOPC, di C22:1PC 
Identified water containing pores with 6 peptides in DOPC and 9 
peptides in diC22:1PC. Also proposed the presence of hexagonally 
packed alamethicin clusters (lacking water) in equilibrium with pores.
31, 32
Cryo-TEM and liposome 
leakage measurements. 
Liposomes POPC 
or POPC/POPG 
Leakage from liposomes clearly confirmed the formation of membrane 
pores, but the pore size was too small for direct detection by the TEM. 33 
Small-angle neutron 
scattering with selective 
deuterium labeling 
Vesicles DMPG 
and chain-
perdeuterated 
DMPG and DMPC 
mixtures 
Alamethicin enriched the outer leaflet of the vesicle with the negatively 
charged DMPG both in its “S” and “I” states. 34 
Sum frequency generation 
(SFG) vibrational 
spectroscopy 
Supported bilayer 
DMPC 
Alamethicin was able to insert into fluid-phase membranes, but on the 
gel phase, it was on the surface either as single peptides or as 
aggregates and did not show significant insertion. 
35 
Sum frequency generation 
(SFG) vibrational 
spectroscopy 
Supported bilayer 
POPC 
Change in membrane orientation was consistent with “S” to “I” 
transition. Orientation of the α-helical component of alamethicin 
changed substantially while that of the 310-helical component remained 
unaffected. 
36 
Electrochemical scanning 
tunneling microscopy 
Langmuir-Blodgett 
film  DMPC + egg 
PG 
Direct imaging showed the formation of cylindrical hexameric 
alamethicin pore incorporating a water channel. 37 
a The lipid molecules are referred to in the Table and the text by abbreviations are as follows: 
DLPC: 1,2-Dilauroyl-sn-Glycero-3-Phosphatidylcholine 
DMPC: 1,2-Dimyristoyl-sn-Glycero-3-Phosphocholine 
DMPG: 1,2-Dimyristoyl-sn-Glycero-3-Phosphocholine 
DOPC: 1,2-Dioleoyl-sn-Glycero-Phosphatidylcholine 
DPhPC: 1,2-Diphytanoyl-sn-Glycero-3-Phosphatidylcholine 
DPhPE: 1,2-Diphytanoyl-sn-Glycero-3-Phosphoethanolamine 
DPPC: 1,2-Dipalmitoyl-sn-Glycero-3-Phosphocholine 
DPPG: 1,2-Dipalmitoyl-sn-Glycero-3-[Phospho-rac-(1-glycerol)] 
DSPC: 1,2-Distearoyl-sn-Glycero-3-Phosphocholine 
DSPG: 1,2-Distearoyl-sn-Glycero-3-[Phospho-rac-(1-glycerol)] 
PC: Phosphatidylcholine 
PG: Phosphatidylglycerol 
POPC: 1-Palmitoyl-2-Oleoyl-sn-Glycero-3-Phosphocholine 
POPG: 1-Palmitoyl-2-Oleoyl-sn-Glycero-3-[Phospho-rac-(1-glycerol)] 
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mass on the crystal surface and vice versa. Changes in dissipation can be related to changes in 
the viscoelasticity, or “softness,” of the membrane on the sensor. Since disordering of lipids 
within a membrane can introduce spaces that would weaken the structure, dissipation 
measurements can reveal information about the level of disruption in a bilayer on the sensor 
surface. In this study, we examined the action of alamethicin on an egg phosphatidylcholine (PC) 
supported bilayer membrane at various peptide concentrations over a period of 1 h.  From 
frequency and dissipation measurements at various overtones of the natural frequency of the 
crystal we have extracted qualitative and quantitative information on the equilibrium as well as 
dynamic nature of alamethicin-egg PC interactions. 
5.3  Materials and methods 
5.3.1  AMP and lipid vesicle preparation 
Alamethicin was purchased from Sigma-Aldrich (St. Louis, MO). Peptide solutions were 
prepared in Tris-NaCl buffer [100 mM sodium chloride and 10 mM Tris(hydroxymethyl) amino 
methane (Sigma-Aldrich, St. Louis, MO) at pH 7.9]. Experiments were performed at 23˚C with 
peptide concentrations between 0.1 M and 10 M, which was within the range of MIC values 
found for alamethicin.16-19 Lyophilized powder egg PC was purchased from Sigma Aldrich (St. 
Louis, MO) and Avanti Polar Lipids (Alabaster, AL). The PC was dissolved in ethanol and 
stored at -20˚C. To prepare small unilamellar vesicles (SUVs), the PC solution was dried with 
nitrogen gas and placed in a vacuum desiccator overnight. Tris-NaCl buffer was then added to 
the dried lipids, resulting in a final concentration of 2.5 mg/mL. The mixture was vortexed and 
homogenized through 5 freeze-thaw cycles. The solution was sonicated using an ultrasonic 
dismembrator (Model 150T, Thermo Fisher Scientific, Waltham, MA) in pulsed mode for 30 
min at 0˚C. A 30% duty cycle was used for sonication (pulse on for 3 s, followed by a pause for 
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7 s) at an amplitude of 60. The vesicle solution was centrifuged at 17,500 rpm (37,000 g) for 10 
min at 4˚C to remove probe particles from the ultrasonic dismembrator (J2-MI Centrifuge, 
Beckman Coulter, Brea, CA). The supernatant containing SUVs was collected and stored at 4˚C 
under nitrogen for up to 5 weeks.38 Dynamic light scattering experiments (Zetasizer Nano ZS, 
Malvern, Worcestershire, UK) determined the diameter of the vesicles to be approximately 37 
nm. The stock solution was diluted to 0.1 mg/mL in Tris-NaCl buffer before each QCM-D 
experiment. 
5.3.2  Quartz crystal microbalance with dissipation monitoring (QCM­D) 
The Q-Sense E4 system (Biolin Scientific, Sweden) was used to monitor the real-time 
mass and viscoelasticity changes to a supported lipid membrane deposited on the quartz crystal 
during AMP exposure. The supported lipid bilayer was formed using a vesicle deposition method 
at 23˚C, which was above the transition (gel-to-liquid) temperature of egg PC, allowing the lipids 
to remain in fluid phase during the experiment.39, 40 The stock solution of PC vesicles injected 
into the QCM-D chamber at a flow rate of 0.15 mL/min. Changes in frequency and dissipation 
were monitored as the PC vesicles attached to the sensor’s silica surface and ruptured to form a 
lipid bilayer. Since the mass and dissipation changes resulting from the attachment and rupturing 
of lipid vesicles on the crystal surface were consistent in each experiment, the QCM-D data 
served to confirm the consistent formation of a stable bilayer.39, 40  This approach to supported 
bilayer formation was robust as we had confirmed in our previous QCM-D studies on 
chrysophsin-3.41 
Following the formation of a stable supported lipid bilayer, the crystals were rinsed with 
buffer to remove any unattached lipids. After establishing a baseline, the solution of alamethicin 
was added for 10 min, at which time the pump was stopped. QCM-D crystals were exposed to a 
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stagnant peptide solution for 1 h, after which the peptide solution was replaced with a final 
buffer rinse at 0.15 mL/min to remove any unattached particles until the frequency stabilized. 
For each concentration of alamethicin, the ∆f and ∆D values at different overtones were 
measured. The Δf was estimated by taking the difference between frequencies at the beginning of 
peptide exposure and after the subsequent buffer rinse.  All the ∆f and ∆D data presented in the 
results refer to the difference between two stages of the interaction process on the crystal surface: 
the lipid bilayer film after contact with the peptide and before contacting the peptide, thus 
accounting for only the peptide-induced effects on the bilayer.  Effects due to liquid properties 
(such as density and viscosity) are cancelled out in this subtraction process.  Experiments at each 
peptide concentration were repeated at least 3 times and the averages of the net changes in 
frequency and dissipation were reported as the final ∆f and ∆D values taken after the buffer 
rinse. Error bars were determined from the standard deviation of the ∆f and ∆D values.  
5.3.3  Analysis of QCM­D data 
Methods to relate the measured frequency and dissipation changes to changes in mass 
and in the viscoelastic properties of the membrane on the surface have been described in detail in 
the literature42 and therefore only a brief summary is provided here. For a rigid film of areal mass 
mf (mass per unit area) deposited on the crystal surface and exposed to air, the normalized 
frequency change ∆f (with respect to the overtone number) and the areal mass of the film are 
related by the Sauerbrey equation, while the dissipation change ∆D is zero. 
∆݂ ൌ െ ௢݂ ݉௙݉௤ , Δܦ ൌ 0 (5.1)
Here, fo is the natural frequency of the oscillator and mq is the areal mass of the quartz crystal. 
The mass addition due to the film deposited on the crystal surface gives rise to a decrease in the 
frequency (negative ∆f) while net mass loss is indicated by a positive ∆f. The dissipation D is 
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related to the loss modulus G′′ and the storage modulus G′ in the form D = G′′/(2π G′) and the 
change in dissipation ∆D can be related to the changes in the rigidity or viscoelasticity of the 
film attached to the crystal surface.  Obviously, for the rigid film, the change is dissipation is 
zero. 
 If the rigid film is immersed in a Newtonian liquid like water, the frequency and 
dissipation changes are modified due to the presence of water and are now given by  
∆݂ ൌ െ ߟ௅2ߨߜ௅݉௤ െ ௢݂
݉௙
݉௤ , Δܦ ൌ
ߟ௅
݊ߨ ௢݂ߜ௅݉௤ (5.2)
where ηL is the viscosity of the liquid medium and δL is the decay length of the acoustic wave in 
the liquid medium.  The first term in Δf and the term appearing in ΔD are due to the solvent 
effect due to the immersion of the crystal in the liquid and they vanish when we consider the 
changes in the crystal properties after and before the deposition of the rigid film. Effectively, the 
film mass changes are given just by the Sauerbrey term.  If the film is not rigid but viscoelastic, 
then the frequency and dissipation changes are given by 
∆݂ ൌ െ ߟ௅2ߨߜ௅݉௤ െ ௢݂
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(5.3)
where ρf is the density of the film on the crystal surface.  As in eq.(5.2), the first term in the 
expressions for Δf and ΔD are due to the solvent effect and they vanish when we consider 
changes in film properties when the film is immersed in the liquid both before and after the 
change.  The film mass change is now given by the Sauerbrey term with a correction factor 
accounting for the viscoelastic properties of the film.  
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The contribution of viscoelasticity of the film to the measured frequency change (or 
equivalently, the measured mass) can be estimated from eq.(5.3). For a 5 MHz crystal, taking the 
density of water and of the bilayer to be 103 kg/m3, the viscosity of water to be 10-3 N s/m2, and 
the viscoelastic ratio G’/G” = 0.1, the second term within the brackets, which provides the 
viscoelastic correction to unity, is approximately 0.03 for G”=1 MPa and 0.3 when G” is 0.1 
MPa. A viscoelastic ratio of 0.1 and G” = 0.1 MPa were used by Voinova et al. for an adsorbed 
layer of vesicles42, and for the supported bilayers, one may expect these values to be somewhat 
different. 
There is also a non-vanishing ΔD accompanying the film mass change in eq.(5.3).  An 
increase in ∆D indicates a less rigid, possibly more disordered film, and a decrease in ∆D 
indicates a more rigid film on the crystal surface. In experiments involving supported lipid 
bilayers (SLBs), ∆D can also provide information about changes in the structure and ordering of 
the lipids. Disruption of the membrane will cause the lipids to become less ordered and 
potentially allow more water to associate with the membrane, increasing the film’s hydration and 
∆D values. 
 As mentioned already, it is possible to measure not only the changes in the fundamental 
resonant frequency of the quartz crystal, but also changes in its harmonics. Available commercial 
instruments allow measurements of odd overtones up to the 13th (or even the 15th) multiple of the 
fundamental frequency. Since higher frequencies dissipate energy faster in a viscous medium, 
the higher overtones decay faster (the decay length is shorter) and are more confined to the 
surface region of the crystal.  In this study, the 3rd through 11th overtones, or harmonics, were 
measured and related to processes throughout the film. Due to varying penetration depths of the 
acoustic waves associated with different overtones, higher overtones are qualitatively more 
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representative of processes occurring closer to the sensor surface while the lower overtones are 
representative of processes occurring near the water-film interface. Similar ∆f and ∆D values at 
all overtones indicate a homogeneous change in mass and viscoelasticity over the depth of the 
film on the crystal’s surface.  On this basis, the overtone analysis has been used by Mechler et 
al.43 to differentiate peptides inserted in bilayers with a vertical orientation (with respect to 
bilayer surface) compared to surface adsorbed peptides.  Further, the molecular mass and 
viscoelasticity changes on the film can be monitored in real time by tracing the relation between 
∆f and ∆D over the entire course of the experiment.   
5.4  Results and discussion 
5.4.1  Changes in ∆f and ∆D with peptide concentration and overtone number  
The measured ∆f and ∆D at 3rd to 11th overtones are presented in Figure 5.3 for aqueous 
phase peptide concentrations ranging from 0.25 M to 10 M. The dissipation changes ∆D were 
small at all peptide concentrations suggesting that the membrane with and without alamethicin 
was rigid and therefore, the measured frequency changes can be directly related to mass changes 
through the Sauerbrey equation. Exposure of the supported lipid membrane to alamethicin 
concentrations above 0.1 M resulted in positive ∆f values implying mass removal from the 
bilayer.  The relative amount of mass lost from the bilayer increased with increasing alamethicin 
concentration. At 0.25 M alamethicin, the ∆f values were ~1 Hz, and they increased to ~5 Hz at 
10 M alamethicin. Since previous experiments showed that the formation of a complete bilayer 
corresponded to a ∆f value of ~-25 Hz, frequency shifts between 1 and 5 Hz were indicative of 4-
20% mass loss from the original lipid bilayer.40, 41 Since the data show a net mass loss, any 
incorporation of alamethicin into the membrane must be overcompensated by depletion of lipid 
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molecules from the bilayer.  This would be consistent with the creation of pore structures with 
water channels in the bilayer, since that would require removal of lipid molecules. 
 
 
 
Figure 5.3. Changes in frequency and dissipation corresponding to various aqueous phase concentrations 
of alamethicin interacting with the PC membrane. Values for f and D are shown for the 3rd through 11th 
overtones and represent the changes induced by alamethicin activity on a stable supported bilayer 
membrane. Initial measurements (t = 0 s) are taken after stable bilayer formation and final measurements 
are taken after the buffer rinse following 1 h of peptide incubation. Higher overtones are associated with 
changes closer to the sensor surface. Error bars represent the standard deviation based on at least 3 
replicate experiments. 
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The measured ∆f values were uniform across all overtones at each concentration of 
alamethicin (Figure 5.3). This would suggest that mass removal from the membrane was uniform 
along the depth of the membrane. This mass depletion likely occurred as a result of peptide 
insertion into the membrane, which was expected to create homogeneous overtone responses. 
This uniformity in the ∆f values for all overtones is consistent with the formation of cylindrical 
pores since such a pore structure is characterized by uniform behavior along the depth of the 
bilayer.  
The measured dissipation values ∆D were small at all peptide concentrations (Figure 5.3), 
suggesting that the ordering of molecules in the membrane before and after exposure to 
alamethicin resulted in the same membrane “stiffness,” or viscosity. This would be consistent 
with a cylindrical pore structure where the lipids are allowed to remain unaffected thanks to the 
creation of peptide wall along the pore boundary.  Even though water channels exist, they do not 
contribute to bilayer viscoelasticity because of the organization of the peptide walls that confine 
the lipids to a state similar to that in the original lipid bilayer. 
One may note that lipid loss from the membrane was observed even at 0.05 M 
alamethicin (data shown in Appendix 1.1). The ∆f and ∆D data suggest that even at low peptide 
concentrations, alamethicin creates cylindrical pores and one may have to go to much lower 
alamethicin concentrations than what has been considered in this study, to observe a surface 
adsorbed “S” state.  
The substantial membrane disruption that occurred at alamethicin concentrations above 1 
M in this study is consistent with results from a previous study that showed that alamethicin is 
effective against mollicutes at ~1.5-25 M alamethicin.18, 19 Alamethicin caused the removal of 
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at least 20% of the lipid membrane mass at 10 M peptide concentrations, which could lead to 
complete membrane destabilization. This estimate of the extent of lipid loss assumes that a stable 
lipid bilayer corresponds to a -25 Hz change in frequency, which was shown through consistent 
PC bilayer formation. Alamethicin has also been shown to inhibit Gram-negative bacterial 
growth at higher 25 M concentrations. The discrepancy between the AMP concentrations 
needed to inhibit bacterial growth and to destabilize the PC membranes in these experiments may 
be due to the presence of a lipopolysaccharide barrier in the bacteria’s outer membrane. Higher 
AMP concentrations may be necessary for AMPs to disrupt and pass through the barrier before 
disrupting the cell membranes. Also, bacterial cell membranes contain different lipids and 
membrane components (e.g. membrane proteins) than our model system in this study, which 
could lead to differences in AMP concentration-dependent behavior. 
5.4.2  Time evolution of ∆f vs ∆D and dynamics of alamethicin – bilayer interactions  
Mechanistic information derived solely from overall ∆f and ∆D values as in Figure 5.3 
give no indication of the dynamic processes that would have occurred during the 1 h period in 
which the PC bilayer membrane was exposed to the peptide. Therefore, the QCM-D results were 
also analyzed using ∆D vs. ∆f plots (Figures 5.4 and 5.5) to infer at least qualitatively the nature 
of dynamics controlling alamethicin–bilayer interactions. The points shown in these graphs 
represent ∆f and ∆D values at evenly spaced time intervals (0.7 s between points). Larger 
spacing between points indicate that the mass or viscoelasticity changes in the membrane occur 
at a faster rate. Changes in slopes in these plots generally indicate a change in mechanism.44  
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Figure 5.4. (A) ∆D and ∆f measurements showing stable supported lipid bilayer (SLB) formation on 
silica, followed by a Tris-NaCl buffer rinse at t = 11.5 min to remove any unattached particles. (B) ∆D vs. 
∆f plot showing the dynamics of SLB formation. The frequency axis has been reversed to make 
interpretation more intuitive. As mass increases on the QCM-D sensor, frequency shifts to the right. The 
initial frequency decrease (i) shows the attachment of vesicles to the surface. The vesicles then rupture, 
releasing trapped water, and forming a bilayer (ii). The arrows (labeled i and ii) indicate the progression 
of data points with increasing time. Data points are taken at 0.7 s intervals. The silica surface of the sensor 
crystal is bare and submerged in Tris-NaCl buffer at t = 0 s. 
 
Figure 5.4 describes how from the time evolution of ∆D and ∆f (Figure 5.4A) the 
dynamic ∆D vs. ∆f plots (Figure 5.4B) were constructed.  As PC vesicles attached to the QCM-D 
sensor’s silica surface, the mass on the sensor increased, causing the frequency to sharply 
decrease (Figure 5.4A). This process was shown in the corresponding ∆D vs. ∆f as the points 
moved in the north-east direction (shown by the arrow labeled i), indicating an increase in mass 
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on the surface as well as the viscoelastic nature of adsorbed vesicle layer (Figure 5.4B). Arrows 
pointing east reveal increases in mass while those pointing north reveal an increase in softness or 
viscoelsticity. Once the vesicles broke up and organized into a planar bilayer, there was a mass 
loss due to release of water from vesicle interior as well as the loss of excess lipid from the 
vesicle.  Simultaneously there was a decrease in dissipation change due to higher ordering of the 
planar bilayer compared to the soft water filled vesicles. Correspondingly, the ∆D vs. ∆f trace 
changed in direction (labeled ii), resulting in a south-west trend that indicated a loss in mass and 
decrease in viscoelasticity. West pointing arrows indicate a decrease in mass while south-
pointing arrows indicate an increase in membrane rigidity and therefore more organized 
molecules.  In Figure 5.4B, data from the 3rd and 11th overtones showed similar behavior and 
extended over the same range of ∆D and ∆f, both being large.  This suggested that the bilayer 
formation process starting from adsorbed vesicles caused significant changes both near the 
crystal surface (11th overtone) as well as at the interface with bulk water (3rd overtone).  
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Figure 5.5. ∆D vs. ∆f plots of alamethicin-bilayer interactions at various concentrations of the peptide in 
aqueous phase. These plots show changes in viscoelasticity of the membrane in relation to the changes in 
mass during the time evolution of the interactions. At t = 0 s, a stable bilayer has been formed on the 
QCM-D crystal. The measurements include 1 h of incubation with the peptide and a subsequent buffer 
rinse. The 3rd and 11th harmonics are shown to represent the different processes occurring near the surface 
of the lipid membrane and near the surface of the QCM-D crystal. These graphs show representative data 
from one experiment based on at least 3 repeated measurements. 
 
The dynamics of alamethicin-bilayer interactions were explored through the ∆D vs. ∆f 
traces during the time course of alamethicin contact with the bilayer in Figure 5.5.  At 0.25 M 
alamethicin, a very small change to membrane mass and virtually no change to viscoelasticity 
were observed at both the 3rd and 11th harmonics. At a concentration of 1 M, the trace (labeled 
i) showed a similar small mass loss and no change in the lipid membrane ordering during 
exposure to alamethicin. Since mass was lost at both overtones, all depths of the membrane 
experienced a loss in lipid mass, possibly due to peptide insertion to create a small number of 
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cylindrical pores. At 5 M, a much larger change in the membrane was observed. Both overtones 
revealed overall loss of lipid mass with simultaneous disordering of the membrane that was not 
captured by the static experimental data in Figure 5.3. Initially, the data points travelled in the 
north-east direction (labeled i), suggesting that alamethicin molecules were added on to the 
membrane and disrupted lipid ordering in the bilayer. Greater mass addition and molecular 
disordering was measured in the 3rd harmonic compared to the 11th harmonic, suggesting that the 
peptides had attached to the surface of the membrane or partially inserted into the membrane. 
The peptide-membrane interaction mechanism then shifted in the north-west direction (labeled 
ii), indicating that the membrane began to lose mass, while still experiencing lipid disorder. The 
traces subsequently changed direction (labeled iii-iv), suggesting that the lipid membrane became 
more rigid as it continued to lose lipid mass. The decrease in dissipation may have been due to 
the alamethicin molecules completely inserting into the membrane and reintroducing order to the 
system as it stabilized the edges of pores in the lipid bilayer. The results for 10 M alamethicin 
revealed a similar trend indicating that the dynamic mechanisms did not change with peptide 
concentration. 
In Figure 5.5, at both 5 M and 10 M alamethicin, the range of ∆f is the same for both 
the 3rd and 11th overtones while the range of ∆D is larger for the 3rd overtone compared to the 
11th overtone.  This clearly suggests that at the water-bilayer interface (qualitatively indicated by 
the 3rd overtone behavior) there was considerable lipid disruption during the dynamic process 
while very close to the quartz surface (indicated by the 11th overtone), the lipid organization was 
not significantly perturbed.  Note that the static data in Figure 5.3 shows that the net change in 
dissipation was negligibly small for both overtones, indicating similar rigidity of the membrane 
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before and after interactions with alamethicin.  Evidently, one could not analyze the process 
dynamics if only the static data were available. 
5.4.3  Calculation of bilayer properties from QCM­D data 
The area per lipid in the bilayer (denoted as aL) and the thickness of the bilayer were 
calculated from the measured frequency change of ~25 Hz, accompanying the formation of the 
supported bilayer.  Noting that the proportionality constant C in the Sauerbrey equation is 17.8 
ng/cm2 for a crystal oscillating at 5 MHz natural frequency, the bilayer areal mass corresponding 
to a frequency change of 25 Hz is equal to 445 ng/cm2.  It has been shown that this mass includes 
the mass of a layer of water between the quartz crystal and the supported lipid bilayer and the 
mass of this water layer has been determined to be ~ 102 ng/cm2.45  Correcting for this water 
mass, we estimate the areal mass of the lipid bilayer to be 343 ng/cm2.  The molecular mass ML 
of the lipid is calculated to be 1.267x10-12 ng/molecule corresponding to an average molecular 
weight of 760 g/mol for the egg PC lipid.  Dividing the areal mass of the lipid bilayer by the 
mass of a single lipid molecule ML, we estimate there are 2.7 molecule/nm2 on the bilayer or 1.35 
molecules/nm2, in each monolayer.  This corresponds to a lipid area aL of 0.739 nm2 /molecule.  
If the molecular volume vL of the hydrophobic tail of the egg PC lipid is 0.96 
nm3/molecule (taken as the composition average based on the constituent C16 and C18 chains), 
then the thickness of the hydrophobic region of the bilayer hL = 2vL/aL = 2.6 nm.  Alternately, if 
we take the lipid density to be about 1 g/cm3, then for a lipid average molecular weight of 760, 
the corresponding lipid molecular volume vlipid is 1.267 nm3.  The lipid bilayer thickness will 
then be hlipid = 2vlipid/aL = 3.43 nm.  If we consider the lipid head groups on the two layers to take 
up 1 nm,9 then the hydrophobic region of the bilayer will have a thickness of 2.43 nm.  These 
estimates based on QCM-D data and molecular properties of lipids can be compared to the x-ray 
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measurements of Huang9 who obtained aL = 0.74 nm2 and hL = 2.66 nm for DOPC, and aL = 0.68 
nm2 and hL = 2.75 nm for POPC. 
5.4.4  Differentiating pore formation vs. cluster formation based on the QCM­D data 
We have used the QCM-D data along with model calculations to explore whether 
alamethicin inserts into the bilayer to create water-free clusters as suggested by Nagle et al.32 in 
addition to their pore formation.  Nagle et al. proposed the formation of hexagonally packed 
clusters of alamethicin with no water channels (Figure 5.6), with the small hydrophilic domains 
on the peptides facing each other and the larger hydrophobic domains facing other hydrophobic 
surfaces or the lipid. The cluster could be of any size generated from a trimeric motif as shown 
on the figure. They also surmised that because the number of peptides in a cluster would be 
larger than in a pore, the ratio of clusters to bundles would increase as the total peptide 
concentration increased. 
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Figure 5.6. Schematic representation of alamethicin insertion into bilayer either as clusters or as pores. 
The lipids are not shown on the figure for clarity. On the left is an alamethicin cluster proposed in 
Ref.(32). It is shown as a cluster of 9 molecules made from 3 trimeric units. Ref.(32) suggests clusters of 
various sizes to be possible in trimeric units. On the right is a cylindrical pore, with 8 alamethicin 
molecules constituting the pore wall. The hydrophilic surface region of the peptide is small and is 
designated by the yellow color.  
  
In the case of the peptide clusters, there are no associated lipids or water channels and the 
area per peptide aP is calculated as aP = πdP2/4 where dP is the diameter of the peptide, visualized 
as a cylinder. The area per peptide aP is estimated to be 0.945 nm2/molecule, taking the diameter 
dP of alamethicin to be 1.1 nm.28 The molecular mass MP of the peptide is calculated to be 3.275 
x 10-12 ng/molecule, corresponding to a molecular weight 1965 g/mol of alamethicin.  
In the case of a pore, the area per peptide is denoted as AH/n, where AH is the pore area 
and n is the number of peptide molecules constituting the pore. If we consider the approximate 
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pore size to be determined by the close packed arrangement of peptides at the pore boundary, 
then the outer diameter DH of a pore with n peptides and the area of the pore per peptide AH/n 
can both be calculated from 
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For alamethicin, taking the peptide diameter dP to be 1.1 nm, the pore diameter DH estimated 
from eq.(7.4) will be about 3.9 nm for n = 8, and 4.6 nm for n = 10.  Indeed, Huang28 has 
estimated the number of peptides per pore to be 8 and the pore diameter of 3.9 nm (close to the 
estimate from eq.(7.4)).  For the purpose of our model calculations, we will consider two values 
for the number of peptides in the pore, n = 8, 10 corresponding to which the pore area per 
peptide AH/n will be 1.494 and 1.663 nm2/peptide. 
 On the addition of peptide to the bilayer, lipid molecules are removed from a fraction λ of 
the bilayer area and replaced either by peptide clusters or pores. The number of lipid molecules 
removed will be 2λA/aL, with the factor 2 again accounting for the two layers of the bilayer.  We 
will denote by β, the fraction of the affected area where clusters form and by (1-β), the fraction 
of the affected area where pores form. Therefore, the 2λA/aL lipids removed will be replaced by 
λβA/aP peptides in the clusters and by λ(1-β)A/(AH/n) peptides, in the pores.  The resulting mass 
change per unit area can be equated to the areal mass change measured by QCM-D:  
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In this equation C is the proportionality constant between frequency change and mass change in 
the Sauerbrey equation, and MP and ML are molecular masses of the peptide and lipid molecule, 
respectively.  The right hand side of eq.(7.5) accounts for the lipid leaving the bilayer and the 
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peptide entering the bilayer either as clusters or as pores. With the measured ∆f, the fractional 
area λ affected by peptide-lipid interactions can be calculated using eq.(7.5) for assumed values 
of n and β.  When β = 0, we have only pore formation and for any value of β > 0, we also have 
peptides inserted as close-packed clusters.  
 Having estimated all the molecular constants, and assuming values for β and n, we can 
calculate the fractional area λ affected by alamethicin–egg PC bilayer interactions using eq.(7.5) 
as a function of the alamethicin concentration in the aqueous phase.  The calculated results are 
shown on Figure 5.7 for three assumed values of β and for n = 8 and 10. As mentioned already, β 
= 0 corresponds to the case when all inserted peptides are part of pores with water channels. The 
areal mass change is very small when alamethicin molecules are inserted as clusters since the 
area vacated by the egg-PC lipids is taken up by the peptides, and the net mass of lipids removed 
is not too different from the net mass of peptide added.  (It should be noted that the areal mass 
change on cluster insertion could be larger for other choices of peptide-lipid molecules, 
depending on their molecular properties). The areal mass change is much larger when peptides 
are inserted as pores because in this case some of the area from which the lipid has been removed 
is replaced by the water channel that does not contribute to the film mass.  Obviously, the change 
in areal mass increases with n since that increases the pore and water channel diameters.   As a 
consequence the calculated results in Figure 5.7 show that in order to account for a given mass 
change, the affected area must be larger for β > 0 compared to when β = 0.  For the same reasons, 
the affected area can be smaller when n is larger. 
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Figure 5.7. The calculated fractional area affected by alamethicin-egg PC bilayer interactions for 
different assumed values of the parameter β as a function of the aqueous phase alamethicin concentration.  
Two values of n are represented: (A) n = 8, (B) n = 10. The fractional area affected is larger for smaller n 
and larger β.  
 
 The ratio between the peptide in clusters and that in water-filled pores (PC/PP) can be 
calculated from eq. (7.6). 
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For n = 8, the ratio PC/PP is 0, 0.39 and 1.06 for β = 0, 0.2 and 0.4, respectively.  For n = 10, the 
ratio PC/PP is 0, 0.44, and 1.17 for β = 0, 0.2 and 0.4, respectively. As β increases, the peptides in 
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clusters become relatively more significant; and for a given β, the larger the n, the larger the 
PC/PP ratio.  Nagle et al. have estimated PC/PP values of about 0.6 for DOPC multilayers when 
P/L values were about 0.05 to 0.10.  From Figure 5.7 we note that cluster formation is possible 
but the QCM-D data cannot confirm or deny the coexistence of clusters. If an alternate technique 
is available to determine the fractional area affected at a given aqueous phase alamethicin 
concentration, then the QCM-D data coupled to these model calculations can be used to draw 
more definitive conclusions.  
5.4.5  Estimation of P/L ratio in the inserted state  
The peptide to lipid (P/L) ratio was a pre-determined experimental value in all of the 
multilayer membrane experiments.  However, in the QCM-D experiments it is an outcome of the 
dynamic peptide-membrane interaction process. The P/L ratio in the bilayer was calculated from 
eq. (7.7).  
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Here, NLO ( = 2A/ aL) is the total number of lipid molecules initially present in the bilayer.  The 
numerator accounts for the number of peptide molecules present as clusters and as pores.  The 
denominator represents the number of residual lipid molecules after some of the lipid has been 
displaced by the peptide.  Having already calculated λ from eq.(5.5) as a function of the peptide 
concentration in the aqueous phase for assumed values of β and n, we can use eq.(5.7) to 
calculate the corresponding P/L ratio. In this manner, the peptide concentration in the aqueous 
phase can be related to the P/L ratio in the membrane inserted state. The calculated P/L ratios for 
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different aqueous phase concentrations of the peptide are plotted in Figure 5.8. The calculations 
show that in order to account for a given mass change, the P/L ratio would be larger for β > 0 
compared to when β = 0; further, P/L would be larger for smaller n (e.g. n=8 compared to n=10).  
This is intuitively obvious because replacing lipids by peptides results in a smaller mass change 
compared to replacing lipids by pores. Also shown in Figure 5.8 are experimental estimates of 
P/L in DMPC vesicles at 21oC and DOPC vesicles at 34oC as a function of the aqueous phase 
alamethicin concentration, obtained more than two decades ago using circular dichroism (CD) 
spectroscopy and phenylalaninol fluorescence spectroscopy.23 Although the lipids are different 
from egg PC and the membrane system is a vesicle rather than a supported bilayer, the 
qualitative comparison between the QCM-D estimate for P/L and these experimental results is 
interesting to note.  
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Figure 5.8. Calculated peptide-to-lipid ratio in the egg PC bilayer inserted state as a function of 
alamethicin concentration in the aqueous phase for different assumed values of the parameter β.  Two 
values of n are represented: (A) n = 8, (B) n = 10. The P/L ratio is larger for smaller n and larger β.  The 
experimental data for comparison 23 were obtained for DMPC and DOPC vesicles membranes using CD 
and fluorescence spectroscopy. 
 
The discrepancies between the calculated and experimental P/L values may be explained 
by differences in experimental parameters and assumptions. For instance, the QCM-D results in 
this study were obtained for egg PC while the experimental data reported were for either DMPC 
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or DOPC. The experimental P/L values also corresponded to vesicles rather than flat bilayers. In 
the experiments, the average vesicle size changed and some vesicle fusion was observed during 
peptide interactions, which may affect the quantitative estimation of the P/L ratio. Also, the 
calculation of the P/L ratio at low peptide concentrations from CD and fluorescence 
measurements showed a larger intrinsic uncertainty. Finally, the consideration of a polydispersed 
pore model would modify the results calculated using the QCM-D data. The model assumes all 
pores to be the same size, which may not be the case in an experimental system. For these 
reasons, we have only mentioned the qualitative similarity between the QCM-D results and the 
vesicle experimental data on Figure 5.8. The QCM-D studies would have to be complemented 
with other experiments to obtain additional information needed for more rigorous quantitative 
comparisons. 
5.5  Conclusions 
 We have explored the extent of useful information on alamethicin-membrane interactions 
that can be extracted from the application of quartz crystal microbalance with dissipation 
monitoring (QCM-D) technique. A supported phosphatidylcholine (PC) bilayer membrane in an 
aqueous environment was used as the membrane model. The QCM-D responses of changes in 
frequency (∆f) and dissipation (∆D) at different overtones were used to estimate changes in mass 
and rigidity of the lipid bilayer as well as the orientation of the peptide in the bilayer. The 
frequency changes at various overtones were equal indicating a homogeneous membrane process 
suggesting a vertical insertion of the peptide. Such an orientation for the peptide coupled to a net 
mass loss in the system supports a cylindrical pore formation with enclosed water channel. The 
very small dissipation change confirming the retention of lipid organization supports the idea 
that the inserted peptides form the walls of the cylindrical pores retaining the lipid organization. 
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Further, an analysis of the time evolution of ∆f vs. ∆D demonstrates that the peptide insertion 
kinetic process involved significant disordering of lipids, especially in the proximity of the 
membrane-water interface, even though this disordering was not present in the end state. By 
developing model calculations we concluded that the QCM-D data cannot confirm or rule out the 
coexistence of peptide clusters along with pores containing water channels.  We also developed a 
way to calculate the peptide to lipid ratio in the membrane as a function of the aqueous phase 
peptide concentration and found that to be qualitatively similar to the experimental alamethicin 
partitioning data reported for vesicles.  
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AFM Imaging of AMP-induced membrane defects 
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6.1  Abstract  
The active mechanism that membrane-active antimicrobial peptides (AMPs) use to 
destabilize bacterial membranes and cause lysis is not well understood, largely due to the 
nanoscale nature of peptide-membrane interactions. Numerous techniques, such as quartz crystal 
microbalance with dissipation monitoring (QCM-D) and oriented circular dichroism (OCD) have 
been used to characterize these interactions by determining the orientation and structural 
organization of the molecules within cell membranes exposed to AMPs. However, the effect of 
these peptides on membrane structure and stability is often difficult to infer from these 
techniques. In this study, atomic force microscopy (AFM) was used to investigate the effect of 
various concentrations of two peptides, alamethicin and indolicidin, on a model cell membrane 
by imaging changes produced in the membrane. Alamethicin and indolicidin were chosen for 
study because they exhibit varied structures and demonstrated different membrane interaction 
mechanisms in previous QCM-D studies. Alamethicin, a 20-amino acid -helical peptide, 
produced large, unstable defects in the membrane at 5 M concentrations and completely 
removed the bilayer at 10 M. The smaller non--helical peptide, indolicidin, produced smaller 
holes in the bilayer at 5 and 10 M, which filled in again over time. Root-mean-square (RMS) 
roughness values for the images showed that surface roughness caused by visible defects peaked 
after peptide injection and gradually decreased over time. Understanding the dynamic 
interactions between different AMPs and cell membranes will facilitate the selection and design 
of more efficient AMPs for use in therapeutics and antimicrobial surfaces. 
6.2  Introduction 
Due to the escalating phenomenon of antibiotic resistance in bacteria in the past several 
decades, interest in the identification and development of antibiotic alternatives, such as 
146 
   
antimicrobial peptides (AMPs), has increased. Although many AMPs, which are part of the 
innate immune systems of most eukaryotic organisms, are thought to kill pathogens through cell 
membrane disruption, the active mechanism behind the membrane destabilization is not well 
understood. Membrane-active AMPs are believed to initially associate with cell membranes 
through electrostatic interactions between the peptides and lipid headgroups. Techniques such as 
oriented circular dichroism (OCD), nuclear magnetic resonance (NMR) spectroscopy and quartz 
crystal microbalance with dissipation monitoring (QCM-D) have determined that peptides can 
exhibit distinct states once they are associated with lipid the bilayers.1-5 According to the carpet 
model, AMPs may adsorb parallel to the bilayer membrane and “carpet” the lipid surface.6 As 
the peptide concentration reaches a critical level, the peptides and lipids reorganize to leave the 
membrane as aggregates or micelles. The barrel-stave model supposes that AMPs may insert 
perpendicularly into the lipid bilayer and form cylindrical or toroidal pores, through which large 
molecules can travel, disrupting ion gradients and causing the cell to die.  
The membrane-active antimicrobial peptides alamethicin and indolicidin were chosen for 
examination in this study due to their different structures and mechanisms of action. 
Alamethicin, an -helical peptide of neutral charge, has been shown to form voltage-gated ion 
channels in membranes.7-9 The peptide is thought to attach to the lipid headgroups and insert into 
membranes, forming pores that can contain 3-11 peptide molecules.10-14 Neutron in-plane 
scattering experiments have shown that in 1,2-dilauroyl-sn-glycero-3-phosphatidylcholine 
(DLPC) membranes, these pores exhibit inner and outer diameters of ~1.8 nm and ~4.0 nm, 
respectively.15 Indolicidin is a shorter, cationic peptide that exhibits a folded, boat-shaped 
conformation due to intramolecular cation- interactions.16 QCM-D studies suggest that 
indolicidin will adsorb to a supported phosphatidylcholine (PC) membrane and partially insert 
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into the bilayer.4 While alamethicin’s -helicity and amphiphilicity promotes membrane 
insertion, indolicidin favors a surface adsorption mechanism over insertion, largely due to its 
folded structure. Indolicidin contains hydrophobic amino acid residues, however, that allowed it 
to also partially insert into the membrane. 
To analyze the effect of AMPs on membrane structure and stability, we chose to use 
atomic force microscopy (AFM) imaging to examine AMP-induced changes to supported lipid 
bilayers (SLBs) that mimic cell membranes. AFM is a sensitive technique that uses a sharp-
tipped cantilever to scan the surface of samples and produce images with nanoscale resolution. 
Forces between the tip and sample cause cantilever deflections that are measured by a laser spot 
reflected into a photodiode array, producing an image reflecting the height variations on the 
surface. AFM has been used to examine changes in supported lipid membrane structure and 
thickness due to exposure to peptides,17-28 surfactants29, 30 and dendrimers.31 For instance, Lam et 
al. recently used AFM to image structural transformations in a zwitterionic 1,2-dimyristoyl-sn-
glycero-3-phosphocholine (DMPC) supported lipid membrane exposed to the cationic AMP 
protegrin-1 and saw evidence of pore formation and wormlike micelles in the membrane.18  
The goal of this study was to elucidate the underlying mechanism of action of 
alamethicin and indolicidin on a supported phosphatidylcholine (PC) lipid membrane using 
AFM. By deriving mechanistic information from AFM images, we aimed to validate mechanistic 
models of alamethicin- and indolicidin-membrane interactions that were developed in previous 
QCM-D studies.4, 32  Various AMP concentrations were examined, as well as time progression of 
AMP-induced membrane destabilization. Understanding the interaction mechanisms between 
AMPs and cell membranes is a crucial step in developing AMPs as an alternative to antibiotics in 
therapeutics. 
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6.3  Materials and methods 
6.3.1  Antimicrobial peptides 
Alamethicin and indolicidin were obtained from Sigma Aldrich (St. Louis, MO) and New 
England Peptide (Gardner, MA), respectively. All peptides were suspended in Tris-NaCl buffer 
(100 mM sodium chloride and 10 mM tris(hydroxymethyl)aminomethane, pH 7.8) and stored at 
-20˚C. A range of AMP concentrations (1, 5, and 10 M) were tested to examine the 
concentration dependency of AMP-membrane interactions. 
6.3.2  Supported lipid bilayer preparation 
Egg phosphatidylcholine (Avanti Polar Lipids, Alabaster, AL) vesicles were made and 
stored in Tris-Nacl buffer. Egg phosphatidylcholine (PC) lipids dissolved in ethanol were dried 
under a stream of nitrogen gas and placed in a vacuum desiccator overnight. The dried lipids 
were reconstituted in Tris-NaCl buffer to create a stock concentration of 2.5 mg/mL. The lipid 
mixture was then vortexed and homogenized through 5 freeze-thaw cycles. 
The egg PC lipids were sonicated with an ultrasonic dismembrator (Model 150T, Fisher 
Scientific, Waltham, MA) in an ice bath for 30 min in pulsed mode with a 30% duty cycle (3 s 
on, followed by 7 s pause) at an amplitude of 60 to form small unilamellar vesicles (SUVs). 
Sonicator probe particles were removed from solution through centrifugation (5415D 
Microcentrifuge, Eppendorf, Hamburg, Germany) at 16,000g for 10 min. The stock solution was 
diluted using Tris-NaCl buffer to 0.1 mg/mL for each experiment. 
Supported egg PC bilayers were formed on muscovite mica (Electron Microscopy 
Sciences, Hatfield, PA), which was cut into 0.7-cm-diameter circular sheets using a 3-hole 
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punch. The mica circles were fixed in a 1.5-cm-diameter well in a 1.2-mm-thick depression slide 
using epoxy. Before each experiment, the microscope slides were rinsed with 2% sodium 
dodecyl sulfate and DI water and dried with nitrogen gas. The mica was cleaved so that the 
surface was visually smooth and etched with a SPI Plasma Prep II Plasma Etcher (SPI Supplies, 
West Chester, PA). 
6.3.3  Atomic force microscopy (AFM) 
All samples were scanned in liquid using a Veeco Dimension Icon with ScanAsyst 
(Bruker, Santa Barbara, CA). A silicon nitride ScanAsyst Fluid+ cantilever with a spring 
constant of 0.7 N/m and nominal tip radius of 2 nm was used. Images were captured with 512 x 
512 resolution at a scan rate of 1 Hz.  
After the mica surface was scanned in Tris-NaCl buffer to validate the smoothness of the 
surface, excess buffer was pipetted from the mica surface and replaced with 0.1 mL of 0.1 
mg/mL egg PC vesicle solution. AFM image scanning began at least 5 minutes after the 
introduction of vesicles to allow sufficient time for stable supported lipid bilayer (SLB) 
formation. Once the presence of a smooth SLB on the mica surface was established, AMPs were 
introduced into the system. At least 0.25 mL of the experimental concentration of alamethicin or 
indolicidin was pipetted onto the periphery of the well in 10 L increments every 5 s, while 
simultaneously removing lipid vesicle solution in 10 L increments to simulate slow pump flow 
that was present in our QCM-D experiments. Before bringing the AFM tip to the mica surface in 
liquid, a drop of AMP solution was placed on the tip, instead of buffer, so that the AMP 
concentration would not be diluted. The surface was then scanned to image AMP-induced 
changes to the SLB at a minimum of 3 different locations on the sample. 
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All images were flattened using the first order polynomial flatten command in the 
NanoScope Analysis software to delete low frequency noise and remove tilt. Scan lines resulting 
from noise or skips were also removed from the final images. Roughness values were reported 
for each 5m x 5m image as the root mean square (RMS) average of height deviations in the 
image: 
ܴ௤ ൌ ට∑௓೔
మ
ேು        (6.1) 
where Zi is a specific Z (height) value and Np is the total number of points. Roughness 
measurements were used as a quantitative method of analyzing changes to the SLB over time. 
6.4  Results and discussion 
6.4.1  Alamethicin forms large defects and causes complete lipid removal 
 AFM imaging of the supported PC bilayer revealed a smooth membrane with small 
particles on the surface (Figure 6.1). These particles may have been small lipid aggregates that 
were present after lipid bilayer formation. Upon injection of 1 M alamethicin, many of the 
particles were removed and no visible membrane destabilization took place over the course of 1 
h.  
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Figure 6.1. Representative AFM images of a supported PC membrane after exposure to 1 M 
alamethicin. The stable lipid membrane before peptide injection is shown at t = 0 min. The scale bars 
represent a distance of 1 m.  
 
Large defects, or pores, formed in the lipid membrane upon exposure to 5 M 
alamethicin, leaving small islands of lipids amidst larger, connected lipid bilayer patches (Figure 
6.2). Due to the rapid nature of peptide-membrane interactions, we were unable to capture the 
initial stages of peptide binding and membrane removal. QCM-D studies have shown that the 
initial peptide binding interactions of alamethicin and indolicidin occur in less than 10 minutes.33 
Since each image required approximately 9 minutes of scanning, these initial interactions could 
not be captured with AFM. Over 3.5 h, lipids continuously shifted around the perimeter of the 
patches and were removed from the mica surface. Smaller patches of lipids also gradually left the 
mica surface or combined with neighboring planar lipid patches over time. 
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Figure 6.2. Defects formed in a supported PC bilayer after injection of 5 M alamethicin over 218 
minutes. Each AFM image was scanned in the same location on the substrate. The scale bars represent a 
distance of 1 m. 
 
Height profiles of the membrane at the same location on the substrate (Figure 6.3A) show 
some defects widening and others filling in as time progressed, indicating that the lipids at the 
perimeter of the planar membrane were fluid. Before alamethicin was introduced to the system 
(t=0 min), the lipid bilayer was a relatively smooth surface with 1-2 nm particles on the surface 
(Figure 6.3B). At 24 min, large membrane defects had formed that were approximately 5 nm 
deep, which is the expected height of a PC bilayer. In the height profile plots, the height of the 
bilayer surface at 0 min is different than that at 24 min (roughly 2 nm) because AFM does not 
allow for the direct comparison of heights between images. Therefore, the y-axis is meant to 
show the depth of the defects, rather than allow for the direct comparison of height value at a 
specific position on the substrate. After the membrane had been exposed to the peptide for 34 
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min, the lipids shifted to fill in some of the spaces observed in the height profile. The membrane 
defects expanded and lipid material left gaps in the membrane at 108 min.  At 162 min, most of 
the lipids had been removed and the profile shown at a height of 0 nm represents the mica 
substrate.  
 
Figure 6.3. Evolution of membrane defects over time during incubation with 5 M alamethicin. The 
dashed line (A) shows the location of the height profiles (B). The scale bar represents 1 m. 
 
At a concentration of 10 M, alamethicin appeared to remove the bilayer entirely before 
the first image was taken at 18 min (Figure 6.4). Unfortunately, due to the length of time 
required to position the AFM tip on the sample surface and scan an image, the first image could 
not be taken sooner than 18 min. Therefore, any action between the peptides and lipid 
membrane that occurred in the first several minutes could not be captured using AFM.  
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Figure 6.4. AFM images of the supported PC membrane after exposure to 10 M alamethicin. The scale 
bars represent a distance of 1 m. 
 
Although differentiating between an SLB and the mica substrate is difficult in these 
images, the particles (<10 nm in height) visible on the substrate surface after 18 minutes of AMP 
exposure (Figure 6.4) offer clues about the nature of the surface. Since large membrane defect 
formation was observed with an alamethicin concentration of 5 M, we expected to see defects 
or bilayer patches remaining on the mica surface if the lipid bilayer were still supported on the 
mica. These particles, which are likely lipid or peptide-lipid aggregates, appear to be all that 
remained of the lipid bilayer on the mica surface, however. Over the course of 4 h, some 
aggregates attached to the surface and most of the original particles present at 18 min gradually 
left the mica surface. The scanning motion of the AFM tip may have also contributed to the 
removal of these particles.  
Root mean square (RMS) roughness values were calculated to provide a quantitative 
method of analyzing changes in the membrane over time (Figure 6.5). As observed in the AFM 
images, 1 M alamethicin did not change the surface of the membrane over 1 hr and, therefore, 
the roughness did not change. At 5 M, alamethicin substantially increased the roughness of the 
membrane surface within 24 min. The roughness peaked at 54 min and gradually decreased over 
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the next 2.5 h. This decrease in roughness corresponds with the loss of small islands of lipid on 
the mica surface and around the bilayer patches, revealing more of the smooth mica surface. The 
complete removal of lipids at 10 M alamethicin produced lower roughness values that remained 
constant over 4 h. The RMS values for 10 M alamethicin were higher than those for 1 uM 
concentrations, however, presumably due to the presence of aggregates left on the surface of the 
mica. 
 
Figure 6.5. Root mean square (RMS) roughness values calculated for each 5m x 5m image of the 
supported PC bilayer after exposure to various alamethicin concentrations. 
The concentration-dependent membrane disruption that was observed as a result of 
alamethicin exposure is consistent with a previous QCM-D study on PC membranes.4 
Monitoring the changes in mass and rigidity of a supported PC membrane formed on silica did 
not show substantial changes to the lipid bilayer when exposed to 1 M alamethicin in QCM-D 
experiments. AFM imaging of the membrane after injection of 1 M alamethicin also did not 
show visible membrane disruption (Figure 6.1).  
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The large defect formations observed in the membrane after exposure to 5 M 
alamethicin (Figure 6.2) agreed with QCM-D results showing decreases in mass at all depths of 
the SLB after 1 h of incubation with the same peptide concentration.4 In QCM-D experiments, 
the lipid membrane lost roughly 15-20% of its original mass. From visual analysis, more than 
15-20% of the lipid bilayer appeared to be removed in the AFM images after 1 h, but this lipid 
removal could have been due to forces resulting from the motion of the cantilever. Previous 
studies have shown that the scanning AFM tip can affect the position of particles on a surface, 
resulting in movement of weakly adsorbed peptide aggregates on a bilayer or even the rupture of 
surface-adsorbed lipid vesicles.19, 34 Although the QCM-D results indicated that alamethicin 
likely lined the pores in the membrane, the individual peptide molecules were not visible in these 
images. Since alamethicin monomers can be approximated as cylinders 3.2 nm long and 1.1 nm 
wide,14, 35 they may not be distinguishable from the adjacent 5 nm tall lipid bilayer when 
scanning with a 2 nm-radius tip. 
The membrane changes induced by 10 M alamethicin observed using AFM (Figure 6.4) 
differed somewhat from the membrane disruption inferred from QCM-D experiments.4 Although 
near-complete bilayer removal was observed in the AFM images, only about 20% of the original 
bilayer mass was removed from a silica surface in a similar QCM-D experiment. These 
variations were likely due to differences in the experimental setup of the two techniques. First, 
the QCM-D measurements were performed in a flow system, whereas the AFM images were 
scanned in a static system. The scanning motion of the AFM tip also may have caused more lipid 
removal than in an undisturbed lipid membrane. Furthermore, variations in the amount of lipid 
removal observed may have been due to differences in the substrates used as lipid bilayer 
supports. In the QCM-D experiments, a silica-coated quartz sensor was used as the substrate, 
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while the AFM images were scanned on a mica substrate. Mica was chosen as the substrate for 
the AFM experiments because its cleaved surface is smoother than that of the silica QCM-D 
sensor. The QCM-D sensor surface exhibits height variations ranging across several nanometers, 
making the identification of lipid membrane defects difficult on these substrates. Although mica 
is mainly composed of silicate minerals, which are related to silica, differences in the surface 
roughness and composition may have impacted the retention of lipid molecules on the surface. A 
previous study by Benes et al. found that supported 1,2-dioleoyl-sn-glycero-3-phosphocholine 
(DOPC) and DOPC/1,2-dioleoyl-sn-glycero-3-phospho-L-serine (DOPS) membranes formed 
and behaved differently on mica and silica surfaces.36 Membranes were less stable in Tris-HCl 
buffer than in HEPES buffer when formed on mica, but the buffer did not influence membrane 
stability when supported on silica. These differences in membrane behavior suggest that the two 
surfaces exhibit different properties that can affect their interactions with lipids. 
The loss of lipid mass from the membrane due to alamethicin action was also observed in 
a study by Oliynyk et al. on 1,2-dipalmitoyl-sn-glycero-3-phosphatidylcholine (DPPC) supported 
membranes.23 Circular and elongated membrane defects were revealed using AFM imaging of 
DPPC membranes with 1 mol% and 4 mol% alamethicin that were formed by direct fusion of 
lipid-peptide SUVs on mica. Less mass loss and smaller membrane defects were observed than 
in our study. The results of the two studies could not be directly compared, however, since the 
peptide concentrations in our experiments were bulk concentrations and the ratio of peptide to 
lipid in our membranes was not known. Also, although DPPC is a major component of the lipid 
mixture that is included in egg PC, egg PC also contains 1,2-distearoyl-sn-glycero-3-
phosphocholine (DSPC) and other phospholipids that may exhibit different behavior with the 
peptides. 
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6.4.2  Indolicidin forms smaller, unstable holes in the membrane 
After exposure to 1 M indolicidin, visible changes to the membrane were not observed 
(Figure 6.6). Before peptide was added, the PC membrane surface contained occasional small 
particles (40-50 nm in height) that may have been vesicles. These particles remained after 
scanning for 2.5 h, although other particles, possibly peptides or peptide-lipid aggregates, were 
observed to attach to the membrane. Peptide-lipid aggregates may have formed in the solution if 
indolicidin attached to the membrane and displaced a small amount of lipids, resulting in defects 
that were too small to be resolved by the 2-nm AFM tip radius. Membrane-bound vesicles were 
also observed in an AFM study by Oreopoulos et al. examining indolicidin action on a 
DOPC:DSPC:cholesterol membrane.24 These vesicles were hypothesized to be lipids displaced 
from the membrane by indolicidin action. 
 
Figure 6.6. AFM image of a supported PC membrane exposed to 1 M indolicidin. The scale bars 
represent a distance of 1 m. 
  
At 5 M, indolicidin formed defects in the membrane that were smaller than those 
created by alamethicin at the same concentration (Figures 6.2, 6.7). Within 26 min, many of the 
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defects appeared to reorganize and consolidate to make the surface less rough. Over 3 h, these 
defects filled in to form a smooth membrane.  
 
Figure 6.8. Defects formed in a supported PC membrane after injection of 5 M indolicidin. The scale 
bars represent a distance of 1 m. 
 
 Filling of the defects can also be observed in height profiles in Figure 6.8. The membrane 
defects may have been replaced with lipids, peptides, or both. The end result was a smooth 
bilayer that appeared to be the same height as the original bilayer, suggesting that the material 
used to seal the defects is a lipid bilayer, rather than peptide-lipid aggregates, which may not 
have resulted in the same height. The shrinking “pores” shown at 98 min maintained a relative 
height of 5 nm (the height of a PC bilayer), suggesting that the resulting membrane at 149 min 
was a lipid bilayer. 
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Figure 6.8. Evolution of PC membrane defects over time after exposure to 5 M indolicidin. The dashed 
line (A) shows the location of the height profiles (B) on the substrate. The scale bar represents 1 m. 
 
Small holes and channels were formed in the membrane at 10 M concentrations (Figure 
6.9). These defects left smaller patches of interspersed lipid bilayer membranes than 5 M 
indolicidin. These defects also appeared to fill in over 3.5 h, although the pores did not remain 
as well-defined as they were with 5 M indolicidin during this process. While the membrane 
pores were clearly differentiated from the lipid bilayer at 98 min in Figure 6.8, the AFM tip 
could not resolve the boundary between the lipid membrane and mica at 54 min in Figure 6.9. 
One possible reason for these “blurry” edges may have been that the lipids were not well 
attached to the mica and were moved by the force AFM tip as it scanned across the substrate 
surface. 
161 
   
 
Figure 6.9. Defects formed in a mica-supported PC bilayer after exposure to 10 M indolicidin. The scale 
bars represent a distance of 1 m. 
 
The height profiles in Figure 6.10 show that the membrane defects that had formed in the 
bilayer 18 min after peptide exposure were 5 nm deep, which was expected in a 5 nm-tall lipid 
bilayer. After 27 min, however, the depth of these defects decreased to 4 nm. Within 54 min, the 
defect heights decreased to 3 nm, leading to a smooth surface at 153 min. The initial 5-nm 
defects that were captured at 18 min may correspond with temporary complete insertion of the 
peptide into the membrane, but we cannot confirm or deny this hypothesis using these AFM 
images alone. 
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Figure 6.10. Filling of PC membrane defects over time with 10 M indolicidin. The dashed line (A) 
shows the location of the height profiles (B). The scale bar is 1 m.  
  
The RMS roughness plots in Figure 6.11 show that not much change occurred in the 
membrane with 1 M indolicidin. The roughness of the membrane exposed to 5 M indolicidin 
peaked at or before 17 min. Then, as the defects reorganized and filled in, the roughness 
decreased to around 1.6 nm until 3 h after peptide exposure, when the majority of the membrane 
became smooth. The roughness of the membrane when exposed to 10 M indolicidin peaked at 
27 minutes and quickly decreased as the membrane filled in. A similar trend was seen in an AFM 
study by Askou et al. showing the effect of 25 M indolicidin on a supported PC membrane.20 A 
plot of the average height roughness of the images over time revealed a peak in roughness 
between 15 and 30 min, which was followed by a gradual decrease in roughness before 
stabilizing. This common trend indicates that at these concentrations, indolicidin-induced 
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membrane damage peaks at most 30 minutes after exposure to the peptide. Therefore, the 
maximum amount of damage to a cell membrane may be observed within this time period when 
incubated with indolicidin. 
 
Figure 6.11. Root mean square (RMS) roughness values calculated for each 5m x 5m image of the 
supported PC bilayer after exposure to various indolicidin concentrations. 
 
 The RMS values for 1 M indolicidin are about 2x larger than those for 1 M 
alamethicin (Figure 6.5) due to the presence of particles originally on the surface of the 
membrane before indolicidin was injected. More particles (possibly peptide aggregates) also 
attached to the membrane surface after 2 hrs of incubation with 1 M indolicidin, resulting in the 
increased RMS values at 140 min. The roughness values calculated for alamethicin-induced 
defects at 5 M and indolicidin-induced defects at 5 M and 10 M also showed that both 
peptides substantially changed the lipid membrane surface within the first 50 minutes of 
exposure and gradually stabilized within 150 min. 
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 The indolicidin-induced membrane disruption captured by AFM imaging in this study 
complements and elucidates the peptide-membrane interactions observed in a previous QCM-D 
study.33 The lack visible defects in the PC membrane after exposure to 1 M indolicidin (Figure 
6.6) was consistent with QCM-D results, which showed little change to the mass and lipid 
organization of the membrane after a 1-h incubation.  
The loss of lipid mass from within the membrane at 5 M indolicidin (Figure 6.7) was 
also observed in QCM-D experiments using the same peptide-lipid system.33 QCM-D 
measurements showed that approximately 10% of the lipid bilayer mass was removed from the 
substrate surface, which is similar to the amount of lipid removal observed in the AFM images at 
62 min. However, the QCM-D results also showed a small amount of mass gain in peptide mass 
on the membrane surface, which the AFM tip may not have be able to capture due to the 
nanometer-scale size of individual peptide molecules. 
At 10 M indolicidin, the incomplete filling of the membrane defects at 54 min (Figure 
6.9) may be explained by partial insertion of the peptide that occurred in previous QCM-D 
experiments.33 The QCM-D results indicated that indolicidin adsorbed to the surface of the PC 
membrane and partially inserted into membrane space where lipids had been removed. The 
mechanistic model that was derived from QCM-D measurements showed indolicidin partially 
inserting into a space where the top layer of lipids had been removed and the peptide associating 
with the remaining monolayer of lipids. If accurate, this mechanistic model would be consistent 
with the 3 nm defects (roughly half the height of the membrane) observed using AFM. The 
QCM-D results also indicated that the lipids within the membrane had become very disordered 
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when exposed to 10 M indolicidin, which may explain the “blurry” lipid patch edges that were 
captured in Figure 6.9. 
Smoothing of peptide-induced defects in the lipid bilayer that was observed with 5 uM 
and 10 M indolicidin has also appeared in several other AFM studies on indolicidin. Ha et al. 
found that 15.7 M indolicidin produced holes in mica-supported membranes (30-100 nm in 
diameter) composed of the synthetic lipid L--dipalmitoylphosphatidic acid (DPPA) that became 
smooth over time.37 The membrane smoothing was thought to be due to the incorporation of 
peptides into the bilayer. Shaw et al. also imaged large, transient defects in the fluid domains of 
DOPC/DSPC membranes that disappeared slowly over time, which was hypothesized to be due 
to fluidity of the membranes.26 
The concentration-dependence of peptide-membrane interactions shown in this study is 
similar to results obtained by Végh et al. on the effect of indolicidin on DPPC membranes 
formed on polyelectrolyte films on mica.27 The polyelectrolyte film was present to create space 
for membrane-penetrating peptides between the bilayer and mica surface. As in our study, no 
membrane alterations were detected at low indolicidin concentrations (0.52 M); though at 
higher concentrations (2.6 M and 5.2 M), the membrane remained intact, but particles 
appeared on the membrane surface. These particles were believed to be aggregates from excess 
amounts of indolicidin. This phenomenon also appeared in our AFM images with 1 M 
indolicidin. In the study by Végh et al., the DPPC bilayer structure did not form detectable 
membrane defects before 50 min of exposure to 15.7 M indolicidin. The membrane was 
completely destroyed after 140 min of incubation with 7.9 M and 15.7 M indolicidin, but 
smoothing of the membrane defects was not observed, as in our study. These differences were 
166 
   
likely due to the variations in lipid membrane composition, as well as the presence of a 
polyelectrolyte film between the lipid membrane and mica surface. The polyelectrolytes may 
have inhibited the filling of defects by lipid or peptide material. 
6.5  Conclusions 
AFM imaging of AMP-induced changes in the membrane is a valuable tool for visual 
analysis of lipid removal and the stability of defects. Using AFM to examine alamethicin- and 
indolicidin-induced defects in supported PC membranes revealed two distinct membrane-
disruption mechanisms. The AFM images showed that 1 M alamethicin did not substantially 
disturb the lipid bilayer, while 5 M and 10 M alamethicin concentrations resulted in 
substantial loss of lipids from the membrane. Membrane defects formed after exposure to 5 M 
indolicidin continued to expand, causing complete destruction of the lipid bilayer. AFM also 
showed the formation of smaller defects in a supported membrane as a result of incubation with 
5 M and 10 M indolicidin. The smoothing of membrane defects over time was also observed 
clearly in the images. The examples of AMP-induced membrane disruption observed in this 
study offer insight into how various concentrations of AMPs may interact with and disrupt cell 
membranes. Fundamental understanding of the molecular mechanisms and dynamics associated 
with AMP-membrane interactions is instrumental for the selection and design of AMPs for 
applications in therapeutics. 
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Chapter 7 
A novel technique for forming supported anionic lipid membranes through vesicle fusion and an 
investigation of its interactions with chrysophsin-3 
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7.1  Abstract 
 Although supported lipid bilayer (SLBs) composed of zwitterionic lipids and 
zwitterionic-anionic lipid mixtures have been used extensively to mimic eukaryotic and Gram-
negative bacterial cell membranes, attempts to form supported bilayers composed entirely of 
anionic lipids have been less successful. SLBs fully composed of anionic lipids are valuable 
models for Gram-positive bacterial membranes that can be used to study the membrane 
interactions of particles such as antimicrobial peptides (AMPs) or nanoparticles. We developed a 
novel method of forming robust anionic lipid bilayers containing 3:2 and 4:1 L-α-
phosphatidylglycerol (PG) and 1-palmitoyl-2-hydroxy-sn-glycero-3-phospho-(1'-rac-glycerol) 
(LPG)  lipid mixtures, which were supported on (3-aminopropyl)trimethoxysilane (APTMS)-
coated silica. Quartz crystal microbalance with dissipation monitoring (QCM-D) was used to 
monitor the formation of the supported bilayers by measuring nano-scale mass changes on a 
sensor surface as anionic lipids vesicles attached and ruptured into a bilayer.  Supported PG 
vesicle layers were also formed to enable experiments that monitor the behavior of anionic 
vesicles. These supported lipid membranes were exposed to various concentrations of the AMP 
chrysophsin-3 to demonstrate the anionic membranes’ capacity as bacterial membrane mimics 
and investigate the molecular effects of the peptide on anionic bilayers. Chrysophsin-3 exhibited 
transmembrane insertion behavior and did not predominantly adsorb to the membrane surface as 
it did on zwitterionic lipid phosphatidylcholine (PC) membranes. Supported anionic lipid 
bilayers can be valuable tools for studying the behavior of Gram-positive bacterial membranes 
for the development of antimicrobial agents or therapeutics. 
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7.2  Introduction 
 One of the primary differences between the plasma membranes of eukaryotic and 
bacterial cells is in the charges of the phospholipids contained within the bilayer. Eukaryotic 
cells, such as erythrocytes, primarily contain zwitterionic lipids, while Gram-positive bacteria, 
such as Staphylococcus aureus (S. aureus), are composed of anionic lipids.1 The plasma 
membranes of Gram-negative bacteria like Escherichia coli can contain a mixture of zwitterionic 
and anionic phospholipids.  
This difference in membrane charge is believed to be a primary method by which 
antimicrobial peptides (AMPs) are able to target bacterial cells over eukaryotic cells. AMPs, 
which are often cationic, are thought to first become attracted to bacterial membranes through 
electrostatic interactions.2, 3 Once attached, some membrane-active AMPs kill bacteria by 
destabilizing their lipid membranes and causing them to lyse. Other AMPs may enter the cell 
through this membrane and destroy intracellular components, killing the cell. Although 
membrane-active AMPs are believed to kill cells through membrane destabilization, the exact 
mechanism behind the membrane disruption is not fully understood.  
Several theories have been developed to explain the mechanisms that allow membrane-
active AMPs to destabilize cell membranes. In the barrel-stave model, AMPs are believed to 
insert into the membrane, forming pores through which large molecules can enter or exit the 
cell.4 Ion gradients can also be disturbed, killing the cell. Alamethicin and other -helical 
peptides are thought to be able to insert into the membranes as single molecules or as clusters.5, 6 
The carpet model supposes that the peptides can “carpet” the lipid headgroup surface of the 
membrane and rearrange with the membrane lipids to form micelles or peptide-lipid aggregates.7 
These aggregates can then leave the bilayer, destroying the membrane. Variations of these two 
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primary mechanisms can occur, such as the formation of toroidal pores, and can depend on 
peptide-to-lipid ratio in the membrane.5, 8 
Due to the low risk of AMP-induced resistance in bacteria, AMPs are being researched 
extensively for their potential as therapeutics. AMPs are believed to avoid the development of 
bacterial resistance because of their unique membrane-destabilization mechanisms of bacterial 
killing. However, before AMPs can be used effectively in therapeutics, their interactions with 
both bacterial cells and eukaryotic cells need to be fully understood. Therapeutic AMPs must be 
able to effectively target and kill pathogens without harming eukaryotic cells in the patient.  
Quartz crystal microbalance with dissipation monitoring (QCM-D) is a sensitive method 
of studying AMP interactions on the molecular level in real-time. AMPs are injected into a 
chamber containing a mimetic cell membrane, which is modeled by a lipid bilayer supported on 
the surface of a QCM-D sensor, or crystal. Measuring frequency and energy dissipation changes 
of the oscillating crystal gives information about changes in the mass and rigidity of the 
membrane. One can also interpret the various measured overtones to infer the organization and 
orientation of peptide and lipid molecules in the membrane. Since this method assumes that the 
mass on the sensor surface is uniform, the supported lipid bilayers must smooth and defect-free. 
Previous QCM-D studies have investigated the action of AMPs on models of eukaryotic 
and Gram-negative bacterial membranes, which consist of purely zwitterionic lipids or a 
combination of zwitterionic and anionic lipids.9-12 These studies revealed valuable information 
about AMP-membrane interactions and showed that QCM-D can be used to differentiate 
between surface adsorption of a peptide onto a membrane and insertion into the membrane. 
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However, examination of the action of AMPs on Gram-positive bacterial membrane mimics 
requires the development of smooth supported lipid bilayers fully composed of anionic lipids.  
Due to the charges associated with anionic lipids, a simple procedure for forming smooth 
and consistent supported lipid bilayers composed entirely of anionic lipids has not been 
developed. Lipid bilayers composed of zwitterionic/anionic lipid mixtures have been formed and 
studied extensively, particularly those containing up to 50 mol% anionic lipids.13, 14 Sparsely 
tethered bilayer membrane systems have also been developed with zwitterionic/anionic lipid 
mixtures, in which a synthetic lipid anchor is used to tether lipids to a surface and a short 
hydrophilic “backfiller,” such as -mercaptoethanol (ME) is used to dilute the grafting points.15 
Attempts to create bilayers composed purely of anionic lipids resulted in incomplete or defect-
rich membranes, however. Blume et al. were able to form an anionic 1-palmitoyl-2-oleoyl-sn-
glycero-3-phosphoglycerol (POPG) supported lipid bilayer using the Langmuir-
Blodgett/Langmuir-Schaefer method, but epifluorescence images of the membrane showed the 
presence of ordered domains or defects in the membrane.16 Also, the vesicle fusion method of 
bilayer formation is preferred for QCM-D experiments, since the entire bilayer formation 
procedure can be performed inside a closed QCM-D flow chamber. The vesicle fusion method 
for forming PC bilayers is a robust method that has been shown to form smooth membranes. The 
technique consists of injecting a solution of small unilamellar lipid vesicles (SUVs) over a silica 
surface. The vesicles attach to the surface and at rupture to form a lipid bilayer when they reach a 
critical concentration. 
We developed a simple protocol for forming supported anionic membranes using various 
compositions of PG and LPG vesicles and verified the results using QCM-D. Once this protocol 
was shown to be robust and consistent, we exposed these membranes to various concentrations 
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of the AMP chrysophsin-3, an amphiphilic and cationic peptide derived from the gills of the red 
sea bream, Chrysophrys major. Chrysophsin-3 contains 20 amino acids that exhibit an -helical 
conformation when in contact with a biological membrane. This peptide was chosen because its 
action with a zwitterionic PC membrane had been investigated in a previous study from our lab, 
which enabled a comparison of AMP-membrane interactions on membranes of varying charge. 
The peptide also contains 4 positively charged amino acid residues near the C-terminus, which 
may result in strong electrostatic interactions with an anionic membrane. 
In this study, we developed a novel technique for forming anionic supported lipid 
membranes on (3-aminopropyl)trimethoxysilane (APTMS)-coated silica. A screening study was 
performed to identify lipid compositions and surface treatments that showed potential for 
forming robust supported bilayers. Three lipid membranes were chosen from this screening study 
for further study and were exposed to various concentrations of chrysophsin-3 to investigate 
AMP-membrane interactions using QCM-D. The AMP experiments were performed to 
demonstrate the capabilities of these membranes as bacterial membrane mimics, which will be 
valuable for investigating the behavior of these membranes in future studies. 
7.3  Materials and methods 
7.3.1 Peptides and lipids 
Chrysophsin-3 (GenWay Biotech Inc., San Diego, CA) was suspended and stored in Tris-
NaCl buffer (100 mM sodium chloride and 10 mM tris(hydroxymethyl)aminomethane, pH 7.8). 
Experimental concentrations of 0.5, 1, 5, and 10 M chrysophsin-3 were examined.  
Egg L-α-phosphatidylcholine (PC), egg L-α-phosphatidylglycerol (PG) and 1-palmitoyl-
2-hydroxy-sn-glycero-3-phospho-(1'-rac-glycerol) (LPG) were purchased from Avanti Polar 
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Lipids (Alabaster, AL). PC was stored in ethanol at -20˚C and PG and LPG were stored in 
chloroform at the same temperature. Lipid vesicle solutions were typically suspended in HEPES 
buffer (10 mM HEPES, 150 mM NaCl, 2 mM NaN3, pH 7.4) with or without the addition of 2 
mM CaCl2 or 4 mM ethylenediaminetetraacetic acid (EDTA). Tris-NaCl buffer (100 mM sodium 
chloride and 10 mM tris(hydroxymethyl)aminomethane, pH 7.8) was also used in vesicle 
solutions. 
7.3.2  Lipid vesicle formation 
 Three anionic lipid membrane compositions were examined in this study: (i) PG, (ii) 3:2 
PG/LPG (molar ratio), and (iii) 4:1 PG/LPG (molar ratio). The 3:2 and 4:1 ratios were chosen 
because they are similar to the lipid composition of S. aureus membranes.1 Zwitterionic PC was 
also used in an initial screening study. The lipids were dried in the appropriate proportions to 
remove the chloroform or ethanol solvents and placed in a vacuum desiccator overnight. The 
dried lipids were suspended in enough of the appropriate buffer (Tris-NaCl or HEPES buffer 
with or without CaCl2 or EDTA) to bring the total lipid concentration to 2.5 mg/mL. The lipid 
solution was mixed well and placed through 5 freeze-thaw cycles. The lipids were then sonicated 
with an ultrasonic dismembrator (Model 150T, Fisher Scientific, Waltham, MA) in pulsed mode 
for 30 min in a 70˚C water bath. A 30% duty cycle (3-sec sonication followed by a 7-sec pause) 
with an amplitude of 60 was used. The vesicles were then centrifuged for 10 min at 16,000g to 
remove probe particles and large lipid aggregates. The supernatant was removed and stored 
under nitrogen at 7˚C and diluted to a concentration of 0.1 mg/mL before each experiment.  
Dynamic light scattering (Zetasizer Nano ZS, Malvern, Worcestershire, UK) (DLS) was 
used to measure vesicle size in solution. DLS measures the Brownian motion of the particles in a 
sample, from which the particle size can be derived. Small particles are known to move quickly 
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in a liquid, while large particles move slowly. The intensity distributions of the suspended lipid 
vesicle samples were measured and used to generate size distributions of the vesicles by volume. 
7.3.3  Quartz crystal microbalance with dissipation monitoring (QCM­D) 
The Q-Sense E4 system (Biolin Scientific, Sweden) was used to monitor the attachment 
of lipid vesicles to a sensor surface and the subsequent peptide-lipid interactions. QCM-D is a 
sensitive method that can capture nano-scale mass changes on a sensor surface. A voltage is 
applied to the QCM-D quartz sensor, causing it to oscillate at its resonant frequency. As mass 
(m) is added to the sensor surface, the frequency associated with this oscillation decreases (f) 
according to the Sauerbrey equation:  
∆݉ ൌ െܥ∆݂      (7.1) 
where C is a proportionality constant (17.8 ng/cm2/Hz for a crystal with a natural frequency of 5 
MHz). It should be noted that the f values are automatically normalized to each overtone so that 
f=f/n, where f is the frequency and n is the harmonic number. 
Energy dissipation is also measured, which is related to the time it takes for the 
oscillation of the mass on the surface to stabilize when the crystal oscillation is stopped. 
Dissipation (D) is related to the rigidity of the mass and can be described by: 
ܦ ൌ ீ"ଶగீᇱ      (7.2) 
where G’ and G” are the loss modulus and storage modulus, respectively.  Higher dissipation 
values are related to softer or hydrated mass on the sensor surface. 
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Various overtones, or harmonics, of the frequency and dissipation are also measured, 
providing information about changes occurring throughout different depths of the attached film. 
Due to the different penetration depths of the acoustic waves associated with the measured 
overtones, each overtone can be related to processes at various thicknesses of an adsorbed film.11, 
17 Higher overtones (e.g. 11th) are more closely related to processes occurring near the sensor 
surface and lower overtones (e.g. 3rd) are related to processes occurring farther from the sensor, 
near the membrane-liquid interface.  
Previous studies have used overtone data to infer the attachment and organization of 
molecules at various depths of supported lipid bilayers.9-12 Frequency decreases in lower 
overtones indicate that mass addition occurred on the bilayer surface, suggesting a mechanism 
involving peptide adsorption to the membrane surface, which was observed for chrysophsin-3 
action on PC bilayers.11 As shown for alamethicin interactions with PC membranes, uniform 
frequency changes at all overtones indicate mass changes throughout the entire membrane 
thickness, which could be a result of peptide insertion in to the membrane.9 Variations of these 
two models can point to more complex interactions, such as partial peptide insertion into the 
membrane that was suggested by QCM-D studies of indolicidin action on PC membranes.10 
To form supported lipid bilayers, a baseline was first established in the frequency and 
dissipation measurements by flowing the buffer that was present in the lipid vesicle solution. The 
lipid vesicle solutions were then injected into the QCM-D chambers at 0.15 mL/min for 35 min 
and the shifts in f and D were measured. The sensor surface was rinsed with another injection of 
the original buffer to remove any weakly attached particles. All experiments were performed at 
23˚C. 
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7.3.4  Surface treatment 
Anionic lipid membranes were formed on silica QCM-D sensor crystal surfaces treated 
with (3-aminopropyl)trimethoxysilane (APTMS) and polyethylenimine (PEI). APTMS and PEI 
were used to make the sensor surface cationic to facilitate the attachment of anionic lipid 
vesicles. Before each experiment, the sensors were rinsed with 2% sodium dodecyl sulfate (SDS) 
and DI water, dried with nitrogen gas and etched with a SPI Plasma Prep II Plasma Etcher (SPI 
Supplies, West Chester, PA). The sensors were then immersed in ethanol for 5 min, methanol for 
5 min, and a 30% (vol%) APTMS/methanol mixture for 20 min. After rinsing with methanol and 
drying with nitrogen gas, the crystals were ready for use in QCM-D experiments. At the end of 
each experiment, the crystals were rinsed with 2% SDS, DI water and methanol and dried with 
nitrogen gas. 
7.3.5  Monitoring of chrysophsin­3 interactions with anionic lipid films  
After the anionic lipid films had stabilized under the final buffer rinse, Tris-NaCl buffer 
was flowed over the sensor surface to establish a new baseline in preparation for the injection of 
chrysophsin-3, which was suspended in Tris-NaCl buffer. Chrysophsin-3 was injected into the 
chamber for 10 min at a flow rate of 0.15 mL/min to ensure that it had replaced the previous 
buffer solution and the flow was paused for 1 hr. After the 1-hr incubation, the flow was 
restarted with Tris-NaCl buffer to remove weakly attached particles from the sensor surface. The 
final buffer rinse continued until the frequency and dissipation measurements stabilized. 
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7.4  Results and discussion 
7.4.1  Anionic lipid vesicle and membrane formation 
Various lipid compositions, vesicle sizes, buffers, and surface treatments were examined 
in a preliminary screening study to identify the most promising systems to pursue in our 
membrane formation experiments. These parameters were chosen because they were important 
factors in PC and dioleoylphosphatidylcholine (DOPC)/dioleoylphosphatidylserine (DOPS) lipid 
vesicle adsorption and bilayer formation in previous studies.13, 18, 19 The results are summarized 
in Table 7.1. Rapid vesicle adsorption (negative frequency peaks) to the surface and subsequent 
stabilization of frequency and dissipation measurements (D < 0) indicated possible formation of 
a supported lipid bilayer.  
From the preliminary screening study, we found that lipid composition, the buffer, and 
the surface treatment were the most critical parameters for enabling bilayer formation. Many 
vesicle systems that contained 3:2 and 4:1 PG/LPG (20-30 nm in diameter) formed supported 
lipid bilayers when suspended in HEPES buffers containing 2 mM CaCl2 or 4 mM EDTA. Both 
APTMS and PEI facilitated vesicle adsorption and rupturing at 30% and 20 mg/mL 
concentrations, respectively. Creating smaller vesicle sizes by repeating the sonication procedure 
did not impact vesicle adsorption or bilayer formation, however. Also, not all the lipid 
compositions examined were capable of forming SLBs. PG vesicles, for instance, adsorbed to the 
APTMS- and PEI-treated surfaces, but did not form a supported membrane after 40 minutes of 
flowing the vesicle solution over the QCM-D sensor surface.  
181 
   
Table 7.1. Results of anionic lipid membrane screening study 
Lipid 
Composition 
Vesicle 
Diameter 
(nm)  
Buffer SiO2 Surface 
Treatment 
Peak 
f 
(Hz) 
Final 
f 
(Hz) 
Peak 
D  
(1E-6) 
Final 
D  
(1E-6) 
Results  Conclusions 
Egg PC 37  Tris-NaCl, 
pH 7.8 
None -70 -26 4.5 0.5 Control: PC SLB formed 
normally 
2 hr. incubation does not result in 
PC vesicle adsorption after stable 
bilayer formation 
Egg PG  35 Tris-NaCl, 
pH 7.79 
5 mg/mL PEI  
(10 min incubation) 
0 0 0 0 No vesicle adsorption PG vesicles in Tris-NaCl buffer will 
not attach to PEI-treated surface 
Egg PG 123.3 
45.74  
HEPES+2 
mM CaCl2, 
pH 7.43 
30% APTMS 
(20 min incubation) 
-75 -68 5.5 4.5 - Vesicles adsorbed, but rupture 
was not directly observed 
- Adsorption not stabilized after 
40 min 
- PG vesicles do not appear to form 
SLB, but may form a supported 
vesicle layer 
- final buffer rinse did not result in 
substantial mass loss 
Egg PG 123.3 
45.74  
HEPES+2 
mM CaCl2, 
pH 7.43 
20 mg/mL PEI  
(20 min incubation) 
-67 -62 5 3.7 - Vesicles adsorbed, but rupture 
was not directly observed 
- Adsorption not stabilized after 
40 min 
Same as above 
3:2 PG/LPG unknown HEPES + 4 
mM EDTA, 
pH 7.37 
10% APTMS 
(20 min incubation) 
-24 -17 0.5 0.8 Vesicle attachment and rapid 
rupturing may have occurred 
10% APTMS will allow for some 
anionic vesicle attachment and 
rupture 
3:2 PG/LPG 35  HEPES+4 
mM EDTA, 
pH 7.37 
30% APTMS  
(20 min incubation) 
-27 -25 0.7 1 Vesicle attachment and rapid 
rupturing may have occurred 
Increased APTMS concentration 
(4x) increases lipid retention after 
buffer rinse but only increases 
vesicle adsorption slightly (-3 Hz) 
3:2 PG/LPG 25.02 
18.95  
HEPES+2 
mM CaCl2, 
pH 7.4 
10% APTMS 
(20 min incubation) 
-27-> 
-21 
-14   
->-22 
0.8 -> 
0.2 
1 - less initial vesicle attachment 
and irreversible mass 
attachment than with 30% 
APTMS 
- Possible vesicle rupturing 
SLB may still form with lower 
APTMS concentration, but less 
mass is retained on crystal surface 
3:2 PG/LPG 19.34 
13.22  
HEPES+2 
mM CaCl2, 
pH 7.38 
30% APTMS 
(20 min incubation) 
-31 -22 1 0.6 Vesicles adsorbed and may 
have ruptured to form a bilayer 
after 39 minutes of vesicle flow 
CaCl2 may enable SLB formation on 
APTMS-coated SiO2, although final 
f is less than we expect for PC SLB 
3:2 PG/LPG 2950 
1018  
HEPES, pH 
7.41 
30% APTMS 
(20 min incubation) 
-25-> 
-21 
-33 0.4 -> 
0.2 
0.4 - Vesicles attached to surface 
and some may have ruptured 
- Final buffer rinse added mass  
PG/LPG vesicles are not stable 
without CaCl2 or EDTA (possible 
aggregation) 
3:2 PG/LPG 25.02 
18.95  
HEPES+2 
mM CaCl2, 
pH 7.4 
2.5 mg/mL PEI  
(20 min incubation) 
-26 -18-> 
-25 
0.6 1.2 - less initial vesicle attachment 
than with 20 mg/mL PEI  
- Vesicles may have ruptured 
SLB may still form with lower PEI 
concentration 
3:2 PG/LPG 19.34 
13.22  
HEPES+2 
mM CaCl2, 
pH 7.38 
20 mg/mL PEI  
(20 min incubation) 
-30 -21 0.5 0.5 - Vesicles adsorption and 
possible rupture 
- stabilized after 5 min 
3:2 PG/LPG  in HEPES+CaCl2 
buffer did not adsorb more than 4:1 
PG/LPG in HEPES+4mM EDTA on 
PEI-Coated SiO2 
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Lipid 
Composition 
Vesicle 
Diameter 
(nm)  
Buffer SiO2 Surface 
Treatment 
Peak 
f 
(Hz) 
Final 
f 
(Hz) 
Peak 
D  
(1E-6) 
Final 
D  
(1E-6) 
Results  Conclusions 
3:2 PG/LPG 2950 
1018 
HEPES, pH 
7.41 
20 mg/mL PEI  
(20 min incubation) 
-34   
->-27 
-40 0.5 -0.5 - More vesicles attachment to 
surface with PEI than with 
APTMS; may have ruptured 
- Final buffer rinse added mass  
PEI resulted in more mass 
attachment than APTMS coating in 
absence of CaCl2 or EDTA 
4:1 PG/LPG 21.87 
42.45  
HEPES+4 
mM EDTA, 
pH 7.38 
None -1.5 1.7 0.5 0.5 A small amount of vesicles 
adsorbed to the bare SiO2 
surface 
The surface treatments are primarily 
responsible for vesicle adsorption 
observed in other experiments 
4:1 PG/LPG 21.87 
42.45  
HEPES+4 
mM EDTA, 
pH 7.38 
30% APTMS 
(20 min incubation) 
-31 -27 1.25 0.7 - Vesicle rupture may have 
occurred 
- Stabilized after 30 min. 
- 2 h incubation with APTMS 
surface may have led to observable 
SLB formation 
- the final f value is consistent with 
PC SLB formation; SLB may be 
forming rapidly 
4:1 PG/LPG 29.47 
23.79  
HEPES+2 
mM CaCl2, 
pH 7.42 
30% APTMS 
(20 min incubation) 
-47 -36 2 1 - Vesicle rupture may have 
occurred 
- Stabilized after 5 min 
Most vesicle adsorption seen on 
APTMS using 4:1 lipid 
composition, rather than 3:2 
PG/LPG 
4:1 PG/LPG 22.37 
18.12  
HEPES+2 
mM CaCl2, 
pH 7.4 
30% APTMS 
(20 min incubation) 
-48 -35   
->-40 
2 1 - Vesicle rupture may have 
occurred 
- Adsorption stabilized after 5 
min 
Creating smaller vesicles does not 
substantially improve adsorption or 
rupturing behavior 
4:1 PG/LPG 28.27 HEPES+4 
mM EDTA, 
pH 7.37 
2.5 mg/mL PEI  
(20 min incubation) 
-50 -32 2 1 More vesicle attachment 
occurred, but no clear rupture 
HEPES buffer may be better for 
anionic vesicle adsorption than tris-
NaCl buffer (or PG/LPG vesicle 
mixture is preferred) 
4:1 PG/LPG 28.27  HEPES+4 
mM EDTA, 
pH 7.38 
10 mg/mL PEI  
(20 min incubation) 
-68 -47 4 1.25 More vesicle attachment 
occurred, but no clear rupture 
Increased PEI concentration 
increases vesicle adsorption 
4:1 PG/LPG 19.76 
6.162  
HEPES+4 
mM EDTA, 
pH 7.39 
20 mg/mL PEI  
(20 min incubation) 
-90 -65 -2 -> 6 0 -  More vesicle attachment 
occurred, but no clear rupture 
Increased PEI concentration 
increases vesicle adsorption, but 
does not lead to rupture 
4:1 PG/LPG 21.87 
42.45  
HEPES+4 
mM EDTA, 
pH 7.38 
20 mg/mL PEI  
(20 min incubation) 
-74 -50 6 1.5 - Vesicle rupture not observed 
- Vesicle adsorption stabilized 
after 1 h. 
2 h incubation with PEI surface did 
not lead to observable SLB 
formation 
4:1 PG/LPG 29.47 
23.79  
HEPES+2 
mM CaCl2, 
pH 7.42 
20 mg/mL PEI  
(20 min incubation) 
-27 -22 0.5 0.5 - Vesicles adsorption and 
rupture possible observed 
- Adsorption stabilized after 5 
min 
On PEI, 4:1 adsorbed less than 3:2 
PG/LPG 
4:1 PG/LPG 22.37 
18.12  
HEPES+2m
M CaCl2, pH 
7.4 
20 mg/mL PEI  
(20 min incubation) 
-27 -22 0.5 0.5 - Vesicles adsorbed, but rupture 
was not observed 
- Adsorption stabilized after 5 
min 
Creating smaller vesicles does not 
improve adsorption or rupturing 
behavior 
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Lipid 
Composition 
Vesicle 
Diameter 
(nm)  
Buffer SiO2 Surface 
Treatment 
Peak 
f 
(Hz) 
Final 
f 
(Hz) 
Peak 
D  
(1E-6) 
Final 
D  
(1E-6) 
Results  Conclusions 
4:1 PG/LPG 22.37 
18.12  
HEPES+2
mM CaCl2, 
pH 7.4 
20 mg/mL PEI  
(20 min incubation) 
-27 -22 0.5 0.5 - Vesicles adsorbed, but rupture 
was not observed 
- Adsorption stabilized after 5 
min 
Creating smaller vesicles does not 
improve adsorption or rupturing 
behavior 
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From this screening study, three anionic vesicle systems were chosen for further 
examination: PG, 3:2 PG/LPG, and 4:1 PG/LPG vesicles in HEPES + 2 mM CaCl2 buffer. The 
PG system represented a supported vesicle layer, on which we could analyze the vesicle 
rupturing capabilities of AMPs. The mixed lipid systems (used to describe 3:2 PG/LPG, and 4:1 
PG/LPG) were used to form supported lipid bilayers to investigate the behavior of different lipid 
compositions. The 30% APTMS surface treatment was chosen for all following experiments to 
increase the amount and rate of vesicle adsorption to the surface and improve the likelihood of 
forming a bilayer. The same buffer and surface treatment was used in the 3 systems so that the 
lipid compositions would be the only variable. Henceforth, all experiments were performed with 
HEPES + 2 mM CaCl2 buffer on 30% APTMS-treated silica sensor surfaces. 
DLS measurements revealed that the PG, 3:2 PG/LPG and 4:1 PG/LPG vesicles were 
approximately 125 nm, 20 nm, and 25 nm in diameter immediately following the sonication and 
centrifugation steps of the vesicle formation procedure (t = day 0). Figure 7.1 shows the size 
distributions of each experimental vesicle composition based on intensity and volume 
percentages. It is important to note that since larger particles scatter more light than smaller 
particles, the area of the intensity peak for larger particles will be greater than the area for 
smaller particles if the numbers of small and large particles in the solution are the same (Figure 
7.1A). The same is true for the volume measurements (Figure 7.1B), since the volume of larger 
particles is greater than the volume of smaller particles. Therefore, these graphs cannot be used 
to directly infer the number of particles of each size present in the solution.  
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Figure 7.1. Size distribution of PG, 3:2 PG/LPG, and 4:1 PG/LPG vesicles by intensity (A) and volume 
(B) measured by DLS. Three time points have been shown for each vesicle type to show the stability of 
the vesicles over time 
 
Stability of the anionic vesicles was also determined from DLS measurements. Vesicle 
size distributions were measured at various time points to monitor the aggregation and stability 
of the vesicles over time (Figure 7.1). Many of the particles in the PG vesicle solution increased 
in size within 1 day, suggesting that the vesicles had aggregated. The PG vesicle solutions were 
therefore sonicated before each QCM-D experiment to ensure that the vesicle sizes were 
consistent between QCM-D trials. The mixed lipid vesicles were more stable (for purposes of 
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clarity, all time points are not shown). These vesicles were used and stored under nitrogen at 7˚C 
for up to 4 days. 
From previous studies on supported PC lipid bilayers, vesicle adsorption and rupturing 
have been identified as two primary mechanisms necessary in supported lipid membrane 
formation using the vesicle fusion method.20, 21 As shown in Table 7.1 (row 1), an initial 
frequency decrease of -70 Hz (labeled peak f) was typically observed as PC vesicles adsorbed 
to the sensor surface. When the vesicles ruptured, releasing water mass, the frequency increased 
and stabilized around -26 Hz (final f) after a buffer rinse. The dissipation also peaked at a value 
of 4.5x10-6 as the hydrated and “soft” vesicles adsorbed and stabilized at 0.5x10-6 (peak and final 
D) after the vesicles ruptured into a rigid bilayer. Since these frequency and dissipation 
responses were consistently characteristic of PC bilayer formation, we expected the f and D 
responses associated with anionic bilayer formation to be similar. Therefore, we used QCM-D to 
monitor the formation of anionic bilayers and compared the f and D measurements to those 
for PC membranes for validation. 
In QCM-D experiments, PG vesicles adsorbed to the surface during 40 minutes of vesicle 
flow and stabilized as a supported vesicle layer (SVL) during the final buffer rinse. Figure 7.2A 
shows the frequency and dissipation shifts resulting from anionic vesicle attachment to an 
APTMS-coated silica QCM-D sensor surface. The stabilized membrane in the representative 
graphs in Figure 7.2A showed a frequency shift of -48 Hz in the 3rd harmonic, which was almost 
twice as large as the frequency shift associated with stable PC bilayer formation (-26 Hz), but 
less than the f value observed for PC vesicle attachment in previous studies (-70 Hz). Based on 
the f and D responses, we believe that a bilayer was not formed, but a layer of anionic vesicles.  
187 
   
The stabilized f value was not consistent between experiments with PG vesicles and 
varied between -48 Hz and -75 Hz, however (all data not shown). This variation may have been a 
result of vesicle aggregation on the sensor surface. From DLS measurements (Figure 7.1), it is 
clear that PG vesicles are prone to aggregation, so it is possible that a layer of vesicle aggregates 
formed on the QCM-D sensor surface. Variation in stable f values could therefore have been a 
result of differences in aggregate sizes between experiments. The inconsistency in f values may 
also have been due to differences in the APTMS coating applied to the sensor surfaces. Each 
QCM-D sensor was used multiple times and treated with the same concentration of APTMS 
before each experiment. Although the crystals were cleaned before and after each experiment, 
residual APTMS from previous experiments may have remained on the surface in some cases 
and affected its interactions with the vesicles. 
It should also be noted that the PG vesicle solution was only injected for 40 min and was 
not allowed to continue until vesicles had saturated the surface of the crystal. In preliminary 
experiments (data shown in Appendix 1.2), vesicle flow was maintained until the frequency 
change reached -70 Hz, but the frequency measurements did not stabilize. The continuing mass 
addition may have corresponded with the formation of multiple layers of vesicles or the 
adsorption of vesicle aggregates. Since the formation of a PG bilayer seemed unlikely, PG 
vesicle flow was stopped at 40 minutes in these experiments. The overtones also separated as 
more mass attached to the surface, as would be expected with hydrated films that are not uniform 
throughout their thickness (e.g. vesicles). The final dissipation value was large (3.4x10-6), 
indicating that the film was more hydrated than a stable PC bilayer. 
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Figure 7.2. Attachment of PG, 3:2 PG/LPG, and 4:1 PG/LPG vesicles on APTMS-coated silica. Time points marking the start of vesicle flow (a) 
and HEPES+2 mM CaCl2 buffer flow (b) are represented in (A) the frequency and dissipation shifts measured over time and (B) D vs. f plots. 
Only the 3rd and 11th harmonics are shown for clarity. The frequency axes in (B) are reversed so that progression of points to the right represents 
mass increase. The green arrows (labeled i, ii, iii) show the progression of data points over time and the sequence of different processes occurring 
on the sensor surface. The data shown for PC bilayer formation was adapted from a previous publication from this lab.9  
189 
   
The 3:2 PG/LPG vesicles attached to the APTMS-treated surface and immediately 
ruptured into a rigid SLB, resulting in a f value of -18 Hz in the 3rd harmonic (Figure 7.2A). 
This process may have been too rapid for a minimum frequency “peak,” the expected indicator 
of vesicle rupture, to be measured. The stable frequency value (-18 Hz) is lower than the 
expected value of PC SLBs, which could be due to differences in lipid masses (as LPG has a 
lower molecular mass than PC). The overtones remained close, indicating that the film was 
uniform at all depths, like a PC bilayer. The dissipation also remained low (<1x10-6) after 
stabilization, as seen with supported PC membranes. The small final dissipation value suggests 
that the membrane formed on the surface is rigid, which was expected for a supported bilayer. 
4:1 PG/LPG also ruptured into a membrane that was a supported lipid bilayer, but not as 
rapidly as with 3:2 PG/LPG (Figure 7.2A). The frequency decreased to -40 Hz as vesicles 
attached to the surface (starting from time point a), which indicated that more 4:1 PG/LPG 
vesicles adsorbed than 3:2 PG/LPG vesicles under the same conditions. Vesicle attachment was 
rapidly followed by mass and dissipation loss, which was likely caused by vesicle rupture. 
Before the final buffer rinse (time point b), the membrane stabilized at f = -32 Hz and D = 
0.5x10-6, which are similar to the f and D changes measured for PC membranes. After rinsing 
with HEPES + 2mM CaCl2 buffer, the frequency and dissipation values stabilized at f = -28 Hz 
and D = 1.2x10-6 in the 3rd harmonic. This final f value associated with the stable film showed 
more mass on the surface of the sensor than with PC bilayers, which may have been a result of 
the different lipids used. The stabilized dissipation value at time b (before the final buffer rinse) 
was similar to that of a PC bilayer, suggesting the formation of a 4:1 PG/LPG bilayer.  
190 
   
The difference in molecular weights between PC, PG and LPG and the greater repulsion 
between anionic lipids may explain difference in mass between the various bilayers. The final 
dissipation value of 1.2x10-6 associated with a stable 4:1 PG/LPG membrane indicates that the 
final buffer rinse created a film that was more hydrated or structurally disordered than a PC or 
3:2 PG/LPG membrane. It is possible that the 4:1 PG/LPG composition is more conducive to 
greater hydration within the membrane. Since LPG is known to partition into water, the buffer 
rinse may have caused some LPG removal from the membrane, leaving spaces that were filled 
by water. 
Plotting D vs. f revealed changes in the dynamic processes that were occurring on the 
sensor surface and showed that anionic bilayer formation differed from that of PC SLB 
formation (Figure 7.2B). The points in these plots represent f and D measurements taken at 
evenly spaced time intervals (0.7 s intervals) and therefore reveal the rate of each process. 
Processes occurring on the sensor surface, such as vesicle adsorption or rupture, are represented 
by the direction of the data points (labeled with arrows i, ii, and iii).  Vesicle adsorption 
mechanisms are expected to result in the addition of mass on the surface, leading to a decline in 
frequency (or progression in the eastward direction in these plots). Vesicle rupture, however, is 
accompanied by mass loss from the adsorbed film in the form of water, resulting in increases in 
frequency and decreases in dissipation (or progression in the south-west direction). These 
processes can be followed in the D vs. f plot for PC bilayer formation, in which the vesicle 
adsorption process (labeled i) is followed by vesicle rupture (ii). 
PC bilayer formation consists of 2 clear stages (i and ii), which were also observed to 
some extent with 3:2 and 4:1 PG/LPG vesicles before the final buffer rinse (Figure 7.2B). The 
third process (iii) that occurred with the mixed lipid membranes was a result of the final buffer 
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rinse, which removed weakly attached particles from the membrane surface and allowed spaces 
in the membrane to be filled with water (resulting in greater hydration). PG adsorption to the 
surface occurred in a single-stage process (i), which was followed by mass and dissipation loss 
due to the final buffer rinse (ii). The addition of LPG in the vesicles seemed to allow this process 
to become a 2-stage series. 
Comparison of the dynamic membrane formation processes of the 4 vesicle types reveals 
that PG adsorbed to the sensor surface at the slowest rate, but more lipid mass adsorbed without 
rupturing the adsorbed vesicles. The 3:2 and 4:1 PG/LPG lipid mixtures initially adsorbed more 
rapidly before stabilizing as bilayer. The lipid mixture containing more PG (4:1 PG/LPG) also 
resulted in more mass adsorption to the surface and was more structurally disordered or hydrated 
than the 3:2 PG/LPG bilayer. 
Using the frequency changes that were observed in Figure 7.2A, we estimated the area 
per lipid (aL) in each bilayer and the thickness of the bilayer’s hydrophobic region. The 
frequency changes (Δf) measured for the stabilized 3:2 and 4:1 PG/LPG membranes were -18 Hz 
and -28 Hz, respectively. Using eqn. 7.1 (Δm = -C Δf), the areal mass of the 3:2 PG/LPG 
membrane was calculated to be 320.4 ng/cm2. If we assume that the anionic membranes behave 
similarly to supported PC bilayers, this areal mass may include a layer of water between the 
bilayer and sensor surface, which has been shown to have a mass of 102 ng/cm2 in PC bilayers 
supported on silica.22 Correcting for the mass of this water layer, the mass of the lipid bilayer 
became 218.4 ng/cm2. Calculating the average molecular weight of the 3:2 PG/LPG lipid 
mixture  to be 671.99 g/mol (given that the molecular weights of PG and LPG are 782 g/mol and 
506 g/mol, respectively), the average mass per lipid molecule (ML) was determined to be 
1.12x10-12 ng/lipid. Dividing the areal mass of the lipid bilayer by the mass of a single lipid 
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molecule ML revealed that there were 1.96 lipids/nm2 in the bilayer, which corresponds to a lipid 
area (aL) of 1.03 nm2/lipid (if aL =2/ML, accounting for the presence of two lipid layers). 
Assuming that the molecular volume vL of the hydrophobic tail of the PG and LPG lipids are 
0.96 nm3/molecule and 0.46 nm3/molecule, respectively, vL for 3:2 PG/LPG was 0.76 
nm3/molecule (the average volume based on the constituent C16 and C18 chains), the thickness 
of the hydrophobic region of the 3:2 PG/LPG bilayer was calculated to be hL = 2vL/aL = 1.48 nm.  
Using the same procedure for the 4:1 PG/LPG bilayer (average MW: 727 g/mol), in 
which ML = 1.21x10-12 ng/lipid and vL = 0.86nm3/lipid, the area per lipid was calculated to be aL 
= 1.03 nm2/lipid and the thickness of the hydrophobic region of the bilayer was determined to be 
hL = 2.81 nm. In a previous study from our lab, a PC bilayer was calculated to allow a lipid area 
of aL = 0.739 nm2/lipid and have a hydrophobic region thickness of hL = 2.6 nm.10 The calculated 
lipid area in the 4:1 PG/LPG bilayer was smaller than that of the 3:2 PG/LPG and PC bilayers. 
This suggested that the 4:1 PG/LPG bilayer may have been more densely packed. Much of the 
additional mass in the membrane may have included water mass, however, which was evidenced 
by the high dissipation values associated with a stable membrane and may have allowed the 4:1 
PG/LPG lipids more space than these calculations indicated.  
The estimated thicknesses of the hydrophobic regions of the 3:2 and 4:1 PG/LPG bilayers 
were similar to that of a PC bilayer. The estimates for anionic membranes were reasonably 
similar to thickness values found for PC lipid bilayer and for the cytoplasmic membrane of 
bacteria, which are 5 nm and 7 nm thick, respectively. 23 The bacterial membrane thickness and 
stability may also be affected by the incorporation of protein molecules that are inherent in these 
membranes. Any discrepancies, however, could also have been due to erroneous estimates for 
the mass of hydration incorporated into the membranes. 
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We believe that anionic lipid bilayers were formed in these experiments with 3:2 and 4:1 
PG/LPG lipid vesicles due to the similarity of frequency shifts associated with the stable 
membranes. Although the anionic membrane thicknesses varied, they were comparable to the 
thickness of a PC bilayer. Also, the dissipation shifts recorded for the anionic bilayers were 
similar to that of a rigid PC bilayer and did not resemble dissipation values recorded for surfaces 
covered with vesicles. QCM-D monitoring of the 4:1 PG/LPG membrane formation process also 
clearly showed vesicle adsorption and rupturing processes. To demonstrate the capabilities of 
these films as model Gram-positive bacterial membranes, we examined the interactions of the 
AMP chrysophsin-3 on PG supported vesicle layers, 3:2 PG/LPG supported bilayers, and 4:1 
PG/LPG supported bilayers. These experiments also provided insight into the ability of 
chrysophsin-3 to rupture anionic vesicles and disrupt anionic SLBs of varying lipid 
compositions. 
7.4.2  Chrysophsin­3 ruptures supported anionic vesicles 
Once stable lipid films had been formed and verified with QCM-D measurements, the 
SVLs or SLBs were exposed to various chrysophsin-3 concentrations. The peptide solutions 
were allowed to flow into the QCM-D chamber for 10 min to ensure that the entire chamber was 
filled with the peptide solution. The flow was paused for 1 hr to allow the AMP solution to 
incubate with the lipid film and subsequently restarted with a buffer rinse to remove any poorly 
attached particles. To analyze AMP-induced changes in the membrane, shifts in frequency and 
dissipation resulting from chrysophsin-3 action were evaluated. These values were calculated at 
each overtone by taking the difference between measurements associated with 2 time points: (1) 
the stable bilayer before peptide injection and (2) the resulting mass after the final buffer rinse. 
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Measurements at these time points were used to capture the changes due to AMP action without 
the effects of other system variables.  
When incubated with surface-adsorbed vesicles, all experimental concentrations of 
chrysophsin-3 caused vesicle rupture (Figure 7.3). The decline in dissipation at all overtones 
revealed decreases in membrane “softness,” which implies that hydration had left the membrane 
system. This change was likely due to vesicle rupture, which released water within the vesicles, 
as was previously observed in the bilayer formation processes of 3:2 and 4:1 PG/LPG. Although 
the error bars on the frequency plots were large, making the frequency results inconclusive, the 
dissipation values reveal that hydration was lost from the membrane and suggest a vesicle 
rupturing process.  
The large error bars associated with the frequency values may be explained by variations 
observed in PG vesicle layer formation, as previously discussed in Section 7.4.1. Variation in the 
amount of vesicle attachment to the surface, which may have been due to vesicle aggregation, 
resulted in variations in AMP-induced mass change in each QCM-D trial. A surface completely 
coated with vesicles would be expected to behave differently from a surface sparsely coated with 
vesicles. Studies on PC bilayer formation have shown that PC vesicles will only rupture to form 
a supported bilayer once the vesicle concentration on the surface reaches a critical level, 
demonstrating the significance of vesicle concentration in determining membrane behavior.24 
The amount of surface coverage and spaces between vesicles may also play a role in determining 
if lipids from a ruptured vesicle will adsorb to the sensor surface as a bilayer or leave the 
membrane altogether.  
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Figure 7.3. (A) Average frequency and dissipation shifts measured during the exposure of a supported 
PG vesicle layer to chrysophsin-3. Error bars represent the standard deviation based on at least 3 replicate 
experiments. (B) Proposed model of chrysophsin-3-induced rupture of supported PG vesicles. 
 
D vs. f plots showing QCM-D measurements taken during peptide exposure and the 
final buffer rinse provided information about the dynamics of chrysophsin-3 interactions with PG 
vesicles (Figure 7.4). Lower chrysophsin-3 concentrations (0.5 M and 1 M) primarily resulted 
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in single-stage mass and dissipation loss. In previous studies on chrysophsin-3 action on PC 
bilayers, membrane disruption was not observed at these concentrations.10  In these bilayers, low 
peptide concentrations did not disrupt the membrane’s mass or structure enough to be detected 
using QCM-D. When in contact with anionic SVLs, however, these peptide concentrations 
destabilized the vesicle membranes enough to break the vesicles, resulting in measureable 
frequency and dissipation changes. Therefore, SVL systems may be used as more sensitive 
methods of analyzing AMP-induced membrane disruption than SLB systems. 
 
Figure 7.4. Representative D vs. f plots showing dynamic processes occurring during chrysophsin-3 
action on a PG vesicle layer. The frequency axis has been reversed so that mass gains are represented by 
progression to the right. The arrows labeled i and ii show the sequence of interactions that occurred 
during the vesicle destabilization. 
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Higher peptide concentrations (5 M and 10 M) resulted in two distinct interaction 
mechanisms. Following a small initial mass gain, likely from peptide adsorption, which was not 
observed at lower chrysophsin-3 concentrations, the PC vesicles rapidly lost mass and hydration 
(labeled i) as vesicles ruptured. As the resulting peptide-lipid film stabilized before and during 
the 1-h incubation, it gradually gained mass (ii). The dissipation did not change significantly 
during this second stage, suggesting that the hydration and lipid organization within the 
membrane did not change. The addition of mass was likely in the form of peptide or lipid 
particles filling in any holes on the APTMS-coated surface. The 3rd and 11th harmonics also 
showed separation throughout the experiment, indicating that different processes were occurring 
at different depths of the membrane. As demonstrated by the different overtone behavior that 
occurred during PC vesicle rupture into a bilayer (Figure 7.2A), overtone separation would be 
expected as PG vesicles ruptured to form a bilayer.  
The vesicle rupture indicated by these experiments between 0.5 M and 10 M 
concentrations is consistent with the minimum inhibitory concentrations (MIC) of peptides like 
chrysophsin-3 that are active against Gram-positive and Gram-negative bacteria.25 Dennison et 
al. have compiled a database of known peptides and their MIC values to identify features that 
determine AMP efficacy. Peptides with demonstrated activity against Gram-positive and Gram-
negative bacteria exhibited an MIC range of 0.2-40 M with a mean value of 7.9 M.26 This 
MIC range encompasses our experimental concentration range (0.5 M - 10 M) that exhibited 
membrane destabilization and vesicle rupturing activity, suggesting that the PG vesicle layer 
may be a plausible bacterial membrane mimic. Specific examples of effective AMPs include 
alamethicin, which has been shown to inhibit the growth of Sinorhizobium meliloti, a Gram-
negative bacterium, at 25 M.27 
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7.4.3  Chrysophsin­3 action on anionic lipid bilayers 
At higher concentrations, chrysophsin-3 exhibited a peptide-insertion mechanism on 
supported 3:2 PG/LPG lipid bilayers (Figure 7.5). Substantial changes to the membrane did not 
occur at the lower chrysophsin-3 concentrations of 0.5 M and 1 M. Higher concentrations (0.5 
M and 1 M), however, led to uniform mass gain in the membrane at all overtones, indicating 
that the same process was occurring throughout all depths of the membrane. The dissipation did 
not change substantially at any concentration, implying that the molecular structure of the 
membrane did not undergo substantial reorganization or hydration as a result of exposure to the 
peptide. 
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Figure 7.5. (A) Average f and D shifts resulting from the exposure of a supported 3:2 PG/LPG bilayer to 
chrysophsin-3. Error bars represent the standard deviation based on at least 3 replicate experiments. (B) 
Proposed model of chrysophsin-3 (green) insertion into 3:2 PG/LPG membranes (violet). 
  
The dynamics of the peptide interactions with 3:2 PG/LPG bilayers were substantially 
different than those observed with the PG membrane (Figure 7.6). As revealed by the overall 
frequency and dissipation shifts in Figure 7.5, chrysophsin-3 did not have a measurable effect on 
the 3:2 PG/LPG bilayer at 0.5 M and 1 M concentrations. Upon exposure to 5 M 
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chrysophsin-3, the SLB rapidly gained mass as peptides attached to the membrane (i). Mass was 
rapidly lost again (ii) before the membrane gradually regained mass during the 1-h incubation 
(iii). The membrane also became more disordered or hydrated during this time, as evidenced by 
the dissipation increase. During the final HEPES + 2 mM CaCl2 buffer rinse, mass was again lost 
as dissipation increased (iv). This phenomenon may have been due to lipid and peptide mass 
leaving the membrane, causing the molecular structure to become disordered. Incubation with 10 
M chrysophsin-3 caused a faster increase in mass in the membrane (i), followed by rapid mass 
and dissipation decrease (ii) and ending with less mass than was present before the peptide 
injection. This net loss in mass, which suggests some lipid removal from the membrane, is 
promising because it shows that the cationic APTMS surface treatment likely does not prevent 
anionic lipids from leaving the crystal surface. During the final HEPES + 2 mM CaCl2 buffer 
rinse, the membrane regained mass and dissipation before stabilizing (iii and iv).  
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Figure 7.6. Representative D vs. f plots showing dynamic processes occurring during chrysophsin-3 
action on a 3:2 PG/LPG supported bilayer. The frequency axis has been reversed so that mass gains are 
represented by progression to the right. The arrows (i, ii, iii and iv) follow the progression of data points 
and show separate interaction mechanisms. 
 
It is unclear why mass and dissipation increased during the final buffer rinse, since new 
particles should not have been introduced into the system to allow for such a change. If the mass 
increase had been a result of the incorporation of buffer into spaces left in the membrane by lipid 
removal, the dissipation should have also increased above 1x10-6, signifying a hydrated film. It is 
possible that some of the mass gain observed during the final buffer rinse was due to the 
incorporation of water molecules, but better understanding of the crystal surface and effects of 
the APTMS coating is required to fully interpret these results. 
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As seen with 3:2 PG/LPG membranes, chrysophsin-3 did not impact 4:1 PG/LPG membranes 
substantially at 0.5 M and 1 M concentrations (Figure 7.7). Exposure to 5 M chrysophsin-3 
resulted in mass gain to the membrane that was uniform at all overtones, suggesting a peptide-
insertion mechanism. At 10 M chrysophsin-3, nearly twice the mass gain was observed in 4:1 
PG/LPG membranes than with 3:2 PG/LPG. Similar to 3:2 PG/LPG, substantial dissipation 
changes did not occur, indicating that the membrane did not undergo measureable structural 
disorder or hydration. The frequency changes (-10 Hz) observed with 10 M chrysophsin-3 
action on the 4:1 PG/LPG membrane were greater than the maximum -3.36 Hz change estimated 
in a previous study10 for insertion of the peptide as a monomer or a cluster into the membrane. A 
different interaction mechanism may therefore be responsible for this large mass addition, but 
again, better understanding about the effects of APTMS on the crystal surface and adsorbed 
lipids is necessary to fully interpret these results. 
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Figure 7.7. (A) Average f and D shifts resulting from the exposure of a supported 4:1 PG/LPG bilayer to 
chrysophsin-3. Error bars represent the standard deviation based on at least 3 replicate experiments. (B) 
Proposed model of chrysophsin-3 (green) insertion into 3:2 PG/LPG membranes (violet). 
 
 The dynamics of chrysophsin-3’s interactions with 4:1 PG/LPG were similar to those for 
3:2 PG/LPG. The lower chrysophsin-3 concentrations (0.5 M and 1 M) did not create 
measurable changes in the 4:1 PG/LPG membrane (Figure 7.8). Three distinct mechanisms were 
revealed for the action of 5 M and 10 M chrysophsin-3. As the peptides attached to the 
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membrane, mass rapidly increased without substantial dissipation change (i). Once a critical 
concentration of peptide on the membrane was reached, mass was removed from the membrane. 
At 5 M chrysophsin-3, this mass removal was small and was not accompanied by a substantial 
change in dissipation, indicating that the membrane had not become more or less disordered. At 
10 M, however, the mass loss was accompanied by a decrease in dissipation (ii), suggesting 
that if spaces had formed in the membrane from mass loss, the peptides may have stabilized the 
lipids surrounding those spaces. This process was followed by an increase in mass and 
dissipation during the final buffer rinse (iii), which was more pronounced with 10 M 
chrysophsin-3 than with 5 M concentrations. This phenomenon (iii) likely corresponded with 
buffer filling in the spaces in the membrane that were left by the removal of lipid mass. 
 
Figure 7.8. Representative D vs. f plots showing dynamic processes occurring during chrysophsin-3 
action on a 4:1 PG/LPG supported bilayer. The frequency axis has been reversed so that mass gains are 
represented by progression to the right. The arrows (i, ii, and iii) follow the progression of data points and 
show separate interaction mechanisms. The large gaps between the data points in i reveal the rapid rate of 
mass addition to the membrane. 
 
205 
   
 The QCM-D results for chrysophsin-3 action on 3:2 and 4:1 PG/LPG membranes 
(Figures 7.5A and 7.7A) revealed that more mass addition resulted from peptide insertion into 
4:1 PG/LPG bilayers. This result suggests that chrysophsin-3 displaced fewer lipids when 
inserting into bilayers containing lower concentrations of LPG. Perhaps the presence of LPG 
alters the stability of the lipid membrane structure, facilitating lipid removal. From QCM-D 
monitoring of anionic membrane formation, higher proportions of LPG (3:2 PG/LPG) allowed 
the anionic lipid vesicles to rupture more rapidly than systems with less LPG (4:1 PG/LPG), 
which may also have been a result of lower vesicle stability as a result of LPG (Figure 7.2A). 
7.4.4  Interaction kinetics 
The kinetics of these peptide-membrane interactions showed that all three anionic 
membranes initially interacted with chrysophsin-3 at similar rates (Figure 7.9). The total 
interaction time (Figure 7.9A) is a measure of the amount of time it takes for the peptide to reach 
peak initial adsorption to the lipid film or for it to reach peak initial mass removal from the film, 
depending on which is the predominant initial interaction. The various membranes had very 
similar interaction times at 10 M concentrations and exhibited more variation at lower 
concentrations. Initial interactions also occurred more rapidly as peptide concentration increased.  
The calculated interaction rates (Figure 7.9B) showed that the anionic membranes 
followed the same trends, although PG experienced initial mass loss, rather than the mass gain 
that occurred in the mixed lipid membranes. When compared to the initial interaction times and 
rates observed for chrysophsin-3 action on a PC membrane,10 the time duration of the initial 
interaction was smaller in anionic membranes than for the zwitterionic PC membrane. This 
variation may be explained by the stronger attractive forces between cationic chrysophsin-3 and 
anionic membranes compared to zwitterionic lipids in initial electrostatic interactions. The initial 
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interaction rates between chrysophsin-3 and the two types of membranes were similar at all 
concentrations, however, indicating that although the peptide required more time to attach to the 
PC membrane, the overall rate of mass attachment was the same. 
 
 
Figure 7.9. Initial interaction times and rates for chrysophsin-3 action on anionic lipid films. These 
values represent the rate of change during the initial stage of contact between the bilayer and the 
peptide.  
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7.4.5  Comparison of chrysophsin­3 action on zwitterionic and anionic membranes 
 The predominant mechanisms of action of chrysophsin-3 on zwitterionic and anionic 
lipid bilayers consisted of different interaction mechanisms and stages. When incubated with the 
anionic 3:2 and 4:1 PG/LPG bilayers in this study, chrysophsin-3 primarily demonstrated a 
peptide-insertion mechanism. In a previous study from this lab, chrysophsin-3 was found to 
adsorb to and insert into zwitterionic PC supported membranes at peptide concentrations 
between 1 M and 10 M.11 At 10 M, chrysophsin-3 caused the removal of at least 12% of the 
original lipid mass of the PC membrane. Substantial mass removal did not occur in the anionic 
membranes, although the reason for this is not clear. It is possible that lipids that were disrupted 
by the addition of peptide preferred to remain on the surface due to attractive forces between the 
lipids and the cationic APTMS coating on the QCM-D sensor surface. 
 The dynamics of these interactions also differed between the two membrane types. 
Compared to the anionic bilayers, when chrysophsin-3 was first introduced to PC bilayers, the 
initial mass addition to the membrane occurred for a longer time duration. This difference in 
adsorption rate was likely a result of the greater attraction of the cationic peptide to the anionic 
PG and LPG headgroups, since AMPs initially interact with cell membranes through electrostatic 
interactions. Also, the initial mass addition of chrysophsin-3 on anionic membranes (labeled i in 
Figures 7.6 and 7.8) was not accompanied by an increase in dissipation, which was observed in 
PC membranes. This indicated that the structure of the anionic membranes with attached 
peptides was more ordered (and less hydrated) than the PC membrane. Perhaps the attractive 
forces between cationic chrysophsin-3 and the anionic membrane caused the peptide molecules 
to immediately assume a more structured and stable orientation parallel to the membrane upon 
adsorption. 
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7.5  Conclusions 
 In this study, we successfully developed a simple method for forming anionic SLBs using 
various compositions of PG and LPG lipids. The creation of these stable bilayers was confirmed 
by monitoring their formation with QCM-D. The resulting frequency and dissipation 
measurements were compared with those obtained for PC bilayer formation, which is known to 
be a consistent and robust process. The lipid area and thickness of the hydrophobic regions of 
these bilayers were calculated from the frequency measurements. Various buffer types and 
surface treatments were also screened, revealing other supported lipid membrane systems that 
could be used in future studies. These anionic membranes are suitable for use as models of 
Gram-positive plasma membranes and may be valuable for examining membrane interactions of 
a wide variety of particles, such as AMPs or nanoparticles. 
Anionic SVLs were formed using PG, on which vesicle breakage studies were performed. 
These experiments allowed us to monitor the effects of low AMP concentrations that would not 
have been detected in a supported lipid bilayer system. In effect, the membrane disruption effects 
are amplified, since vesicle rupture results in more measurable mass and dissipation changes on 
the QCM-D sensor surface. Chrysophsin-3 was found to rupture PG vesicles at concentrations as 
low as 0.5 M and 1M, which did not result in measureable changes to zwitterionic bilayers in 
previous studies. 
 The interactions between chrysophsin-3 on anionic SLBs were also examined, revealing 
faster initial interaction rates than those measured on zwitterionic membranes in previous 
studies. Chrysophsin-3 primarily demonstrated peptide insertion mechanisms, but not surface 
adsorption to the anionic membrane, which was a predominant mechanism observed on 
zwitterionic membranes. More understanding of the anionic membrane surface and structure is 
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needed to fully comprehend the effects of AMP exposure that were measured, however, and to 
fully understand the differences in AMP interactions with eukaryotic and bacterial cell 
membranes. 
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 Infections involving antibiotic-resistant microbes have increased dramatically in recent 
decades, posing a significant health threat to patients.1 The short doubling time exhibited in 
bacteria enables them to evolve quickly, thereby increasing their likelihood of developing drug 
resistance. AMPs have shown promise as antibiotic alternatives due to their broad spectrum of 
activity and low occurrence of bacterial resistance.2 Membrane-active AMPs are believed to be 
less prone to the development of pathogen resistance than antibiotics because of their unique 
mechanisms of bacterial killing.3 However, these mechanisms must be fully understood before 
AMPs can be selected and designed to maximize effectiveness and ensure that the patient will 
not be harmed. 
The studies presented in this thesis provided fundamental knowledge about how AMPs 
are able to destabilize and destroy cell membranes. These concentration-dependent interactions 
were related to specific characteristics known about AMP structural properties, such as charge, 
secondary structure, hydrophobicity and hydrophobic moment. QCM-D experiments showed that 
the -helical peptides alamethicin, chrysophsin-3 and SMAP-29 demonstrated membrane 
insertion mechanisms when in contact with a zwitterionic PC membrane. The amphiphilic and -
helical properties of these peptides likely promoted insertion into the hydrophobic region of the 
bilayer. Chrysophsin-3 and SMAP-29, which contain many positive charges from amino acid 
residues, also adsorbed to the membrane surface in QCM-D experiments. This phenomenon was 
hypothesized to be due to attractive charge-dipole interactions with zwitterionic headgroups in 
the PC bilayer. Indolicidin, which exhibits a folded, boat-shaped conformation, showed evidence 
of surface adsorption and partial insertion into the bilayer. Indolicidin’s lack of amphiphilicity 
and non--helical structure likely did not promote complete peptide insertion, but the presence 
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of hydrophobic amino acid residues within the peptide enabled it to partially insert into the 
bilayer. 
In the context of therapeutic development, this understanding of AMP disruption of 
membranes is crucial for selecting and designing AMPs to kill pathogens. This study showed 
that -helical structure and hydrophobic amino acid side chains promote peptide insertion into 
lipid membranes, indicating that peptides with these properties could be used to form holes in 
bacterial membranes and thereby cause cell death. These AMPs could also work in tandem with 
other therapeutics, including those that may experience difficulties passing through cell 
membranes, by forming holes through which these drugs can pass into the cell interior. AMPs 
can also be designed to carry large positive charges, which can target anionic lipid headgroups of 
bacterial membranes and facilitate adsorption to the surface of cell membranes (as shown in this 
study). Once on the membrane surface, other therapeutics combined with the peptides may be 
able to pass into the cell.  
A novel process of interpreting QCM-D overtone data was developed to derive details 
about interactions occurring at different thicknesses of a supported membrane. Overall frequency 
and dissipation shifts in response to AMP exposure to supported lipid bilayers were used to infer 
changes to the membranes at equilibrium. D  vs. f plots revealed the dynamics of AMP-
membrane interactions and showed that each AMP studied exhibited a unique QCM-D signature. 
These signatures indicated that each AMP interacted with the membranes differently. QCM-D 
data was also used to calculate the initial interaction rates of each AMP to estimate some kinetic 
information about peptide-membrane interactions. SMAP-29 exhibited the largest rate of initial 
mass change in the bilayer and alamethicin and chrysophsin-3 demonstrated the smallest rate. 
Bilayer characteristics and AMP-induced pore properties were also calculated from measured 
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frequency changes, revealing that the anionic membranes contained a larger hydrophobic region 
than the zwitterionic membranes. 
AFM imaging was used to investigate morphological changes in lipid membranes that 
were produced during exposure to various concentrations of alamethicin and indolicidin. Visible 
membrane destabilization was observed at 5 M and 10 M concentrations of both peptides. 
Alamethicin formed large defects in the membrane that expanded over time until the membrane 
was completely destroyed. Indolicidin formed smaller membrane defects that filled in over time. 
At 10 M indolicidin, partial filling of the bilayer was observed, which supported our 
interpretation of QCM-D results that showed membrane removal from parts of the bilayer and 
partial insertion of peptides. 
A simple technique for forming supported lipid membranes composed purely of anionic 
lipids was developed to mimic Gram-positive bacterial membranes. A screening study was 
performed using QCM-D to identify combinations of lipid compositions, buffer types, and 
surface treatments that showed promise in bilayer formation. Three anionic lipid systems were 
chosen for further study: (1) a supported PG vesicle layer, (2) a supported 3:2 PG/LPG bilayer, 
and (3) a supported 4:1 PG/LPG bilayer. The QCM-D responses measured during membrane 
formation were compared to those recorded for PC bilayer formation to confirm the creation of 
stable anionic bilayers. Chrysophsin-3 ruptured PG vesicles at peptide concentrations as low as 
0.5 M, showing that supported vesicle layers are a sensitive platform for studying the 
membrane destabilization of AMPs at lower concentrations. The peptide also adsorbed to anionic 
bilayers more rapidly than with zwitterionic membranes and exhibited a membrane insertion 
mechanism. 
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The QCM-D overtone interpretation process developed in these studies may be valuable 
for the future examination of lipid bilayer behavior when exposed to other materials, such as 
nanoparticles. Unpublished work in our lab has shown that similar interpretation methods can be 
used to derive information about molecular-scale nanoparticle interactions with cell membranes. 
Frequency changes were measured at all overtones when zwitterionic lipid membranes were 
exposed to gold nanoparticles, suggesting that the nanoparticles interacted with all depths of the 
membrane rather than resting on the surface.4 These experiments are valuable for understanding 
the potentially toxic effects of nanoparticles on organisms. 
It is very likely that there is much more information buried in QCM-D overtone 
measurements that have not been discovered yet. The unique QCM-D signatures of each AMP in 
this study suggest that the frequency and dissipation measurements may be sensitive to nuances 
in interaction mechanisms that have not been identified. Some QCM-D responses recorded for 
chrysophsin-3 action on anionic membranes, such as a mass increase observed during the final 
buffer rinse when the bulk solution should not have contained more mass to be added to the 
membrane, are still unresolved. Therefore, further development of QCM-D data interpretation is 
necessary to advance our ability to examine AMP-membrane interactions. 
 From the information about peptide-membrane interactions gathered in these studies and 
the techniques that were developed, our ability to study AMP-membrane interactions and 
identify structural properties of peptides that promote specific behavior has expanded. We 
developed a novel process for analyzing QCM-D data that allowed us to derive detailed 
molecular-level mechanisms of AMP-membrane interactions that were validated by AFM 
imaging. QCM-D analysis revealed that peptide charge, amphiphilicity, and secondary structure 
play large roles in determining a peptide’s preference for membrane insertion or surface 
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absorption. When designing multi-faceted therapeutics that target multiple cellular structures or 
processes, pore forming peptides could potentially be designed to create holes in the membrane 
through which other drugs could enter and target intracellular components.  
More fundamental mechanistic research involving AMPs with varied structural properties 
is certainly necessary to fully understand AMP effects on bacterial and mammalian cells, 
however. Also, more studies investigating AMP interactions with the anionic lipid membranes 
developed in this study need to be conducted before AMP activity or specificity against bacterial 
or mammalian cells can be predicted based on peptide structural properties. Building on the 
techniques and information gained in this study will greatly facilitate the development of more 
effective peptides for use in therapeutics.1 
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Appendix 1: Relevant experimental data 
This appendix includes data that was not included in the main thesis chapters. This 
includes f and D results for low AMP concentrations and QCM-D results corresponding to 
supported PG vesicle layer formation.   
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A1.1  QCM­D results for all experimental AMP concentrations  
 
Figure A1.1. Changes in frequency and dissipation corresponding to various aqueous phase 
concentrations of alamethicin interacting with the PC membrane. Values for f and D are shown for the 
3rd through 11th overtones and represent the changes induced by alamethicin activity on a stable supported 
bilayer membrane. Initial measurements (t = 0 s) are taken after stable bilayer formation and final 
measurements are taken after the buffer rinse following 1 h of peptide incubation. Higher overtones are 
associated with changes closer to the sensor surface. Error bars represent the standard deviation based on 
at least 3 replicate experiments. 
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Figure A1.2. Changes in frequency and dissipation corresponding to various aqueous phase 
concentrations of chrysophsin-3 interacting with the PC membrane. Error bars represent the standard 
deviation based on at least 3 replicate experiments. 
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Figure A1.3. Changes in frequency and dissipation corresponding to various aqueous phase 
concentrations of indolicidin interacting with the PC membrane. Error bars represent the standard 
deviation based on at least 3 replicate experiments. 
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Figure A1.4. Changes in frequency and dissipation corresponding to various aqueous phase 
concentrations of SMAP-29 interacting with the PC membrane. Error bars represent the standard 
deviation based on at least 3 replicate experiments. 
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A1.2  PG Membrane Formation 
 
Figure A1.5. Examples of frequency and dissipation responses during PG membrane formation. Only two 
overtones are presented for simplicity. The 9th harmonic is shown in place of the 11th harmonic for the 
second figure because we were unable to measure the 11th harmonic during that experiment. 
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Appendix 2: Typical output from a QCM­D run 
 
Figure A2.1. QCM-D run for 10 µM SMAP-29. At time t0, a PC vesicle solution was allowed to flow 
over the QCM-D silica sensor surface.  At time t1, the buffer was injected into the QCM-D chamber to 
rinse away any unattached particles.  At time t2, a solution of the AMP in the buffer at the desired peptide 
concentration was allowed to flow.  At time t3, the flow was stopped and the system was left to equilibrate 
for 1 hr. At time t4, a final buffer rinse was applied until the frequency and dissipation stabilized at time t5. 
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Appendix 3: Calculation of maximum frequency changes for various 
peptide interaction modes  
For different modes of interaction of the peptide with the bilayer, we can calculate what 
will be the anticipated maximum frequency change from the QCM-D experiment by considering 
the changes to the bilayer from the addition of peptide and possible removal of lipid. Since the 
peptide-induced changes occur on the supported bilayer, we first establish the characteristics of 
this bilayer. The area per lipid in the bilayer (denoted as aL) and the thickness of the bilayer were 
calculated from the measured frequency change of ~25 Hz, accompanying the formation of the 
supported PC bilayer.  Noting that the proportionality constant C relating the frequency change 
to mass change in the Sauerbrey equation (C Δf = Δm) is 17.8 ng/cm2/Hz for a crystal oscillating 
at 5 MHz natural frequency, the bilayer areal mass corresponding to a frequency change of 25 
Hz is equal to 445 ng/cm2.  It has been shown1 that this mass includes the mass of a layer of 
water between the quartz crystal and the supported lipid bilayer and the mass of this water layer 
has been determined to be ~ 102 ng/cm213313384.  Correcting for this water mass, we estimate the 
areal mass of the lipid bilayer to be 343 ng/cm2.  The molecular mass ML of the lipid is 1.267x10-
12 ng/molecule corresponding to an average molecular weight of 760 g/mol for the egg PC lipid.  
Dividing the areal mass of the lipid bilayer by the mass of a single lipid molecule ML, we find 
there are 2.7 molecule/nm2 on the bilayer.  This corresponds to a lipid area aL of 0.739 
nm2/molecule. If the molecular volume vL of the hydrophobic tail of the egg PC lipid is 0.96 
nm3/molecule (taken as the composition average based on the constituent C16 and C18 chains), 
then the thickness of the hydrophobic region of the bilayer hL = 2vL/aL = 2.6 nm.  These 
estimates based on QCM-D data and molecular properties of lipids can be compared to the x-ray 
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measurements of Huang2 who obtained aL = 0.74 nm2 and hL = 2.66 nm for DOPC, and aL = 0.68 
nm2 and hL = 2.75 nm for POPC. 
If a peptide enters the bilayer in the pore state or as inserted peptides or peptide clusters, 
some lipid molecules have to be removed from the bilayer area to create space. If a peptide or a 
peptide cluster (without a water pore) is inserted into the bilayer, the area cleared per peptide aP 
is calculated as aP = πdP2/4 where dP is the diameter of the peptide, visualized as a cylinder. The 
area per peptide aP is estimated to be 0.945 nm2/molecule, taking the diameter dP of alpha-
helices to be 1.1 nm. If the peptide is part of a pore incorporating a water channel, then the area 
cleared per peptide is AH/n, where AH is the pore area and n is the number of peptide molecules 
constituting the pore. If we take the approximate pore size to be determined by the close packed 
arrangement of peptides at the pore boundary, then the outer diameter DH of a pore with n 
peptides and the area of the pore per peptide AH/n can both be calculated from 
ܦு ൌ ݊ ݀௉ߨ ൅ ݀௉ ,
ܣு
݊ ൌ
1
݊
ߨܦுଶ
4 ൌ
1
݊
ߨ݀௉ଶ
4 ቀ
݊
ߨ ൅ 1ቁ
ଶ
 (1) 
For a peptide diameter dp = 1.1 nm, the pore diameter DH estimated from eq.(4) will be about 3.9 
nm for n = 8.  Indeed, for alamethicin, Huang2 has estimated the number of peptides per pore to 
be 8 and the pore diameter of 3.9 nm.  For the purpose of our interpretive needs, we will consider 
two values for the number of peptides in the pore, n = 8, 20 corresponding to which the pore 
diameters will be 3.9 nm and 4.6 nm and pore area per peptide AH/n will be 1.494 and 1.663 
nm2/peptide. 
On the addition of peptide to the bilayer, lipid molecules are removed from a fraction λ of 
the bilayer area and replaced either by pores or inserted peptides or peptide clusters. The number 
of lipid molecules removed will be 2λA/aL, with the factor 2 accounting for the two layers of the 
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bilayer.  The 2λA/aL lipids removed will be replaced by λA/aP peptides if peptide or peptide 
clusters are inserted into the bilayer and by λA/(AH/n) peptides, if the peptides are part of pores.  
However, if the peptide adsorbs on the bilayer surface without any lipid removal, then each 
adsorbed peptide occupies an area Ap = dpLp (Lp being the length of the peptide, calculated from 
its molecular volume and assuming the peptide is a cylinder of 1.1. nm diameter) and the number 
of peptides adsorbed will be λA/Ap. The resulting frequency changes can be calculated as the 
areal mass change divided by C: 
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(2) 
In this equation MP and ML are molecular masses of the peptide and lipid molecule, respectively, 
calculated from their molecular weights. Setting the fractional area λ to be unity, we can 
calculate the theoretical maximum in the frequency change.   
References for Appendix 3 
 
(1) T.J. Zwang, W.R. Fletcher, T.J. Lane and M.S. Johal, (2010) Quantification of the layer of 
hydration of a supported lipid bilayer, Langmuir, 26,  4598-4601. 
(2) H.W. Huang, (2006) Molecular mechanism of antimicrobial peptides: The origin of 
cooperativity Biochim Biophys Acta, 1758, 1292–1302. 
 
  
227 
   
Appendix 4: Hydrophobicity scales 
A number of hydrophobicity scales are available in the literature to represent the 
properties of amino acids. The first scale was proposed by Nozaki and Tanford1 in 1971 based on 
free energies of transfer of amino-acid side chains from water to ethanol. Another is the scale of 
Wolfenden et al2 for the transfer of the amino acids from water to vapor. The scales of Chothia3 
and Janin4 are based on calculated free energy changes for the transfer of amino-acid side chains 
from the surface to the interior of a protein, based on the observed distribution (between surface 
and interior) of each residue type for globular proteins of known structure. von Heijne and 
Blomberg5, developed a scale based on the free energy changes associated with the transfer from 
aqueous to non-aqueous media of the amino-acid side chains including the effects of buried non-
polar atoms, removal of charges and decrease of hydrogen bonding during burial. These are 
among the earliest developments of hydrophobicity scales.  
In the 90s, White and coworkers6-8 proposed additional hydrophobicity scales, composed 
of experimentally determined transfer free energies for each amino acid. One corresponds to the 
transfer of unfolded chains from water to POPC bilayer interface and the other describes the 
transfer of folded chains into an n-octanol interior. These scales include the contributions of the 
peptide bonds and not just side chains and thus represent whole-residues. The experimental 
values have been obtained using host-guest pentapeptides. 
A different type of hydrophobicity scale was developed by Urry9,10 based on the 
hydrophobic association between peptides. The elastic model protein, (GVGVP)n in aqueous 
medium undergoes reversible phase transition on raising the temperature, with the hydrophobic 
residues going from water to a state of hydrophobic association.  To determine the 
hydrophobicity of an amino acid X, the amino acid was included as a guest within the host 
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protein in the form (GXGVP) replacing the residue V, and from the temperature and enthalpy 
change at the transition, the contribution of X to the hydrophobic association free energy was 
determined.    
A widely used hydrophobicity scale in the protein literature is that due to Eisenberg11-14. 
He developed a so-called “consensus scale” by averaging the normalized hydrophobicity for 
each residue over the five scales mentioned above1-5. 
All scales correspond to some sort of a free energy value and have units of kcal/mol, 
although the units are not needed and the numerical values are just used as measures of 
hydrophobicity for comparison purposes.  Five different scales are listed on Table S1.  As one 
can expect, the numerical values in the different scales differ from one another and therefore one 
should use a given scale consistently for calculating the hydrophobicity of an amino acid 
sequence. 
One may expect the different hydrophobicity scales to have some correlation between 
one another.  Figure S2 shows the relations between five different scales.  Once can observe 
some correlation as well as deviations.  The deviations clearly reflect the different basis on which 
the hydrophobicity values are derived and how the side chains and peptide bonds may contribute 
differently in each experimental method. 
For the four peptides studied in this paper, the hydrophobicity was calculated and plotted 
in Figure S3 based on the Urry scale and Figure S4 based on the Eisenberg consensus scale. In 
calculating for alamethicin, for the unnatural amino acid aminoisobutyric acid, the values are 
taken to be the average of alanine and valine; for phenylalaninol, the values are taken to be those 
for phenylalanine. 
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Table A4.1: Examples of Hydrophobicity Scales from Literature 
Amino Acid 
Designation 
Hydrophobicity Scales 
Urry–Phase 
Transition 
Tanford–
Ethanol 
Eisenberg-
Consensus 
White-
Interface 
White-
Octanol 
W Trp -7.00 6.50 0.81 -1.85 -2.09 
F Phe -6.15 5.00 1.20 -1.13 -1.71 
Y Tyr -5.85 4.50 0.26 -0.94 -0.71 
L Leu -4.05 3.50 1.10 -0.56 -1.25 
I Ile -3.65 5.00 1.40 -0.31 -1.12 
V Val -2.50 3.00 1.10 0.07 -0.46 
M Met -1.50 2.50 0.64 -0.23 -0.67 
H+ His+ -1.90 1.00 -0.40 0.96 2.33 
C Cys -1.90 0.00 0.29 -0.24 -0.02 
P Pro -1.10 1.50 0.12 0.45 0.14 
A Ala -0.75 1.00 0.62 0.17 0.50 
T Thr -0.60 0.50 -0.05 0.14 0.25 
N Asn -0.05 -1.50 -0.78 0.42 0.85 
G Gly 0.00 0.00 0.48 0.01 1.15 
S Ser 0.55 -0.50 -0.18 0.13 0.46 
R Arg 0.80 nd* -2.50 0.81 1.81 
Q Gln 0.75 -1.00 -0.85 0.58 0.77 
D- Asp 3.40 nd -0.90 1.23 3.64 
K+ Lys 2.94 nd -1.50 0.99 2.80 
E- Glu 3.72 nd -0.74 2.02 3.63 
 
*nd indicates the value was not determined 
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Figure A4.1. Correlation among different hydrophobicity scales 
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Figure A4.2. Hydrophobicity of peptides based on Urry hydrophobicity scale 
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Figure A4.3. Hydrophobicity of peptides based on Eisenberg consensus scale 
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